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Summary 
Originally established as an analytical technique in the fields of physics and 
chemistry, mass spectrometry has recently become an essential tool in biological 
research.  Advances in ionisation methods and novel types of instrumentation have 
led to the development of mass spectrometry for the analysis of a wide variety of 
biological samples.  The work presented here describes the use of mass spectrometry 
to characterise a variety of synthetic and natural macromolecules. 
 
Transmissible spongiform encephalopathies (TSEs), also known as prion diseases, 
are a class of fatal, infectious neurodegenerative diseases that affect both humans 
and animals.  Prion proteins are unprecedented infectious pathogens that cause a 
group of invariably fatal neurodegenerative diseases by means of an entirely novel 
mechanism.  Ion mobility mass spectrometry (IM-MS) was used to probe the 
conformation of a variety of different prion proteins in the gas-phase.  It was shown 
that IM-MS could distinguish between two recombinant structures representative of 
normal cellular prion protein, PrPC and the pathogenic scrapie form (PrPSc).  The 
structure of the full-length prion protein was probed by means of IM-MS.  A 
comparison of the estimated cross-sections of truncated prion protein constructs and 
full-length constructs suggested that the N-terminal flexible tail was associated with 
the core structure.  Metal binding to two different prion protein constructs was 
investigated.  It was observed that copper coordination to the N-terminal fragment 
could induce conformational changes in the octarepeat fragment.  These changes 
were relatively small and could not be measured in the full-length prion protein.  The 
data suggested that minor structural changes in the N-terminal could stimulate 
endocytosis via a minor, undetected, conformational change in the C-terminal 
domain.   
 
IM-MS was used as a high resolution separation technique to distinguish between 
mixtures of isobaric synthetic polymers.  It was observed that the resolving power of 
IM-MS/MS was insufficient to resolve the higher molecular weight oligomers.  In 
comparison, gel permeation chromatography (GPC)-nuclear magnetic resonance 
(NMR) spectroscopy (GPC-NMR) analysis of the same isobaric mixture could not 
separate the two components.  It was observed that IM-MS was better than GPC-
NMR at separating isobaric poly(ethylene glycol) mixtures, especially when taking 
speed and sensitivity into account.   
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Introduction to Mass Spectrometry 
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1.1 Foundations of mass spectrometry 
The ability to make precise mass measurements is fundamental to all scientific 
investigations.  The use of scales to measure the weight of an object was first 
depicted in the hieroglyphics of the ancient Egyptians.  Since this initial description 
there has been a considerable advance in the design and use of scales and balances in 
daily life and within the scientific community.  Mass spectrometry is an elegant 
example of the progress that has been made in the measurement of mass. 
 
During the latter half of the nineteenth century, aided by the development of 
increasingly reliable vacuum pumps, chemists and physicists in various European 
countries endeavoured to understand the nature of electrical discharges through 
rarefied gases.  In 1876 Eugene Goldstein extended the studies of Johann Wilhelm 
Hittorf (who described experiments on discharges in gases at low pressures) and was 
the first person to use the term cathode rays.  The nature of these cathode rays 
remained unclear.  It was initially believed that the rays were either atoms or 
molecules that had picked up a charge.  Goldstein, however, demonstrated that the 
cathode rays could travel in a straight line over distances far greater than the mean 
free paths of atomic and molecular species.  Consequently, he and others considered 
that the rays were electromagnetic in nature (Jennings 2009). 
 
Years later the cathode ray problem was eventually resolved by Joseph John (J. J.) 
Thomson.  He showed that cathode rays were composed of particles which, in 
relation to the hydrogen atom, had a charge to mass ratio of approximately 1/1800.  
These particles were named electrons.  In 1906 J. J. Thomson was awarded the 
Nobel Prize for Physics for his theoretical and experimental investigations on the 
conduction of electricity by gases.  His pioneering work leading to the discovery of 
the electron (Thomson 1899) led to the creation of the first mass spectrometer, called 
a parabola spectrograph.  This new technology allowed Thomson to separate the 
isotopes of neon (Thomson 1911); the first observation of non-radioactive isotopes.  
Francis W. Aston inspired by the discoveries and work of Thomson designed and 
built a new mass spectrometer.  This new instrument had improved resolution which 
could discriminate between the isotopes in lighter elements such as neon and 
chlorine (Aston 1919a; Aston 1919b; Aston 1920).  Aston was awarded the 
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Chemistry Nobel prize in 1922 and eventually discovered over 200 non-radioactive 
isotopes after building an improved instrument in 1927. 
 
Mass spectrometry has been transformed since the initial studies of J. J. Thomson.  
The technique has experienced crucial developments in ionisation methods; it has 
been coupled to other separation techniques including gas chromatography, liquid 
chromatography and, of important relevance to this thesis, ion mobility 
spectrometry.  The recent developments in mass spectrometry have led to entirely 
new instrument designs and applications.  It is now considered an essential analytical 
tool for chemists and structural biologists alike.   
 
1.2 What is a mass spectrometer? 
Mass spectrometry (MS) is a powerful analytical technique that offers both high 
selectivity and sensitivity.  A mass spectrometer is a device that can measure the 
mass-to-charge ratio (m/z) of an ion in the gas phase.  This is achieved by ionising 
the sample, separating these ions according to their m/z and subsequently detecting 
and recording their relative abundance.  Figure 1.1 shows a schematic of the four 
essential components within a modern mass spectrometer: sample 
introduction/ionisation, mass analysis, ion detection and a computer system.  The 
analyte is introduced into the mass spectrometer and ionised in the ion source.  These 
ions are resolved in the mass analyser according to their m/z.  A detector registers the 
ions at each value of m/z and a computer system records the resulting data and 
presents it in an accessible format.  Variations in each of the component parts of the 
instrument give rise to a wide range of types   of mass spectrometer.  
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Figure 1.1:  Schematic block diagram of a mass spectrometer. 
 
Mass spectrometers and MS-based techniques are used throughout the industrial 
world to analyse and identify a variety of different substances.  These include 
flavours, fragrances, natural products, pollutants, synthetic polymers, 
pharmaceuticals and metabolites (de Hoffmann and Stroobant 2007).  The invention 
and application of soft ionisation techniques such as matrix-assisted laser desorption 
ionisation (MALDI) and electrospray ionisation (ESI) have allowed significant 
improvements, and progress, to be made in biochemical MS research.  These 
ionisation methods allow large, polar and thermally liable bio-molecules to be 
characterised by means of MS.   
 
1.3 Ionisation 
Various ionisation techniques can be employed in mass spectrometry analysis.  In 
the early 1980s the ionisation methods of choice were electron impact (EI), chemical 
ionisation (CI) and fast atom bombardment (FAB).  The EI and CI methods require 
the analyte to be in the gas-phase.  These ionisation methods are therefore limited to 
the analysis of thermally stable and volatile compounds.  Electron impact ionisation 
is widely used to characterise small organic molecules.  EI produces M+. ions with 
significant internal energy that can induce fragmentation.  In contrast, CI is a 
technique that produces MH+ ions with lower internal energy.  The amount of 
internal energy can, to some extent, be controlled by the careful choice of the reagent 
ion.  The CI ionisation method produces mass spectra that contain fewer fragment 
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5 
 
ions than the corresponding EI mass spectrum.  Consequently, the two ionisation 
methods (EI and CI) can provide complementary information.   
 
In general, biological samples such as proteins are polar and thermally liable.  This 
implies that, without prior derivatisation of the sample, ionisation methods such as 
EI and CI are not suitable to characterise biological samples.  The invention of the 
FAB source in 1981 (Barber, Bordoli et al. 1981) allowed, for the first time, routine 
MS analysis of polar thermally liable molecules that were up to a few thousand 
Dalton (Da) in mass.  In contrast to the gas-phase ionisation methods, FAB requires 
the sample to be dissolved in a non-volatile liquid matrix such as glycerol or m-
nitrobenzylic alcohol.  The technique is based on accelerated argon atoms 
bombarding the surface of a sample:matrix solution to produce ions.  These newly 
formed ions are passed into the mass analyser and then detected.  In the 1980s the 
advantage of the FAB method was that it could produce ions from high molecular 
weight polar compounds (up to 5000 Da) (El-Aneed, Cohen et al. 2009).  The 
disadvantage of this technology was the need to use a matrix.  The presence of 
matrix-associated chemical noise could often mask the signal of sample ions.  This 
made interpretation of the sample mass spectrum extremely difficult.  The use of 
FAB as the ionisation method of choice for non-volatile and biological samples has 
been superseded by MALDI and ESI.   
 
1.3.1 Matrix assisted laser desorption/ionisation (MALDI) 
MALDI is a soft pulsed ionisation technique.  The principal mechanism for MALDI 
was developed by Karas and co-workers in 1988 (Karas and Hillenkamp 1988).  In 
1985, however, Koichi Tanaka discovered soft laser desorption (SLD) and later filed 
a patent for his work as a new ionisation method for use in mass spectrometry.  In 
2002, Tanaka and John Fenn (the latter invented ESI) were awarded the Nobel Prize 
in Chemistry for their development of soft desorption ionisation methods for mass 
spectrometric analyses of biological macromolecules.  It is, however, the work of 
Karas and Hillenkamp that established MALDI as an essential ionisation process for 
mass spectrometry analysis. 
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The MALDI technique is based on the sample being mixed with a solvent that is 
saturated with an organic matrix.  The matrix must be able to form a solution with 
the sample but also contain a chromophore that can absorb radiation at the 
wavelength of a laser.  The matrix must absorb the laser pulse very strongly and act 
as a proton donor to help the formation of the MH+ ions (in most cases).  The matrix 
is also essential to protect, dilute and isolate analyte molecules from one another by 
the formation of a solid solution upon evaporation of the solvent (Karas, Glückmann 
et al. 2000).  In addition, the solid-solution matrix can shield the analyte from the 
direct laser ablation and absorb any excess energy.  The choice of matrix depends on 
the properties of the analyte.  Aromatic acids with an unsaturated substituent, that 
conjugates with the ring, are good matrix candidates because of their absorption 
characteristics.  For example the most common matrices chosen to aid ionisation are 
α-cyano-4-hydroxycinnamic acid (CHCA) for peptide analysis, sinapinic acid (3,5-
dimethoxy-4-hydrocinnamic acid) is used for protein characterisation and DCTB 
(trans-2-3-(4-tert-butylphenyl)-2-methyl-(2-propenylidene)-malononitrile) is 
commonly employed to analyse synthetic polymers.  Alkali and transition metal salts 
are also added to the DCTB matrix to aid the cationisation of synthetic polymers.  
The analyte:matrix:salt mixture is subsequently spotted onto a stainless steel MALDI 
plate and allowed to dry.  The solvent evaporation can produce a crystal that contains 
a homogenous dispersion of analyte and matrix molecules.  The crystal is ablated 
with short pulses of a nitrogen laser at wavelength 337 nm.  The irradiation from the 
laser is absorbed by the matrix molecules which cause them to vibrate.  As a 
consequence, the analyte:matrix lattice disintegrates and a plume of desorbed and 
ionised molecules is generated.  The proposed ion formation process is summarised 
in Figure 1.2.  
 
Several hypotheses have been outlined to explain the MALDI ionisation process 
(Zenobi and Knochenmuss 1998).  The most widely accepted theory is the ion 
formation mechanism.  In this mechanism it is proposed that, in the gas-phase, 
protons are transferred from the energetically excited matrix molecules to the analyte 
whilst in the desorption plume (see Figure 1.2).  Singly charged species resulting 
from the attachment of a proton (or cation in the presence of an alkali/transition 
metal salt) are the most commonly formed MALDI ion species.  Another ion 
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formation mechanism proposed by Karas and co-workers is the “lucky-survivor” 
model (Karas, Glückmann et al. 2000).  The “lucky-survivor” theory states that large 
charged analyte:matrix clusters are formed in the initial laser ablation.  These highly 
charged clusters cannot survive in the plume and instantly undergo charge reduction, 
via neutralisation reactions from electrons trapped in the matrix, to generate charge 
states +1 and 0.  The singly charged ions are the only ions that have a sufficiently 
low neutralisation cross-section to survive in the desorption plume (Karas, 
Glückmann et al. 2000).   
 
Figure 1.2:  Schematic representation of the proposed MALDI ionisation process.   
 
1.3.2 Electrospray ionisation (ESI) 
In contrast to the pulsed laser ablation mechanism of MALDI, ESI is a continuous 
ionisation process.  The technique requires the sample to be dissolved in a suitable 
aqueous/organic solvent system prior to the solution being sprayed into the ion 
source.  The particular solvent system that is used is dependant on the compound 
class and the ionisation mode required (i.e. positive or negative ion mode).  For 
example, positive ion mode ESI-MS analysis requires a sample to be dissolved in an 
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aqueous solution that contains varying concentrations of organic solvent (such as 
methanol or acetonitrile) and acid.  This solution can contain a mixture of single- or 
multiply- protonated sample molecules.  The solution is then sprayed through a 
capillary needle.  The capillary needle is held at a high electrical potential with 
respect to the entrance of the mass spectrometer.  This electric field induces a charge 
accumulation at the liquid surface, located at the end of the capillary, to form a 
Taylor cone.  At a critical point the liquid breaks away, from the tip of the Taylor 
cone, to form highly charged droplets.  The creation of a Taylor cone reduces the 
charge-to-surface ratio of the newly formed droplet.  The droplet’s release is 
facilitated by a nebulising gas (usually nitrogen) which flows around the outside of 
the capillary and directs the droplet towards the mass spectrometer.  There are two 
proposed mechanisms that describe the production of gas-phase ions from aqueous 
charged droplets; these are the ion evaporation model (IEM) and the charge residue 
model (CRM) (see Figure 1.3).  The IEM suggests that once airborne, the charge 
repulsion in the droplet can exceed the surface tension (known as the Rayleigh limit) 
and the solvent molecules evaporate.  The reduction in droplet size increases the 
surface charge density and therefore increases the charge repulsion forces 
(Coulombic forces).  This charge repulsion creates a Coulombic explosion which 
causes the droplet to divide.  Ions within these newly formed droplets are desorbed 
into the gas-phase and enter the mass spectrometer.  It is believed that ions with a 
relatively low m/z value are preferentially formed by means of this mechanism 
(Kebarle 2000).  In contrast, the CRM suggests that once airborne the charge 
repulsion in the droplet can exceed the Rayleigh limit; solvent molecules evaporate 
and the droplet can fragment by means of a Coulombic explosion.  This process is 
continuously repeated until a single, multiply-charged, analyte ion is produced.  It 
has been suggested that the CRM is the dominant mechanism for multiply charged 
ions at a high m/z ratio (Kebarle 2000).  Figure 1.3 illustrates the two proposed 
mechanisms of the ion formation within the ESI process.  The main advantage of 
ESI is that for instruments of limited m/z range the multiple charges allow one to 
observe ions of a higher mass at lower m/z values.  This permits mass spectrometer 
systems which have limited m/z range analysers to characterise higher molecular 
weight materials.   
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Figure 1.3:  Schematic representation of the two proposed ESI ionisation mechanisms.  Adapted from (Kebarle 2000)  
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1.4 Mass analysers 
Once ions have been produced, in the ion source, they are separated according to 
their m/z ratio in the mass analyser.  There are many different types of mass analyser 
but, in general, analysers can be classified as those that can scan, detecting ions of 
each m/z in turn, and those that detect ions of all m/z simultaneously.  A scanning 
mass analyser, such as a quadrupole or magnetic sector, can successively detect ions 
of different m/z over a period of time.  In contrast, analysers such as the time-of-
flight (ToF) mass analyser, the ion trap and the ion cyclotron resonance instrument, 
allow the simultaneous detection of all ions.  All mass analysers share three main 
characteristics: an upper mass limit, transmission efficiency and resolving power.  
The upper mass limit determines the highest m/z value that can be measured.  The 
transmission efficiency is defined by the ratio of the number of ions that reach the 
detector and the number of ions that are produced in the ion source.  The resolving 
power of a mass analyser is described as its ability to distinguish between two 
adjacent ions that are of similar mass.  Conventional MS resolution is defined as 
(m/∆m) at a certain m/z ratio with the value calculated at full-width half-height 
maximum (FWHM) of the peak. 
 
1.4.1 Quadrupole mass analyser 
The principle of the quadrupole mass analyser was first described by Paul and 
Steinwedel in 1953 (Paul and Steinwedel 1953).  The analyser consists of four 
parallel rods that are circular or hyperbolic in cross-section.  These rods are arranged 
as two pairs of electrically connected rods.  A combination of direct current (DC) 
and alternating radio frequency (RF) potentials are applied to each pair of rods.  This 
produces a complex oscillating motion of ions as they transverse the mass analyser.  
These oscillating electric potentials can focus the trajectory of the ions towards the 
centre of the quadrupole mass analyser.  The motion of the ions depends on the 
electric field they experience.  If the quadrupole mass analyser is operated in 
scanning mode, (both DC and RF voltages are applied to the rods) ions of a specific 
m/z value will have a stable trajectory.  This will allow their passage through the 
analyser and into the detector.  The remaining ions, of different m/z values, will 
either collide into the four parallel rods or be lost at the walls of the analyser.  If 
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suitable RF voltages are applied to all four parallel rods, all ions will have a stable 
trajectory and can successfully pass through the mass analyser to be detected.  A 
variety of multipole mass filters have been developed based on the quadrupole RF-
only method.  These include a hexapole (six parallel rods) and an octapole (eight 
parallel rods).  The multipole mass filter device is often placed in series with other 
mass analysers.   
 
1.4.2 Time-of-Flight (ToF) mass analyser 
The first commercial linear ToF instrument was based on the concepts and designs 
of Wiley and Mc Laren in 1955 (Wiley and McLaren 1955).  The ToF mass analyser 
is classified as a simultaneous transmission device.  It measures the m/z of an ion 
according to the time it takes to transverse a field-free region.  The ToF analyser 
requires the ions to be produced in bundles and is therefore the ideal mass analyser 
for pulsed ion sources such as MALDI.  These ion bundles are accelerated by a 
potential (Vs) which provides each ion with a fixed amount of initial kinetic energy.  
After acceleration the ions enter a field-free region, known as the flight tube, where 
they travel a distance (d) at a velocity inversely proportional to the square root of 
their mass (see Equation 1.4).  The m/z ratio can be calculated by measuring the time 
it takes an ion to transverse the flight tube from the ion source to the detector.  An 
ion with a mass (m) and a total charge (q = ze) has a kinetic energy. 
 
2    	
    
Equation 1.1 
where v is velocity, Vs is the applied potential, z is the number of charges, e is the 
electronic charge.  The time taken to transverse the flight tube is given by. 
   
Equation 1.2 
Replacing v with its value from Equation 1.1 gives. 
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Equation 1.3 
Rearranging Equation 1.3 assuming v is a constant gives. 
   	    
Equation 1.4 
 
Equation 1.4 suggests that the m/z can be calculated from measuring the time (de 
Hoffmann and Stroobant 2007).  The general concept of the ToF mass analyser is 
that the larger the mass of an ion the longer the time required for it to transverse the 
flight tube. 
 
The advantage of a linear ToF mass analyser is high sensitivity and high mass range.  
In principle, the mass range does not have an upper mass limit.  The major 
disadvantage of the linear ToF is the poor resolution.  Factors such as the length of 
the flight tube, the volume of space where the ions are formed and the variation of 
initial kinetic energy of the individual ions, can all affect the resolving power.  Ions 
with the same m/z ratio but with different initial kinetic energies will transverse the 
flight tube at different velocities.  This will result in each ion reaching the detector at 
a slightly different time which can create a broad ion peak.  This peak broadening 
phenomena can be reduced by means of delayed pulsed extraction (Vestal, Juhasz et 
al. 1995).  An extraction pulse is applied to the ions after a certain time delay 
(ranging from hundreds of nanoseconds to several microseconds) (de Hoffmann and 
Stroobant 2007).  As a result, more kinetic energy is transferred to ions that have 
remained in the ion source compared to ions that are further away from the ion 
source.  The delayed pulse extraction technique attempts to balance the initial kinetic 
energy within a bundle of ions, reducing peak broadening at the detector.    
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Mass resolution is also proportional to ion flight time.  The longer the flight tube, in 
theory, the better the resolution.  Modern ToF instruments achieve higher mass 
resolution by means of a reflectron.  The reflectron is composed of a series of ring 
electrodes (Mamyrin, Karataev et al. 1973).  These electrodes are an optic device 
that can act as an electrostatic ion mirror.  The reflectron can reflect ions back down 
the flight tube which effectively doubles their flight path (see Figure 1.4).  Ions with 
higher initial kinetic energy can travel further into the reflectron ring electrodes than 
ions with less initial energy.  Ions with the same m/z value but different initial kinetic 
energy should reach the detector at the same time.  Figure 1.4 shows a schematic 
representation of the reflectron mechanism.  A compromise is made when employing 
an ion reflectron.  Although the mass resolution of the ions will be improved, there is 
a potential loss in sensitivity and a reduction in the upper mass limits that can be 
measured. 
 
Figure 1.4:  Schematic representation of a ToF mass analyser equipped with a reflectron.  
Both ions have the same mass but different initial kinetic energies.  The ion with the highest 
initial kinetic energy (blue) will travel further into the reflectron in comparison to the ion 
with less initial kinetic energy (red).  Both ions will reach the detector simultaneously.   
  
Ion source
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Ion with high initial kinetic energy
Ion with low initial kinetic energy
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1.5 Detectors 
A variety of different mass spectrometer detectors can be employed.  The method is 
based on detecting an ion beam from the mass analyser and transforming this 
information into a usable signal.  Detectors can be classified into one of two 
categories.  These are direct measurement, such as a Faraday cage, which measure 
the direct charge that reaches the detector, or detectors that increase the intensity of 
the signal, such as electron- or photon-multipliers and array detectors (de Hoffmann 
and Stroobant 2007).    
 
The electron and photon multiplier detectors are based on an ion (positive or 
negative) colliding with a plate (conversion dynode) to create an emission of 
secondary electrons.  These newly generated electrons are accelerated so that they 
collide with a continuous-dynode.  These collisions create enough energy to dislodge 
more electrons from successive dynodes.  This process is repeated until a cascade of 
electrons is produced which generates an electrical current.  The electric current is 
passed through a resistor to generate a voltage that can then be amplified.  In this 
approach an amplification of up to 107, of the original signal, can be obtained (de 
Hoffmann and Stroobant 2007).   
 
An array detector, such as microchannel plate (MCP) detector, contains an array of 
parallel miniature electron multiplier channels which are typically placed at an 8° 
angle to the surface of the plate (Wiza 1979) (see Figure 1.5).  The internal diameter 
of the electron multiplier channel is coated with a semi-conducting material.  Upon 
the ion beam colliding with the semi-conductive material secondary electrons are 
emitted.  In a similar mechanism to the electron multiplier, a cascade of newly 
generated electrons is created and the number of electrons can be amplified by 105 – 
108 (de Hoffmann and Stroobant 2007).  A single ion reaching the MCP detector will 
affect a few channels only; therefore the multiple channels can detect several 
different ions simultaneously.  Figure 1.5 shows a schematic representation of an 
electron multiplier channel.  Great care needs to be taken not to saturate the MCP 
detector with ion signals because the channels must have time to recover (dead time) 
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before they can detect new signals.  If the MCP detector becomes saturated with a 
large signal, it will not be able to detect any smaller signal which may follow directly 
afterwards.  The array detector is ideally suited to ionisation methods such as 
MALDI and ESI which can produce hundreds of ions that must be analysed 
simultaneously.   
 
 
Figure 1.5:  Schematic representation of an array plate and the electron multiplication 
within one of the channels.  Adapted from (de Hoffmann and Stroobant 2007). 
 
In modern mass spectrometry the most commonly used detector is either an analog-
to-digital (ADC) or a time-to-digital (TDC) detector.  Both ACD and TDC detectors 
use a multiplier, such as a MCP detector, as a first stage.  An ADC detector registers 
the ion current produced from the mass analyser, amplifies the signal and removes 
high frequency noise using a filter.  The voltage derived from the ion current is then 
plotted on a m/z scale with respect to previously acquired calibrated data.  In 
contrast, a TDC detector records the time at which an ion strikes the detector and 
sums the signal from all individual acquisitions to create the observed mass spectrum 
(de Hoffmann and Stroobant 2007).  TCD detectors have the advantage of greater 
speed of detection, whereas ADC detectors have an improved dynamic range. 
Array plate
Electron multiplier channel
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1.6 Tandem mass spectrometry 
To perform tandem mass spectrometry (MS/MS) at least two mass analysis steps are 
required.  Common configurations of instrumentation include the hybrid Q-ToF 
(quadrupole mass analyser coupled to a ToF instrument), ToF-ToF mass analysers 
and the triple quadrupole (QQQ) mass analyser.  MS/MS experiments can take place 
in either time (Iontrap, Orbitrap, Fourier transform ion cyclotron resonance (FT-ICR-
MS)) or in space (Q-ToF, ToF-ToF, QQQ).  In time MS/MS experiments are 
performed by a sequence of events within an ion storage device whereas at least two 
physically distinct mass analysers are required to conduct in space experiments.  
Both methods require the fragmentation of a selected ion (precursor ion) within the 
first mass analyser to allow the second mass analyser to characterise the fragment 
ions (product ions) produced.   
 
In the 1960s Jennings (Jennings 1968) and McLafferty (McLafferty and Bryce 1967) 
pioneered collision-induced dissociation (CID).  This technique is based on a 
precursor ion colliding with an inert gas.  The translational energy from the 
collisions is converted into internal energy which is rapidly distributed throughout 
the ion.  Consecutive collisions increase the internal energy to induce fragmentation.  
Interpretation of the resulting product ion mass spectrum can determine sequence 
and/or structural information about the precursor ion.  The production of peptide 
fragment ions by means of CID has been well characterised.  The nomenclature to 
describe the product ions was proposed by Roepstorff, Fohlmann and extended by 
Biemann (Biemann 1992; Roepstorff and Fohlman 1984).  The fragmentation 
pathway of particular synthetic polymer systems is described in Chapter 6 and 7.   
 
A different and nonergodic process, namely electron capture dissociation (ECD), can 
also be used to achieve the fragmentation of peptides and certain types of synthetic 
polymers (Cerda, Horn et al. 1999; Syka, Coon et al. 2004).  The production of 
fragment ions by means of ECD is, however, limited to the use in FT-ICR-MS 
instruments.  Complementary to this technique is electron transfer dissociation 
(ETD).  The mechanisms of reactions initiated by ETD are not well understood and 
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several different processes resulting from an initial electron transfer or proton 
abstraction can occur.  The ECD and ETD mechanisms have been extensively used 
to investigate the position of post translation modifications (PTMs) (Mehlhorn, 
Groth et al. 1996).  In contrast to CID, ECD and ETD are site-specific reactions; 
fragmentation occurs along the peptide backbone and leaves little excess energy for 
further fragmentation such as PTM loss.  In general, CID sensitivity is much higher 
than that obtained from ECD and ETD.   
 
1.7 Ion mobility mass spectrometry 
Ion mobility spectrometry (IMS) is a well-established analytical technique that is 
used throughout the industrial world to characterise explosives, drugs and chemical 
welfare agents.  Invented in the 1970s IMS, also known as plasma chromatography 
or ion chromatography, is a technique that separates ions based on their mobility 
through an inert gas (Cohen and Karasek 1970; Karasek 1974).  In the constraints of 
a drift tube, the ions migrate through a counter flowing buffer gas under the 
influence of a weak electric field.  A constant electric field (E), produced by a series 
of ring electrodes, propels the ions through the drift tube whilst collisions with the 
buffer gas decelerate the motion of these ions.  This process creates a quasi-constant 
velocity vd.  The ions collide with the buffer gas and separation occurs according to 
their mass, charge and shape.  Compact ions with small collision cross-sections will 
drift more quickly than extended ions.  The measurement of this mobility yields 
information about the rotationally-averaged cross-section of each ion (i.e. whether it 
is compact or extended).  The ion mobility K is the ratio of vd to the electric field 
strength E. 
     
Equation 1.5 
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The ion mobility is expressed as the reduced mobility (K0) of an ion under standard 
temperature T0 and pressure P0 (T0 273 K and P0 760 Torr). 
        273  760 
Equation 1.6 
Using kinetic theory (Mason and McDaniel 1988) the reduced mobility K0 can be 
related to the collision cross-section of the ion species by means of the following 
equation. 
   3	
16#    1$ % 2&'() 
Equation 1.7 
where z is the number of charges, e is the electronic charge, N0 the buffer gas 
number density at standard temperature and pressure, σ is the average collision 
integral or collision cross-section, µ the reduced mass of the buffer gas and ion, kB is 
the Boltzmann constant and T is the effective temperature.   
 
The average collision cross-section can be obtained from the average of all possible 
collision geometries (Clemmer and Jarrold 1997).  Several models have been 
proposed to calculate the exact average collision cross-section.  The simplest method 
is the projection approximation (PA) which replaces the cross-section of an ion with 
its projection (shadow) and averages the projections created by every orientation of 
the ion.  The PA is an adequate approximation for small molecules but can 
underestimate the cross-section of proteins when interactions with the buffer gas 
become important (Scarff, Thalassinos et al. 2008).  The trajectory method (TM) 
gives the most reliable estimate, incorporating all interactions, but is computationally 
intense.  A compromise is to use a third model, the exact hard sphere scattering 
(EHSS) method. This ignores electrostatic interactions so requires substantially less 
computational time, and can calculate cross-sections to within a few percent of 
values obtained by the TM (Jarrold 1998).  
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1.7.1 Instrumentation 
Two different types of ion mobility instrumentation have been developed; travelling 
wave (T-Wave) ion mobility and drift-cell ion mobility (DCIM) mass spectrometry.  
Both techniques can be coupled to a range of ion sources, such as ESI and MALDI, 
and mass analysers.  Different configurations of mass analysers have been used to 
perform mass analysis including quadrupole mass analysers (Shelimov, Clemmer et 
al. 1997a), ToF mass analysers (Srebalus, Li et al. 1999) and FT-ICR spectrometers 
(Bluhm, Gillig et al. 2000).   
 
To date, the majority of DCIM-MS instruments have been designed, developed and 
built in-house.  The number of these instruments is limited because of the 
mechanical, electrical, engineering and software expertise required to build each 
instrument.  Recently, however, a DCIM device has been incorporated into a 
commercial instrument (McCullough, Kalapothakis et al. 2008) and a drift cell was 
added into a commercial Q-ToF hybrid instrument (Thalassinos, Slade et al. 2004).  
This instrument benefited from the ability of the ToF mass analyser to acquire mass 
spectra on a time scale significantly faster (microseconds) than the time required for 
mobility separation (milliseconds).  The ToF mass analyser allowed a large number 
of mass spectra, typically 200, to be obtained during a single mobility separation.  
The DCIM-MS approach has been used to study a variety of different compounds 
including carbon clusters (von Helden, Hsu et al. 1991; von Helden, Hsu et al. 2002), 
synthetic polymers (Gidden, Bowers et al. 2002; Gidden, Jackson et al. 1999; 
Gidden, Wyttenbach et al. 1999; Gidden, Wyttenbach et al. 2000), proteins 
(Shelimov, Clemmer et al. 1997a; Wyttenbach, von Helden et al. 1996) and peptides 
(Kaleta and Jarrold 2003).  von Helden and co-workers describe a method in which 
the theoretical cross-section of a molecule can be related to its equivalent 
experimental value (von Helden, Wyttenbach et al. 1995).  Their approach involves 
the use of molecular mechanics/dynamics calculations to generate three-dimensional 
structures which can be minimised, by means of specific programs (Wyttenbach, 
Helden et al. 1997).  These programs can determine the lowest-energy conformations 
and so calculate their respective theoretical cross-sections.  The calculations have 
been shown to be in excellent agreement with experimental data (Wyttenbach, von 
Helden et al. 1996).   
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In contrast to DCIM, T-Wave technology uses a series of transient DC voltages to 
propel ions through a stacked-ring ion guide.  RF voltages are applied to consecutive 
ring electrodes to stabilise the trajectory of the ions (Pringle, Giles et al. 2007a).  The 
electrodes in the stacked-ring ion guide are arranged orthogonally to the ion 
transmission axis.  Opposite RF phases are applied to alternating adjacent rings to 
create a radially-confining effective potential barrier.  This reduces ion loss by 
diffusion.  Figure 1.6 shows a schematic representation of the stacked-ring ion guide.  
Ions are propelled through the stacked-ring ion guide by a superimposed DC 
potential.  This DC potential moves across electrode pairs, the length of the stacked-
ring ion guide, at regular time intervals.  A stacked-ring ion guide that contains 61 
electrode pairs has a DC potential repeat pattern of six.  This suggests that a DC 
potential can be applied to the 1st and 7th pair of electrodes, then a pulse is applied to 
the 2nd and 8th pair of electrodes and so on across the electrode rings.  This pattern of 
pulsed DC voltages generates a sequence of travelling waves.   
Figure 1.6:  A schematic representation of the stacked ring ion guide region within a T-
Wave device. 
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T-Wave technology has been integrated into a Q-ToF instrument to create the 
commercially available Synapt HDMS system (Waters, Manchester, UK).  Figure 
1.7 shows a schematic of the Synapt instrument (Pringle, Giles et al. 2007a).  The 
instrument comprises three T-Wave enabled stacked ion guides: trap; IM cell and 
transfer region.  The trap and transfer regions are 100 mm long and consist of 31 
electrode pairs.  A DC-only potential is applied to the last pair of electrodes in the 
trap ion guide.  This voltage is periodically modulated to create an ion gate/packet 
prior to their entry into the IM cell.  The mobility cell is 185 mm long and contains 
61 electrode pairs.  The flow of buffer gas within the mobility cell can be optimised 
for each sample and a maximum pressure of 1 mbar can be sustained (Pringle, Giles 
et al. 2007a).  In contrast to the trap region, the transfer region has a T-Wave voltage 
applied to the stacked-ring ion electrodes.  This T-Wave voltage allows the ions that 
have been separated in the mobility cell to be carried through the transfer region and 
into the detector.  The orthogonal acceleration-ToF mass analyser acquisition time is 
synchronised with the gated release of ion packets from the trap region into the 
mobility cell.  These ion packets are released every 100 µs.  For each ion packet, 200 
orthogonal acceleration pushes (mass spectra) are measured by the ToF mass 
analyser.  This synchronisation allows both the arrival time distribution (ATD) 
information and mass spectral data to be obtained simultaneously.  The process is 
repeated until a mass spectrum with the desired signal-to-noise is obtained.  
 
The T-Wave device has a number of potential advantages when compared to DCIM 
approaches.  These include high sensitivity and the ability to collect mass spectra 
data and ATD information simultaneously.  Another advantage of the T-Wave 
device is that CID experiments can be performed in either or both of the trap and 
transfer region.  This allows a variety of different experiments to be performed.  The 
physical principles behind DCIM are well characterised and data obtained can be 
used to measure the absolute collision cross-section of an ion.  Mobility separation 
obtained by means of the T-Wave technology depends on a number of different 
variables including complex ion trajectories, collisions with the buffer gas and the 
time-dependent, non-uniform electric field of the T-Wave cell.  Due to these T-Wave 
features, absolute collision cross-sections of an ion cannot be obtained directly from 
mobility measurements.  In order to compare the results from the two mobility 
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techniques a calibration method for the T-Wave technology has been developed 
(Ruotolo, Benesch et al. 2008; Thalassinos, Grabenauer et al. 2009).  This 
calibration produces an estimated cross-section based on the measurement of the 
mobility of reference standards of known cross-sections obtained under similar 
experimental conditions. 
 
 
Figure 1.7:  Schematic representation of the Synapt.  (Inset). Enlargement of the T-Wave 
ion mobility device.  Adapted from (Pringle, Giles et al. 2007b). 
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1.7.2 T-Wave calibration 
Several approaches have been proposed to calibrate data obtained by means of the T-
Wave device (Ruotolo, Benesch et al. 2008; Thalassinos, Grabenauer et al. 2009).  
The majority of these calibration methods require the mobility measurement of 
known standards, by means of the T-Wave device, to create a calibration curve from 
which the estimated cross-section of unknown compounds can be derived.  A 
universal calibration method has yet to be established.  To create a successful 
calibration, standards of known absolute cross-sections obtained by means of a 
DCIM-MS are used (Clemmer; Valentine, Anderson et al. 1997; Valentine, 
Counterman et al. 1999).  The calibration method used throughout this body of work 
has been developed within the Scrivens research group (Thalassinos, Grabenauer et 
al. 2009; Thalassinos and Scrivens 2009) and is described below.   
1. Measure arrival time in scan (scan number (n)) 
2. Convert to time (multiply by pusher time) 
    *+,
- .
 /0 
Equation 1.8 
3. Correct for m/z independent time of flight 
The independent time of flight is related to the T-Wave velocity and is the time an 
ion spends in the mobility region (tm) and transfer region (tt).  The time is calculated 
for each ion electrode pair.  For example the mobility cell contains 61 electrode pairs 
therefore the independent time of flight of an ion in the mobility cell is 61  tm.  The 
transfer region contains 31 electrode pairs (31  tt).  The independent time an ion 
spends in the mobility cell and transfer region must be subtracted from the drift time 
(td).  At the wave velocity 300 m s
-1, the values for tm and tt are equal to 10 µs 
therefore [(61  10) + (31  10)] µs = 920 µs.  The corrected drift time (t’d) can be 
calculated from the following equation. 
1    2  920 
Equation 1.9 
4. Correct for m/z dependent time of flight 
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At 1000 m/z, the time taken for an ion to transverse the ToF mass analyser flight tube 
is 44 µs and the transit time from being expelled from the transfer region to the ToF 
mass analyser is 41 µs.  The addition of these two times is equal to 85 µs.  This value 
must be subtracted from the drift time.  The corrected effective drift time (t”d) is 
proportional to the square root of the m/z value. 
"   1 2 %  	⁄1000   0.085 
Equation 1.10 
5. Obtain calibration coefficients from published absolute cross-section data 
(σ).  Correct the published cross-section by taking into account the reduced 
mass and charge state.  Where e is the charge on the ion, mi is the mass of the 
ion and mn is the mass of the mobility gas.  
$1   $
 9 1: ;  1<=
 
Equation 1.11 
6. Plot σ’ against t”d. 
7. Fit appropriate curve to data points either a power series fit (y = AxB) or a 
linear series fit (when y = Ax + B). 
8. Calculate A and B from the gradient. 
9. Convert T-Wave experimental mobility data into estimated cross-sections by 
calculating either a power fit (Equation 1.12) or a linear fit (Equation 1.13). 
$   ")  >  
  % 1:  1< 
Equation 1.12 
$   ?/"  >0 ;  @A    
  % 1:  1< 
Equation 1.13 
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The T-Wave height, wave velocity and pressure of buffer gas within the mobility cell 
can all affect an ion’s ATD but these parameters do not affect the calibration.  It is 
therefore essential that data from the calibration standard is obtained under the same 
conditions as the unknown compound (Leary, Schenauer et al. 2009).  Figure 1.8 
shows a plot of the corrected effective drift time (t”d) vs the corrected published 
absolute cross-sections used to create a calibration.  A recent study showed that a 
valid T-Wave device calibration requires the corrected arrival times of the 
calibration standards to bracket those of the unknown sample (Shvartsburg and 
Smith 2008).  Furthermore, it was observed that a power series is appropriate for 
calibrating large compounds such as proteins whereas a linear relationship has been 
found to be more appropriate for smaller molecules such as peptides (Thalassinos, 
Grabenauer et al. 2009).    
 
 
Figure 1.8:  An example plot of the corrected effective drift time (t”d) of equine myoglobin 
vs the corrected published absolute cross-sections.  The power series fit is displayed.  This is 
the type of plot used in the T-Wave calibration. 
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1.8 Classical tools of structural biology  
The properties of a compound, in particular proteins, are largely determined by its 
structure.  The secondary structure, defined as the local conformation of the protein’s 
backbone and the tertiary structure, the three-dimensional fold of the protein, can be 
determined by means of a variety of biophysical techniques.  Techniques such as 
circular dichroism (CD) and infrared spectroscopy are used to characterise the 
secondary structure of proteins, whereas X-ray crystallography and nuclear magnetic 
resonance (NMR) spectroscopy are the classical biophysical methods used to 
determine the tertiary structure of a protein.  All of these techniques measure the 
population-average structure in solution and can provide complementary information 
to mass spectrometry data. 
 
1.8.1 Circular dichroism (CD) 
CD is recognised as a valuable technique for examining the structure of proteins in 
solution.  It is an absorption spectroscopy technique based on measuring the 
absorbance signal of circularly polarised light.  Plane polarised light consists of two 
circularly polarised light components of equal magnitude; one rotates in a counter-
clockwise direction (left handed) and the other in a clockwise direction (right 
handed).  CD refers to the differential absorption of these two components.  A CD 
signal is observed when an optically active chromophore is either chiral because of 
its structure, it is covalently linked to the chiral centre in the molecule or it is placed 
in an asymmetrical environment by virtue of the three-dimensional structure adopted 
by the molecule (Kelly, Jess et al. 2005).  The CD technique is based on measuring 
the difference in absorbance between the two circularly polarised components.   
 
Proteins and peptides are optically active because they possess two different types of 
asymmetry; configurational and conformational.  Amino acid residues, except 
glycine, have optical activity because of their intrinsic L-chirality about the α-carbon 
atom.  The secondary structure of proteins also contributes to the optical activity.  
The near-ultra violet (UV) CD region (wavelength 250-300 nm) detects the optical 
activity of aromatic side chains in phenylalanine, tyrosine and tryptophan.  In this 
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region the chromophores are sensitive to the overall tertiary structure of the protein.  
The secondary structure of a peptide or protein can be determined by means of far-
UV CD spectroscopy (wavelength < 250 nm).  The far-UV CD spectra of a protein 
can yield information about the asymmetric features of the amino acid backbone.  
Common types of secondary structure, adopted by peptides and proteins, give rise to 
distinctive features in a far-UV CD spectrum (see Figure 1.9).   
 
 
Figure 1.9:  Far-UV CD spectra associated with the various types of secondary structure.  
Solid line α-helix, dashed line β-sheet and dotted line random coil structure.  Taken from 
(Kelly, Jess et al. 2005). 
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Figure 1.9 shows a far-UV CD spectrum associated with various types of secondary 
structure.  An α-helical structural motif is characterised by two negative absorbance 
bands at ~222 nm and 208 nm and a positive band at 190 nm.  The far-UV CD 
spectrum of a β-sheet rich protein will have a negative band at 216 nm and a random 
coil structure is characterised by a negative band near 200 nm.    
 
1.8.2 Infrared (IR) spectroscopy  
The infrared region in the electromagnetic spectrum encompasses wavelengths 0.78 
– 300 µm (wavenumber 1.3  104 – 3.3  101 cm-1).  The absorption of IR radiation 
does not create an electronic transition in a molecule (as in CD spectroscopy); 
instead small changes between discrete quantised vibrational energy levels are 
induced.  Molecules that have a charge separation either across the whole molecule 
or across a specific bond possess a permanent dipole moment.  An atom’s position 
within a molecule fluctuates continuously because of the various types of molecular 
vibrations that are possible.  These vibrations can be classified as either bending or 
stretching motions and can give rise to a transient dipole moment.  There must be a 
change in the permanent or transient dipole moment, during a vibration, for a 
molecule to absorb IR radiation and be classified as IR-active.  When a molecule 
vibrates, a regular fluctuation in the dipole moment occurs which allows the dipole 
moment to interact with the electrical field associated with the IR radiation.  If the 
frequency of the IR radiation is the same as that of the vibration for which there is a 
change in dipole moment, a quantum of vibrational energy is absorbed by the 
molecule.  This results in a change in the molecule’s vibrational amplitude and the 
radiation is absorbed (Skoog and Leary 1992).  An IR spectrum is a representation of 
a sample’s vibrational frequency fingerprint.  Molecules absorb IR radiation at 
characteristic wavelengths determined by their atomic composition and bond 
structure.  Consequently, each molecule will produce a unique IR absorption 
spectrum. 
 
IR spectroscopy is widely used to determine the secondary structure of peptides and 
proteins (Pelton and McLean 2000).  The IR spectra of peptides and proteins can 
exhibit a number of amide bands, each of which represent a different vibration of the 
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peptide group (Goormaghtigh, Cabiaux et al. 1990).  Nine characteristic amide bands 
are observed in the IR spectra of proteins but the dominant species is from the amide 
I (1600-1700 cm-1) band.  This band represents the vibration frequencies of a C=O 
stretch, C-N stretch and N-H bend within a peptide group.  Goormaghtigh and co-
workers found that the wavenumber of the amide I band could suggest the secondary 
structure of the protein.  They observed that predominantly α-helical conformations 
had an amide I band at 1655 cm-1, whereas β-sheet rich structures gave a maximum 
at 1630 cm-1 in the IR spectrum (Goormaghtigh, Cabiaux et al. 1990).   
 
1.8.3 Nuclear magnetic resonance (NMR) spectroscopy 
The three-dimensional structure of a protein can be determined by means of NMR 
spectroscopy.  Two-dimensional (2D) NMR spectroscopy data can describe the 
inter-atomic distances between specific protons that are <5 Å apart in a protein of 
known sequence, that contains ≤ 250 amino acid residues (Voet and Voet 1995).  
NMR spectroscopy is the technique of choice to study the three-dimensional 
structure of proteins that have a molecular weight ≤ 30, 000 Da and do not form 
crystals.  In addition to the average three-dimensional structure, NMR can provide 
information on a wide array of short-lived transient conformational states (Pelton 
and McLean 2000).  A disadvantage of NMR spectroscopy is that the sample may 
have to be chemically modified to incorporate isotopes that give NMR signals such 
as 13C and 15N.  The resulting one-dimensional (1D) and 2D NMR spectrum of a 
biological macromolecule can be complex and obtaining resonance assignments is 
non-trivial (Pelton and McLean 2000).   
 
1.8.4 X-ray crystallography 
X-ray crystallography is a spectroscopy technique based upon the measurement of 
emission, absorption, scattering fluorescence and diffraction of X-rays striking a 
crystal.  These measurements provide information on the position of atoms within a 
crystal and allow the three-dimensional structure to be determined (Skoog and Leary 
1992).  Proteins that do not form crystals cannot be analysed by means of X-ray 
crystallography.    
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1.8.5 Mass spectrometry 
Mass spectrometry, in particular ESI-MS, is the ideal tool to characterise 
heterogeneous populations of soluble protein species that differ in their m/z ratio.  
When coupled to IMS, MS analysis of proteins can provide information on minor 
species within a complex mixture whilst also offering the means to monitor the 
appearance and disappearance of individual species during a reaction.  This feature is 
unique to MS and is therefore an advantage over the complementary classical 
biophysical techniques mentioned above.  The small amounts of sample required, the 
ability to maintain non-covalent interactions in the gas-phase and the fast time-scale 
of data acquisition suggest that ESI-MS is a technique of choice to characterise 
protein and synthetic polymer structure.   
 
1.9 Conserved solution-phase structure in the gas-phase 
The question of whether or not the solution-phase structure is conserved in the gas-
phase is a hotly debated topic.  There is a common belief amongst structural 
biologists that the gas-phase structure cannot be equivalent to the solution-phase 
structure because, in the absence of solvent, all hydrophobic/hydrophilic interactions 
that stabilise the structure are removed.  The wooden carving entitled “Sky and 
Water I” by the graphical artist Escher represents the solution-phase structure/gas-
phase structure discussion (see Figure 1.10); where the fish represent that solution-
phase structure and the birds resemble the equivalent gas-phase structure.  In 
addition, it is debated whether the in vitro protein structure, that has been obtained 
without the presence of a crowding agent, is relevant to the protein’s in vivo structure 
(Ellis 2001).  Indeed, there is evidence to suggest that thermodynamic and kinetic 
properties of macromolecules are dramatically different in the cell than those 
experienced in an uncrowded solution in the test tube (Ellis 2001).  To date, 
solution-phase NMR and solid-phase X-ray crystallography are the best tools a 
structural biologist has to observe the structure of a biological system.  It is therefore 
assumed that the structures observed by means of these techniques are relevant to the 
biological form.   
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Figure 1.10:  Wooden carving entitled “Sky and Water I” by M.C. Escher (1930).  This 
carving is representative of the conserved solution-phase structure to the gas-phase structure 
debate.   
 
A recent study showed that the published X-ray and NMR cross-sections could be 
related to the estimated collisional cross-section determined by means of IM-MS 
(Scarff, Thalassinos et al. 2008).  This suggests that IM-MS is a technique that can 
be used to investigate the three-dimensional structure of a protein and that the results 
obtained are similar to those attained by means of X-ray crystallography and NMR 
spectroscopy (see section 1.7).  It has been suggested that the gas-phase structure can 
be related to the solution phase structure (Shelimov, Clemmer et al. 1997b).  The 
time-scale required for a gas-phase structure to rearrange, to account for its 
environment, is 30-60 ms (Badman, Myung et al. 2005).  The IM-MS experiments, 
undertaken on the T-Wave device and many DCIM instruments, operate within a 15-
30 ms time frame (Wyttenbach, Grabenauer et al. 2009).  This limits the opportunity 
for the sample solution-phase structures to rearrange within the gas phase.  Shelimov 
and co-workers observed that in the absence of solvent a protein’s conformation 
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became more compact.  They proposed that the intramolecular interactions present, 
in the protein structure, can make the protein pack more tightly and can cause the 
polar side chains to collapse onto the protein surface.  It was reported that the gas-
phase structure had a 10-16% decrease in the cross-section compared its solution 
phase counterpart (Shelimov, Clemmer et al. 1997b).  It is therefore assumed that the 
gas-phase structure is similar to the observed in vitro solution-phase structure. 
 
1.10 Aims and objectives 
Ion mobility mass spectrometry is a relatively new area of research.  The first T-
Wave device, incorporated into the Synapt HDMS system, was developed by 
Waters, Manchester, UK and was commercially available in January 2007.  Because 
of this new instrumentation, extensive method development was required to evaluate 
the potential of this technique as the new method of choice for characterising the 
three-dimensional structure of a compound.   
 
The present project was focussed on using ion mobility mass spectrometry to 
characterise synthetic and natural macromolecules and to relate their structure to 
observed properties and function.  Two different systems were studied; synthetic 
polymers and recombinant prion proteins.  Investigations using synthetic polymers 
as the sample set were as part of a CASE Award project.  These studies were 
conducted, in part, at the industrial site of Intertek MSG (formerly ICI Measurement 
Science Group), under the supervision of Dr. Tony Jackson.  Structural studies of 
recombinant prion protein were partially funded by the department for environment, 
food and rural affairs (DEFRA).  The aim of this work was to develop and evaluate a 
mass spectrometry-based method to distinguish between the prion isoforms and 
assess the technique’s ability to be used as an ante-mortem diagnostic test.   
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The aims of this project were to: 
1. Utilise the novel ion mobility mass spectrometry (IM-MS) technique to study 
the structure of the prion protein.  Further elucidate the structural properties 
of normal cellular prion protein by means of IM-MS to distinguish this from 
a pathogenic scrapie form (Chapter 4).  Characterise full-length prion protein 
and compare its structural properties to the truncated prion protein 
counterpart (Chapter 4).  Compare and contrast the structural stability of 
various mammalian prion protein species. (Chapter 4). 
 
2. Confirm or challenge previous characterisation of the metal binding sites in 
the prion protein by means of IM-MS.  (Chapter 5). 
 
3. Analyse the structural properties of synthetic polymer mixtures by means of 
gel permeation chromatography (GPC) coupled to NMR spectroscopy and 
IM-MS.  (Chapter 7). 
1.11 Research papers 
The research involved in this project has already resulted in seven peer reviewed and 
published papers with others in preparation. 
Hilton,
 
G. R.*, Thalassinos, K.*, Grabenauer, M., Sanghera N., Slade, S. E., 
Wyttenbach T., Robinson P. J., Pinherio T. J. T., Scrivens, J. H  and Bowers, M. T   
Structural Analysis of Prion Proteins by means of Drift Cell and Travelling 
Wave Ion Mobility Mass Spectrometry.  Accepted.  Journal of the American 
Society for Mass Spectrometry (2009). 
*joint first author 
 
Hilton, G. R., Thalassinos, K., Sanghera N., Blindauer C. A., Pinherio T. J. T., Gill 
A. C., and Scrivens, J. H.  Conformational Studies of Copper Coordination in 
Full-Length and N-terminal Fragments of Prion Proteins.  Submitted.  
Biochemistry (2009). 
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Thalassinos, K., Grabenauer, M., Slade, S. E., Hilton, G. R., Bowers, M. T. and 
Scrivens, J. H.  Characterisation of Phosphorylated Peptides Using Travelling 
Wave-Based and Drift Cell Ion Mobility Mass Spectrometry.  Analytical 
Chemistry (2009) 81: 248–254 
 
Hilton, G. R., Jackson, A. T., Thalassinos, K. and Scrivens, J. H.  Structural 
Analysis of Synthetic Polymer Mixtures using Ion Mobility and Tandem Mass 
Spectrometry.  Analytical Chemistry (2008) 80: 9720–9725 
 
Scarff, C. A., Thalassinos, K., Hilton, G. R. and Scrivens, J. H.  Travelling Wave 
Ion Mobility Mass Spectrometry Studies of Protein Structure: Biological 
Significance and Comparison with X-ray Crystallography and Nuclear 
Magnetic Resonance Spectroscopy Measurements.  Rapid Communications in 
Mass Spectrometry (2008) 22: 3297-3304 
 
Williams, J. P., Hilton, G. R., Thalassinos, K., Jackson, A. T. and Scrivens, J. H.  
The Rapid Characterisation of Poly(ethylene glycol) Oligomers using 
Desorption Electrospray Ionisation Tandem Mass Spectrometry Combined 
with Novel Product Ion Peak Assignment Software.  Rapid Communications in 
Mass Spectrometry (2007) 21: 1693-1704 
 
Thalassinos, K., Jackson, A. T., Williams, J. P., Hilton, G. R., Slade, S. E. and 
Scrivens, J. H.  Novel Software for the Assignment of Peaks from Tandem Mass 
Spectrometry Spectra of Synthetic Polymers.  Journal of the American Society for 
Mass Spectrometry (2007) 18: 1324-1331 
 
1.12 Conference Papers (Peer Reviewed)  
 
Hilton, G. R., Thalassinos, K., Sanghera, N., Slade, S.E., Pinheiro, T.J.T. and 
Scrivens J.H. Travelling Wave Ion Mobility Mass Spectrometry-based 
Conformational Studies of Prion Protein - Comparison of Recombinant Truncated 
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Mouse and Syrian Hamster. 57th ASMS Conference on Mass Spectrometry & Allied 
Topics, Philadelphia, Pennsylvania (2009)  
 
Scrivens, J. H.  Hilton, G. R.,  Thalassinos, K.,  Slade, S. E.,  Sanghera, N., 
Grabenauer M., Pinheiro, T. J., Bowers, M. T. Utilising Ion Mobility Mass 
Spectrometry as a Diagnostic Tool for Differentiating Conformational Variants of 
Prion Proteins. Joint Funders' Transmissible Spongiform Encephalopathies 
Workshop, University of Warwick, Warwick UK (2008) 
 
Hilton, G. R., Thalassinos, K., Slade, S. E., Sanghera, N., Blindauer, C. A., 
Pinheiro, T. J., Bowers, M. T. and Scrivens, J. H. Travelling wave ion mobility mass 
spectrometry-based conformational studies of prion protein - effects of metal cation 
binding and buffer gas. BMSS 30th Annual Meeting University of York, York UK 
(2008)  
 
Slade, S. E., Thalassinos, K., Hilton, G. R., Pinheiro, T., Blindauer, C. A., Bowers, 
M. T. and Scrivens, J. Travelling wave ion mobility mass spectrometry-based 
conformational studies of prion protein – effects of metal cation binding and buffer 
gas. 56th ASMS Conference on Mass Spectrometry & Allied Topics Denver, 
Colorado (2008)  
 
Thalassinos, K., Hilton, G. R., Slade, S. E., Grabenauer, M., Bowers, M. T. and 
Scrivens, J. H. Improved characterisation of phosphorylated peptides utilising 
travelling wave-based and drift cell ion mobility mass spectrometry with molecular 
modelling studies. 56th ASMS Conference on Mass Spectrometry & Allied Topics 
Denver, Colorado (2008)  
 
Thalassinos, K., Hilton, G. R., Slade, S. E., Pinheiro, T. J., Blindauer, C. A. and 
Scrivens, J. H. Use of a travelling wave-based ion mobility mass spectrometry 
approach to study metal binding to the prion protein. ASMS Sanibel Conference on 
Ion Mobility and Related Emerging Areas Daytona Beach, Florida (2008)  
 
Thalassinos, K., Hilton, G. R., Slade, S. E., Sanghera, N., Robinson, P., Pinheiro, T. 
J. T., Bowers, M. T. and Scrivens, J. H. Use of a travelling wave based ion mobility 
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mass spectrometry approach to resolve prion proteins of varying conformations. 
Prion 2007 Edinburgh Scotland (2007)  
 
Hilton, G. R., Williams, J. P., Holland, R. J., Thalassinos, K., Jackson, A. T. and 
Scrivens, J. H. Enhanced information content of direct desorption experiments 
utilising reactive DESI combined with ion mobility mass spectrometry and tandem 
mass spectrometry. 54th Annual American Society for Mass Spectrometry 
Conference Indianapolis, U.S.A. (2007)  
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Chapter 2 
Introduction to the Prion Protein 
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2.1 Transmissible spongiform encephalopathies 
Transmissible spongiform encephalopathies (TSEs), also known as prion diseases, 
are a class of fatal, infectious neurodegenerative diseases that affect both humans 
and animals.  Examples of prion diseases include bovine spongiform encephalopathy 
(BSE) in cattle, chronic wasting disease (CWD) in deer, scrapie in sheep, and kuru 
and Creutzfeldt-Jakob disease (CJD) in humans (Collinge and Palmer 1992).   
 
The neurodegenerative disease kuru was discovered in the members of the Fore 
tribe, Papua-New Guinea in the late 1950s.  As part of their funeral ceremonies the 
tribe practised ritualistic cannibalism to pay their respects to the dead and the 
spiritual world.  In particular, women and children ate the internal viscera including 
the central nervous system (CNS) of the deceased relative whilst the men consumed 
less infectious material such as the skeletal muscle.  As a consequence of this ritual 
the tribal people started to develop pronounced symptoms such as tremors, fevers 
and cerebellar ataxia until death occurred months later.  Unable to explain these 
incidents the Fore tribe concluded that this was the work of sorcery; the physician 
Carleton Gajdusek and co-workers, however, believed the symptoms were indicative 
of a spongiform encephalopathy, now known as kuru (Gajdusek 1977).  It was 
observed that the neuropathology of kuru resembled scrapie and CJD (Hadlow 
1959a; Klatzo, Gajdusek et al. 1959) and that CJD could be transmitted after 
intracerebral inoculation of human brain extracts into apes (Hadlow 1959b).  The 
agent that linked these diseases was at the time still unknown.   
 
TSEs came to prominence in the 1980s-90s when an epidemic of BSE in the UK 
caused the death of many hundreds of cattle (Brown, Will et al. 2001; Dabaghian, 
Mortimer et al. 2004; Khamsi 2006).  In the 1980s the UK government changed the 
rendering and livestock feeding practices to allow protein-rich nutritional 
supplements, from rendered TSE infected animals, to be fed to healthy cattle.  This 
change in regulation resulted in a rapid amplification of BSE to epidemic proportions 
in the UK cattle population and led to the introduction of infected meat-products into 
the human food-chain.  A new TSE, designated variant CJD (v-CJD), subsequently 
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appeared in humans and was linked to the consumption of BSE-infected material 
from cattle (Collinge 1999).  The social and economic impact of this epidemic and 
evidence that another epidemic could occur (d'Aignaux, Cousens et al. 2001; 
Valleron, Boelle et al. 2001) has led to a new urgency in the study of TSE diseases.    
 
2.2 Discovery of PrP 
It was initially believed that a “slow virus” was the cause of kuru and scrapie 
because of the extended incubation period for both of these diseases.  The 
transmissibility of kuru was reported in 1966 when the passage of the disease was 
observed in chimpanzee models (Gajdusek, Gibbs et al. 1966) and later studies 
showed that CJD could also be transmitted to chimpanzees following intracerebral 
inoculation (Gibbs, Gajdusek et al. 1968).  The cause of these diseases was still 
unknown when it was noted that scrapie, kuru and CJD could cause death to the host 
without provoking an immune system response to a “foreign agent”.  Investigations 
into the scrapie reagent showed that it was extremely resistant to ionising and 
ultraviolet (UV) radiation (Alper, Cramp et al. 1967; Alper, Haig et al. 1966; 
Latarjet, Muel et al. 1970).  This observation stimulated numerous hypotheses 
concerning the nature of the infectious agent ranging from a small DNA virus to a 
polysaccharide but it was eventually shown to be a protein (Prusiner 1999). 
 
2.3 What is a prion? 
Stanley Prusiner was awarded the Nobel Prize for Physiology or Medicine in 1997 
for his discovery of prions – a new biological principle of infection.  He describes 
prions as unprecedented infectious pathogens that cause a group of invariably fatal 
neurodegenerative diseases by means of an entirely novel mechanism (Prusiner 
1998).  Although the precise molecular details of the mechanism are not clearly 
known, it is thought that the key event in prion diseases is the conversion of the 
normal cellular form of the prion protein, PrPC to a pathogenic scrapie form (PrPSc).  
Prion diseases may be present as genetic, infectious or sporadic disorders. 
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2.3.1 Is a prion a virus? 
Prions and viruses share many similar features; both can stimulate a process to 
produce more pathogen.  Both can cause disease by accumulating in an infected host 
and both can exist as different strains.  In contrast to viruses, which are encoded by a 
viral genome, prions lack a nucleic acid genome and are composed of an alternative 
isoform of a cellular protein.  Prions are nonimmunogenic because the host is 
tolerant to PrPSc because of its exposure to the native PrPC (Prusiner 1999; 
Williamson, Peretz et al. 1996).  The same cannot be said for viruses whose presence 
as a foreign body in the host usually provokes a reaction from the immune system.  
Unlike viruses, prions do not have a consistent structure and can exist in multiple 
molecular forms.  Viruses, however, usually have a single molecular form which can 
vary by having distinct ultra-structural morphologies.  It is believed that different 
strains of the prion occur through conformational changes in PrPSc while viral strains 
arise from distinct differences in the nucleic acid sequence.  Investigations have been 
conducted to elucidate if nucleic acids are present in the infectious material 
(Kellings, Meyer et al. 1992; Kellings, Prusiner et al. 1994; Manuelidis, Sklaviadis et 
al. 1995) but to date no evidence has been found to suggest that the prion is a type of 
virus.  Experiments which altered or destroyed the nucleic acids/viruses, thought to 
be responsible for the prion disease, retained scrapie infectivity (Prusiner 1982).  In 
contrast, infectivity was dramatically reduced using methods that modified or 
destroyed the protein structure (Gabizon, McKinley et al. 1988; Soto and Castilla 
2004).  These observations led to the “protein-only” hypothesis, which states that the 
scrapie causing agent is devoid of nucleic acid and seems to be composed 
exclusively of a modified protein (Prusiner 1982). 
 
Genetic studies have shown that knockout mice lacking the PrP gene (Prnp0/0) were 
resistant to scrapie infection.  These mice developed normally.  They were unable to 
propagate new infectious particles and showed no sign of scrapie clinical symptoms 
(Bueler, Fischer et al. 1992).  Once the gene encoding PrP was restored the mice 
became susceptible to PrP disease again.  Other evidence to support the “protein-
only” hypothesis was the successful propagation of infectivity in neuroblastoma cells 
(Race, Fadness et al. 1987; Rubenstein, Carp et al. 1984) in which cells containing 
PrPC were chronically infected with brain homogenate and infectivity was monitored 
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for several months.  Since the absence of PrPC expression does not provoke disease, 
it is likely that scrapie-causing diseases are a consequence of PrPSc accumulation 
rather than inhibition of PrPC function (Bueler, Fischer et al. 1992).   
 
2.4 Human TSE diseases 
2.4.1 Inherited 
Familial CJD, Gerstmann-Sträussler-Scheinker (GSS) syndrome and fatal familiar 
insomnia (FFI) are the three dominant genetically determined phenotypes of 
inherited TSEs.  Familial prion diseases are inherited in an autosomal dominant 
manner and are linked to mutations in the human prion protein (PRNP) gene 
(Crowther 2002).  Several hypotheses have been outlined which suggest that 
mutations in PRNP can destabilise the PrPC structure and could facilitate the 
conversion of PrPC  to PrPSc (Cohen, Pan et al. 1994; Harrison, Bamborough et al. 
1997; Huang, Gabriel et al. 1994).  Up to 14% of familiar CJD patients have died 
from the disease due to mutations in PRNP (Windl, Dempster et al. 1996).  These 
mutations can vary from several point mutations to insertions in the octarepeat 
region with inconclusive evidence, from neuropathology studies, to connect specific 
mutations to the corresponding disease phenotype.  The mutation E200K has been 
identified as a contributing factor to the high incidence of familial CJD in Slovakia, 
Poland, Germany, Tunisia, Greece, Libya, and Chile and within certain ethnic sub-
groups (Goldfarb, Brown et al. 1991).   
 
Slow progressive cerebellar ataxia is a characteristic clinical symptom of GSS 
syndrome and typically begins when a patient is 50-60 years in age.  Unlike familial 
CJD, a common PRNP mutation, P102L, has been described and found to be 
reproducibly associated with transmission of GSS in up to 40% of cases (Hsiao, 
Baker et al. 1989).  In more recent years a variety of other GSS PRNP mutations and 
their associated phenotypes have been discovered, however, P102L and G131V 
mutations are still believed to account for the majority of incidents (Collins, McLean 
et al. 2001).   
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2.4.2 Sporadic 
Sporadic CJD accounts for the majority of TSE disease cases in humans to date with 
a worldwide incidence rate of 1 in every 1,000,000 people per year (Chesebro 2003).  
Data from the United Kingdom CJD surveillance unit, over a 19 year period, 
indicates that there are no links in the incidence rate of sporadic CJD with any other 
forms of the disease (see Figure 2.1).  The cause of sporadic CJD remains uncertain 
as mutations in the PRNP gene have not been found.  One theory suggests that a 
somatic mutation occurs in PRNP which could stimulate a rare spontaneous 
conversion of PrPC, present in the brain, to PrPSc which would result in disease 
(Prusiner 1998).  This non-mutating spontaneous conversion theory could explain 
the different clinical symptoms and brain histology observed in patients with 
sporadic CJD to those with other forms of the disease (Will, Ironside et al. 1996).  
Alternative theories suggest that sporadic CJD results from a switch to a 
neurovirulence in a silent ubiquitous strain of the CJD agent (Kimberlin 1990) or 
that the normally harmless form of PrPC can actually be harmful in a small number 
of genetically susceptible individuals (Collee and Bradley 1997). 
 
2.4.3 Iatrogenic 
Iatrogenic CJD has arisen as a complication of neurosurgery usually as a result of 
inadequate sterilisation of neurological surgical electrodes or from instrumentation 
that has been previously contaminated (Soto 2004).  It has also been associated with 
treatments involving the transmission of human-cadaveric pituitary-derived growth 
hormone and gonadotrophins, dura mater and corneal grafting (Soto 2004).  In 2004 
a novel case of preclinical v-CJD was reported in a patient who had received a blood 
transfusion from an asympotomatic carrier of v-CJD.  The blood donor later 
developed and died from v-CJD with the recipient of the blood transfusion also 
showing clinical symptoms of v-CJD before their death (from a non-neurological 
disorder) five years later (Peden, Head et al. 2004).  There is other evidence to 
suggest that v-CJD can be transmitted via blood transfusion.  Houston et al. showed 
that blood donated from a pre-symptomatic BSE infected sheep into other healthy 
sheep could induce BSE infection (Houston, Foster et al. 2000).  Further studies also 
suggest that blood taken from animals during the pre-clinical and clinical stages of 
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BSE infection can transmit the infection through blood transfusion (Hunter, Foster et 
al. 2002).  This has raised concerns over the safeguarding of the blood supply, with 
potentially many asympotomatic carriers unknowingly donating blood.  The 
development of a non-invasive highly sensitive preclinical diagnostic test for prion 
diseases is highly desirable not only to stop the spread of the disease but may also 
lead to better clinical outcomes in the future.   
 
Kuru was the first human TSE disease shown to be caused by the prion protein 
(Gajdusek 1977).  In the 1960s, as a consequence of their ritualistic cannibalism, 
kuru reached epidemic proportions in the members of the Fore tribe of Papua-New 
Guinea.  It was found that the disease was more prevalent in women and children 
(Klatzo, Gajdusek et al. 1959) and this was later concluded to be due to their 
preferred consumption of the brain and CNS from the deceased relative.  The 
cessation of the Fore tribe’s cannibalistic rituals in the 1950s decreased the incident 
rate of historic kuru, some cases have been reported, however, in older tribal 
members (≥40 years of age) of the contemporary Fore survivors (Mead, Stumpf et al. 
2003).  Factors contributing to the later onset of the disease have been associated 
with the older age at exposure to the infectious material and the concentration of 
prion agent present in the ingested material.  It has also been noted that methionine 
homozygosity at codon 129 of PRNP can increase the risk of contracting kuru at a 
younger age with homozygous sufferers tending to have shorter incubation and 
gestation periods of the disease than their heterozygote counterparts.(Cervenakova, 
Goldfarb et al. 1998; Lee, Brown et al. 2001). 
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Figure 2.1:  The number of people referred to the National Creutzfeldt-Jakob disease 
surveillance unit which have confirmed or suspected cases of CJD in Britain since 1990.  
Taken from (CJD) last updated 7th December 2009. 
 
2.4.4 Variant CJD 
In 1996 the first case of new variant-CJD (v-CJD) was reported in Britain following 
the population’s exposure to BSE-infected food-stuffs (Will, Ironside et al. 1996).  In 
contrast to sporadic CJD, patients with v-CJD are much younger in age at the time of 
death (median age at death 65 years and 29 years old respectively) (Will, Ironside et 
al. 1996) and experience distinctly different psychiatric symptoms to that of sporadic 
CJD, such as dysphoria, anxiety, insomnia and withdrawal (Spencer, Knight et al. 
2002).  After the initial presentation of psychiatric or behavioural symptoms, the 
gestation period of v-CJD can be several months or years.  The incidence rate of v-
CJD in the UK has been on the decline since 2000 (see Figure 2.1) scientists believe, 
however, that a possible new epidemic could occur in the next 10-15 years (see 
Figure 2.2).  To date, all cases of v-CJD have been in patients who are methionine 
homozygotes at codon 129, the only exception being a heterozygous 
(methionine/valine (MV)) patient diagnosed with preclinical v-CJD in 2004 (Peden, 
Head et al. 2004).  This finding has major implications for future estimations of 
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numbers of v-CJD cases in the UK, as the heterozygote genotype constitutes the 
largest genetic subgroup in the population (Hilton, Ghani et al. 2004).   
 
Figure 2.2:  Profile of BSE-infected cattle in the British human food chain (red) and the 
subsequent predicted profile of v-CJD (blue and green).  Taken from (Collins, Lawson et al. 
2004). 
 
2.5 Codon 129 
It has been postulated that a polymorphism at codon 129 can determine a patient’s 
susceptibility to sporadic, iatrogenic and variant forms of CJD (Chesebro 2003).  
Experiments were conducted in which transgenic mice carrying three different 
genotypes of human codon 129, MM, MV and VV, were inoculated with v-CJD.  
The results of these experiments suggested that the greatest transmission efficiency 
of the disease occurred in HuMM mice (Bishop, Hart et al. 2006).  This implies that 
homozygosity for methionine at codon 129 could lead to an earlier onset of TSE-
related pathological features and clinical disease compared to their heterozygous 
genotype counterparts.  It has also been suggested that this heterozygous subgroup 
could also have a different incubation period after exposure to either primary 
infection of the BSE agent or as a secondary infection by blood transfusion (Peden, 
Head et al. 2004).  Codon 129 MV and VV individuals currently constitute 51% and 
11% of the UK population respectively (Hilton, Ghani et al. 2004) and the 
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potentially prolonged incubation period in these individuals, who could be 
asymptomatic carriers of v-CJD, makes predicting a new v-CJD epidemic a difficult 
task (d'Aignaux, Cousens et al. 2001; Mead, Poulter et al. 2009; Valleron, Boelle et 
al. 2001). 
 
2.6 Protein conformational disorders 
Protein misfolding, aggregation and accumulation in the brain, to instigate neuronal 
apoptosis, are common causes of a diverse range of neurodegenerative diseases.  
During the onset of neurodegenerative diseases a patient’s skilled movements, 
emotions, cognition, memory and numerous other abilities can all be affected 
(Martin 1999).  Protein conformational disorders are attributed to many common 
neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, 
Huntington’s disease (and related polyglutamine disorders including several forms of 
spinocerebellar ataxia), TSEs and amyotrophic lateral sclerosis (Soto 2003).  
Although all of these diseases have distinct clinical symptoms and disease 
progression they also share similarities.  The onset of the majority of these 
neurodegenerative diseases appears later in life (usually ≥ 50 years old).  Most can 
be sporadic and/or inherited, their pathology is characterised by neuronal loss and 
synaptic abnormalities (Martin 1999) and there is recent evidence to suggest that the 
accumulation of aggregates formed by the different proteins take the same molecular 
form (Soto 2003) (see Figure 2.3).  The mechanism of protein misfolding for all 
these diseases is still not fully understood however, and structural studies have 
shown that in general it is a self propagating conformational change from a 
predominantly α-helical state to a β-sheet rich isoform.  Kinetic studies have also 
revealed that the aggregation of Aβ (Alzheimer’s disease), α-synuclein (Parkinson’s 
disease), huntingtin (Huntington’s disease) and PrP involve systematic amyloidosis 
following a seeding/nucleation mechanism, which can act as a template for further 
oligomer/aggregate growth.  The proposed similarities in the molecular pathways, 
protein misfolding, aggregation and neuronal death have given hope that a common 
therapeutic strategy to treat all of these illnesses can be developed (Soto 2003).   
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Figure 2.3:  Images of cerebral aggregates in neurodegenerative diseases.  Different protein 
compositions show similar ultrastructure of deposits and appear to be mainly composed of a 
network of fibriluar polymers.  (a and b),  Intracytoplasmic aggregates are typically present 
in neurons of people affected by (a) amyotropic lateral sclerosis (b) and Parkinson’s disease.  
(c), Extracellular prion amyloid plaques are located in different brain regions and are present 
in some cases of transmissible spongiform encephalopathy. (d), Intranuclear inclusions of 
huntingtin are observed in Huntington’s disease.  (e), Extracellular amyloid plaques (white 
arrows) and intracytoplasmic neurofibrillary tangles (purple arrows) are the pathological 
signature of Alzheimer’s disease.  Adapted from (Soto 2003). 
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2.6.1 Parkinson’s disease 
There is evidence to suggest that α-synuclein behaves like a prion protein and that 
Parkinson’s disease (PD) could be classed as a prion disorder (Desplats, Lee et al. 
2009; Olanow and Prusiner 2009) (see Figure 2.4).  Parkinson’s disease is an age-
related neurodegenerative disease affecting approximately one in 500 people in the 
UK and 4 million people worldwide per year (Parkinsons).  The disease is 
characterised by a loss of dopamine neurons and the appearance of inclusion bodies 
in the Lewy bodies of the brain.  The cause of cell death and the appearance of these 
inclusion bodies in PD patients is not known, but there are suggestions that 
proteolytic stress followed by the accumulation of misfolded proteins, in particular 
α-synuclein, could be a major contributing factor (McNaught, Olanow et al. 2001).  
α-Synuclein is a 140 amino acid synaptic protein which can adopt an α-helical 
conformation when bound to a cell membrane.  At increased concentrations of α-
synuclein the protein can misfold to form a β-sheet rich conformational isoform.  
These β-sheet rich structures readily polymerise, which can interfere with 
proteasomal and lysosomal functions (Cuervo, Stefanis et al. 2004; Snyder, Mensah 
et al. 2003), and further accumulation of the protein can lead to the formation of 
fibrils (see Figure 2.4b).  Protein aggregates formed in both prion and Parkinson’s 
disease can promote the misfolding of wild-type proteins in unaffected cells and can 
extend the disease process.  It has been observed that α-synuclein spreads in a 
sequential manner, beginning in the lower brainstem dorsal motor nucleus and 
extending to the upper brainstem nuclei and cerebral hemispheres (Braak, Del 
Tredici et al. 2003), and the proposed similarity to the prion protein mechanism (see 
Figure 2.4) could account for the PD pathological findings.  It has therefore been 
speculated that PD is a prion protein disease resulting from an increased production 
of α-synuclein which in turn promotes a conformational change in the protein to 
form toxic oligomers, aggregates and eventually leads to cell death (Olanow and 
Prusiner 2009).   
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Figure 2.4:  Schematic representation illustrating the similarities between PrP in prion 
diseases and α-synuclein protein in Parkinson’s disease.  (a), PrPC is predominantly α-helical 
and resides on the surface of cell membranes.  It undergoes a misfolding process to form a β-
sheet rich conformation.  These β-sheet rich isoforms can aggregate into rods that coalesce 
to form amyloid plaques.  (b), α-Synuclein adopts a largely α-helical conformation when 
bound to a cell membrane.  It can undergo a misfolding event to create a β-sheet rich 
conformational isoform.  The β-sheet rich proteins can polymerise into fibrils which are 
associated to the formation of Lewy bodies.  Adapted from (Olanow and Prusiner 2009). 
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2.7 Properties of PrP 
The PrP isoforms have very different biochemical properties and the ability to 
distinguish between these could help in the identification of infectious prion 
disorders. 
• PrPC and PrPSc have an identical amino acid primary sequence with no 
evidence to suggest modifications that could differentiate between PrPC and 
PrPSc.  
• PrPC is readily soluble in non-denaturing conditions whereas PrPSc is 
insoluble in detergents (Meyer, McKinley et al. 1986). 
• PrPC is fully degraded in the presence of the common protease, proteinase K.  
In contrast PrPSc is partially resistant to proteinase K digestion with cleavage 
just after the octarepeat region to form the truncated fragment named PrP 27-
30 (amino acid residues 90-231)(Meyer, McKinley et al. 1986; Oesch, 
Westaway et al. 1985).  
• When intact on the cell surface, PrPC can be removed by 
phosphatidylinositol-specific phospholipase C (PIPLC) (Caughey, Race et al. 
1989; Stahl, Borchelt et al. 1987) whereas PrPSc cannot.  This suggests that 
the PrPSc polypeptide chain is interacting with the cell surface to prevent a 
successful PIPLC cleavage (Safar, Ceroni et al. 1991; Stahl, Borchelt et al. 
1990). 
• PrPC has a half life of 3-6 hours (Borchelt, Scott et al. 1990; Caughey, Race 
et al. 1989; Caughey and Raymond 1991; Yedidia, Horonchik et al. 2001) 
before it is catabolised, secreted or released from the cell surface, once 
accumulated on the cell membrane, however PrPSc cannot be removed or 
recycled by the cell. 
• PrPSc can form aggregates and amyloid fibrils in brain tissue which can be 
stained with Congo red dye (Prusiner, McKinley et al. 1983), in contrast PrPC 
exists as a monomeric form and does not form aggregates. 
• The secondary structure of the two isoforms dramatically differs.  Syrian 
hamster PrPC and PrPSc were purified under non-denaturing conditions and 
their secondary structure was measured by Fourier-transform infrared (FTIR) 
spectroscopy and circular dichroism (CD).  These measurements showed that 
monomeric PrPC has a high α-helix content (42%) with little β-sheet (3%) 
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present whereas, oligomeric PrPSc has a higher proportion of β-sheet (43%) 
content than α-helical (30%) (see table 2.1) (Pan, Baldwin et al. 1993) (Safar, 
Roller et al. 1993).  To date other biochemical characterisation methods have 
not identified any covalent differences between PrPC and PrPSc indicating that 
the isoforms differ only in their conformation.   
 
Table 2.1:  Percentage content of secondary structure of purified SHaPrP determined 
from deconvolution and curve fitting of FTIR amide 1’ bands (Pan, Baldwin et al. 
1993) 
Structure PrPC (23-231) PrPSc (23-231) PrP (90-231) 
α-helix 42 30 21 
β-sheet 3 43 54 
Turn 32 11 9 
Coil 23 16 16 
 
All of these properties are useful to aid the identification of PrPSc and in some cases 
can be used as a surrogate marker for prion disease but the lack of some or all of 
these characteristics does not relate to a lack of prion infectivity.  For example, 
resistance to partial proteinase K digestion has been demonstrated to be an effective 
tool for detecting PrPSc, recent studies, however, have shown that not all PrPSc 
molecules possess protease resistance, and different species or prion strains can 
exhibit different degrees of protease resistance (Hsiao, Groth et al. 1994; Telling, 
Parchi et al. 1996). 
 
2.8 Structure 
The mammalian PrP gene encodes for a protein containing approximately 250 amino 
acid residues.  PrPC is a glycosyl phosphatidylinositol (GPI)-linked glycoprotein and 
contains two N-linked glycosylation sites (Aguzzi and Heikenwalder 2006).  Like 
other GPI-linked proteins PrP can attach to the cell’s plasma membrane which is 
enriched with insoluble detergent domains that are rich in cholesterol and 
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sphingolipids, referred to as lipid rafts (Brown and Rose 1992; Naslavsky, Stein et 
al. 1997; Taraboulos, Scott et al. 1995; Vey, Pilkuhn et al. 1996).  The mature PrPC 
structure is similar throughout the mammalian species.  These similarities include a 
long flexible N-terminal tail (residues 23-124), and secondary structural 
characteristics such as three α-helices and two-stranded anti-parallel β-sheets which 
are located in close proximity to the first α-helix (see Figure 2.5).  In the majority of 
mammalian species, the second β-sheet and the third α-helix are connected by an 
extremely flexible large loop, it has been shown in deer and elk, however, that this 
loop region is rigid (Gossert, Bonjour et al. 2005).  The carboxyl terminus (C-
terminus) of PrPC is stabilised by a disulphide bond, between cysteine residues 179 
and 214 (in humans), which links α-helices two and three.  Twenty-three residues are 
removed from the C-terminus during the addition of the GPI-anchor, so that the 
protein can be anchored to the cell membrane. 
 
Figure 2.5:  Schematic representation illustrating the structural features of the cellular prion 
protein.  There is a signal peptide, residues 1-22, at the N-terminus.  The green wavy line 
represents the approximate cleavage site by proteinase K.  The green arrow shows the 
hydrophobic core region.  The secondary structure regions are highlighted in yellow for β-
sheet and red for α-helices.  The glycosyl phosphatidylinositol (GPI) anchor is located at the 
C-terminus.  Adapted from (Aguzzi and Heikenwalder 2006). 
 
A signal peptide consisting of 22 amino acids (the amino-terminal) is cleaved during 
the biosynthesis of PrP, producing a protein of ~230 amino acid residues.  The 
unstructured N-terminal region of PrP contains two defined highly conserved 
regions.  The first region, known as the octarepeat region, consists of five repeat 
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units each of which contains a highly conserved eight amino acid sequence.  The 
second region is downstream of these octarepeat peptides and contains a region of 
highly conserved hydrophobic amino acid residues referred to as the hydrophobic 
core.  Within this region is a palindromic repeat (AGAAAAGA) which is conserved 
between all species implying that it has an important functional or structural role.  
From spectroscopic data it was predicted that amino acids 23-124 in the unstructured 
N-terminal flexible tail may possess some secondary structure when present in 
membrane-rich environments (Morillas, Swietnicki et al. 1999).  Proteinase K 
digestion of PrPSc removes ~ 67 N-terminal residues to produce a truncated form of 
PrP which corresponds to amino acids 90-231 (PrP 27-30) (Meyer, McKinley et al. 
1986; Oesch, Westaway et al. 1985).  (See Figure 2.6) 
 
Mammalian PrP contains five copies of the octarepeat sequence, with the exception 
of bovine PrP which contains an additional repeat unit.  The octarepeat sequence, 
(PHGG[G]WGQ)n where the square brackets denote the non-conserved residues, is 
highly conserved throughout all species suggesting that it has a functional role.  The 
repeating sequence in the chicken hexarepeat unit, (PGYPHN)n, is dramatically 
different to that in mammals.  Previous studies have shown that copper binds to the 
histidine residues in the octarepeat motif with a saturation stoichiometry of one 
copper per histidine residue (Brown, Qin et al. 1997).  This suggests that PrPC could 
bind copper ions and aid the transportation of these ions into the cell.  
 
PrPC and glycosylated PrPC, purified from cattle brains, have similar tertiary 
structures (Hornemann, Schorn et al. 2004).  This observation suggests that neither 
the attachment of N-linked glycans nor the GPI-anchor has an influence on the 
overall conformation of the prion.  Circular dichroism (CD) spectroscopy studies, 
however, suggest that structural modifications do occur in PrPC when it is GPI-
anchored to the cell surface.  This implies that the prion can interact with the cell 
plasma membrane (Morillas, Swietnicki et al. 1999).  The two glycosylation sites 
(residues asparagine Asn181 and Asn197 in humans) can be non-, mono- or di-
glycosylated in both the full-length and truncated PrPC.  Varieties of N-glycans can 
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attach to PrPC with different glycan combinations found to be differentially 
distributed throughout the CNS. 
 
2.8.1 NMR structure of recombinant PrP 
The three-dimensional structure of recombinant PrP proteins expressed in E. coli has 
been determined by nuclear magnetic resonance (NMR) spectroscopy.  The structure 
of the refolded recombinant α-helical conformation is believed to resemble that of 
PrPC.  The first structure to be solved was the truncated recombinant mouse fragment 
MoPrP(121-231) (Riek, Hornemann et al. 1996).  It showed the presence of three α-
helices (helix 1, 2 and 3) and two stranded anti-parallel β-sheets connected to helix 2 
and 3 via a disulphide bond.  The twisted V-shaped structure formed by the longest 
helices (helix 2 and 3) forms a scaffold onto which the short β-sheet and helix 1 are 
anchored (see Figure 2.7a).  This structure revealed that there is a global domain for 
residues 125-228 and a short flexible chain end at residues 229-230.  Further studies 
using full-length constructs showed that the N-terminal fragment, residues 23-120, 
has features of a flexible random coil-like polypeptide (Riek, Hornemann et al. 
1997).  The actual positions/structure of this flexible tail have never been defined 
because of missing assignments caused by residues moving and exchange-
broadening in the NMR spectrum.  The truncated NMR structure of recombinant 
Syrian hamster PrP, SHaPrP(90-231), was solved soon after the mouse structure was 
published (James, Liu et al. 1997).  The structure was in good agreement with 
previous FTIR (Pan, Baldwin et al. 1993) studies with the results showing that of the 
142 resolvable residues, 63 were present in α-helices (44%) and 6 residues 
comprised the short anti-parallel β-sheets (6%).  See Table 2.2 to for a comparison of 
secondary structure percentage   
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Figure 2.6:  Schematic representation of the Syrian hamster prion protein.  The major 
structural features are shown including the copper binding sites.   
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The NMR structures of truncated and/or full-length recombinant prion proteins from 
mouse (Hornemann, Korth et al. 1997; Riek, Hornemann et al. 1996; Riek, 
Hornemann et al. 1997), Syrian hamster (Donne, Viles et al. 1997; James, Liu et al. 
1997; Liu, Farr-Jones et al. 1999), chicken (Calzolai, Lysek et al. 2005), turtle 
(Calzolai, Lysek et al. 2005), frog (Calzolai, Lysek et al. 2005), cat (Lysek, Schorn 
et al. 2005), dog (Lysek, Schorn et al. 2005), pig (Lysek, Schorn et al. 2005), sheep 
(Lysek, Schorn et al. 2005), cow (Lopez Garcia, Zahn et al. 2000) , elk (Gossert, 
Bonjour et al. 2005), vole (Christen, Perez et al. 2008), wallaby (Christen, 
Hornemann et al. 2009) and human (Zahn, Liu et al. 2000) have been published.  
The NMR structures show that the secondary structure is highly conserved 
throughout the mammalian species (see Table 2.2) with three α-helices (labelled 
helix 1, 2 and 3) and two β-strands (S1 and S2) always present.  The numbers of 
amino acid residues creating helix 1 and β-strands S1, S2 are conserved throughout 
the mammalian species each containing 12 residues and 3 residues respectively.  The 
lengths of helix 2 and 3, however, differ dramatically with mouse having the shortest 
α-helices (14 residues helix 2 and 17 residues helix 3) compared to voles and 
humans which consist of 22 residues in helix 2 and 28 residues in helix 3 
respectively.  It is thought that these differences in the tertiary structure could 
contribute to the species barrier (see Section 2.11) 
 
A comparison of truncated recombinant mouse (MoPrP), hamster (SHaPrP), elk 
(ePrP) and human PrP (HuPrP) NMR structures show that the three-dimensional 
structure is similar (see Figure 2.7b).  This similarity is expected because of the high 
sequence identity between the proteins.  There are local differences between the 
backbone conformations of the four proteins especially in helix 3 and the nearby 
loop between β-sheet S2 and helix 2.  In elk (vole and wallaby also) residues 165-
175 define a 310-helical turn in the loop connecting β-strand 2 to the helix 2 
(Christen, Hornemann et al. 2009; Christen, Perez et al. 2008; Gossert, Bonjour et 
al. 2005).  This feature is in contrast with the mouse, hamster, human and all other 
mammalian PrP structures where a disordered loop region has been observed.  Helix 
3, in MoPrP, ends at residue 217 and a kink is observed in segment 219-222 before 
the chain forms a helix-like turn, whereas a regular α-helix is formed in SHaPrP, 
ePrP and HuPrP (Zahn, Liu et al. 2000).  This kink can be seen in Figure 2.7b.  
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Differences in the helix 3 and loop residues 165-175 are of specific interest as there 
is a hypothesis that this is the binding site for protein X which may aid the 
conversion of PrPC to PrPSc.  (See Section 2.9 for protein X explanation). 
 
 
Figure 2.7:  Representations of the three-dimensional structures of cellular prion proteins.  
(a). Cartoon representation of the NMR structure of recombinant SHaPrP(90-231) in 
aqueous solution indicating the positions of the three α-helices (Helix 1,2 and 3) and the two 
anti-parallel β-strands (S1 and S2), drawn in Pymol.  (b) Superposition of the NMR 
structures of the polypeptide segment 121-231 of SHaPrP (red), MoPrP (yellow), HuPrP 
(blue) and ePrP (green).  Structures have been superimposed to obtain the best fit of the 
polypeptide backbone residues 124-228.  The flexible loop region has been highlighted.   
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Table 2.2:  The positions and lengths of α-helices (1, 2 and 3) and β-strands (S1 and 
S2) in the NMR structures of a variety of recombinant PrP mammalian species.  
Mammal PrP 
Construct 
Helix 1 Helix 2 Helix 3 S1 S2 pH 
Syrian 
Hamster  
SHa(29-231) 144-156 172-193 200-227 137-
140* 
160-163 5.2 
Syrian 
Hamster  
SHa(90-231) 144-156 172-193 200-227 129-131 161-163 5.2 
Human  h(23-230) 144-154 173-194 200-228 128-131 161-164 4.5 
Human  h(90-230) 144-154 173-194 200-228 128-131 161-164 4.5 
Mouse  m(23-231) 144-154 179-193 200-217 128-131 161-164 4.5 
Mouse  m(121-231) 144-154 179-193 200-217 128-131 161-164 4.5 
Cow  b(23-230) 144-154 173-194 200-226 128-131 161-164 4.5 
Red-eared 
slider turtle  
t(121-225) 144-154 174-188 200-226 128-131 161-164 4.5 
Bank Vole  bv(121-231) 144-156 172-194 200-225 128-131 161-164 4.5 
Tammar 
Wallaby  
tw(121-231) 144-153 172-189 200-226 128-131 160-163 4.5 
Cat  f(121-231) 144-154 174-194 200-226 128-131 161-164 4.5 
Dog  c(121-231) 144-154 174-194 200-226 128-131 161-164 4.5 
Pig  sc(121-231) 144-154 174-194 200-226 128-131 161-164 4.5 
Sheep  ov[H168](12
1-231) 
144-154 174-194 200-226 128-131 161-164 4.5 
Elk  e(121-231) 144-155 172-190 200-225 128-131 160-163 4.5 
*The NMR data did not suggest a β-sheet between residues 128/129-131 as observed in all 
other species, instead a β-sheet was proposed to be located at residues 137-140.  This may 
reflect the poor resolving power of the technique as the β-sheet is very small and essential 
residues could not be detected (Gossert, Bonjour et al. 2005).  Alternatively it could indicate 
that there is a different native conformation for this protein.  The full-length structures are 
only partially assigned because of missing assignments caused by residues moving and 
exchange-broadening in the NMR spectrum. 
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2.8.2 Structure of PrP
Sc
 
A variety of conflicting structures for PrPSc have been proposed but to date no NMR 
structures of PrPSc have been published.  This could be due to the difficulties in 
purifying the protein and its propensity to aggregate.  A model structure for PrPSc, 
residues 108-217 only, has been proposed in which the unstructured N-terminal tail 
and helix 1 are in β-sheet conformations.  The overall structure of this model 
contains a four-stranded β-sheet with one face covered by two α-helices (Huang, 
Prusiner et al. 1995) (see Figure 2.8b).  NMR structural studies of a reduced short-
lived intermediate state, namely reduced β-PrP*, have been performed (Hosszu, 
Trevitt et al. 2009).  This structure showed that helix 1 and 3 have the same α-helical 
characteristics as PrPC, whereas helix 2 exhibited little evidence of having any α-
helical features.  From these results it was proposed that helix 2 is the region likely 
to interact with PrPSc and transform into β-sheets – this is in contrast to the previous 
model.  Negative stained electron crystallography has been used to characterise 2D 
crystals of two infectious variants of the prion protein (Wille, Michelitsch et al. 
2002).  The 2D crystal diffraction patterns suggest that PrP 27-30 can adopt a 
parallel β-helical fold.  When these constraints were applied to modelling studies the 
result was a protein conformation with the C-terminal α-helices and glycosylation 
sites on the periphery of the oligomer and the highly flexible N-linked sugars 
pointing above and below the plane of the oligomer.  This was the only conformation 
which could fit into the electron micrscopy (EM) density observed and be 
compatible with the amount of β-sheet structure observed by FTIR studies (see 
Figure 2.8 a and c).    
 67 
 
 
Figure 2.8:  Representation of the three-dimensional structures of plausible scrapie prion 
proteins.  (a) PrPSc model of SHaPrP(90-231) created from FTIR data (Pan, Baldwin et al. 
1993).  (b) Plausible tertiary structure model for HuPrPSc(108-217) adapted from (Huang, 
Prusiner et al. 1995).  (c) Model created from EM data showing the side-view of β-helical 
model of PrP27-30 taken from (Wille, Michelitsch et al. 2002). 
2.9 Conversion 
The biosynthesis pathway of PrPC begins in the endoplasmic reticulum (ER) and is 
directed to the cell membrane by a signal peptide.  After its release from the ER the 
PrPC journeys through the Golgi apparatus where glycosylation and the addition of 
the GPI moiety take place (Caughey 1991).  It takes approximately 60 minutes for 
the mature PrPC to cycle from the Golgi apparatus to its final position which is GPI-
anchored onto the cell membrane where it is predominantly located in specialised 
detergent-resistant microdomains known as caveolae.  Once at the cell surface the 
half life of PrPC is between 3-6 hours (Borchelt, Scott et al. 1990; Caughey, Race et 
al. 1989; Caughey and Raymond 1991; Yedidia, Horonchik et al. 2001) in which 
time it will be either catabolised/secreted or released from the cell surface (see 
Figure 2.9).   
a
H3 H4
N-terminal 
C-terminal S2b
S2a
S1b
S1a
b
c
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Figure 2.9:  Schematic representation of the proposed PrPC synthesis and cell-turn over pathway for the conversion of PrPC into PrPSc. 
The exact conversion site for PrPC to PrPSc is not known.  It is believed to occur by a 
post-translational modification (glycosylation) once PrPC reaches the cell membrane.  
In scrapie infected cells, PrPC molecules destined to become PrPSc exit the cell 
surface before conversion into PrPSc (Prusiner 1996).  PrPC can then re-enter the cell 
using a subcellular compartment in caveolae or early endosomes.  PrPC can migrate 
to late endosomes of lysosomes via caveolae-containing endocytic structures and can 
be either converted into PrPSc or partially degraded under non-acidic conditions.  
PrPSc is trimmed at the amino acid terminus in an acidic compartment in scrapie-
infected cultured cells, to form PrP 27-30 (Prusiner 1996) (see Figure 2.10).  PrPSc 
can accumulate in the cytosol to form aggregates which are resistant to protease 
digestion.  The minimal number of residues required for PrP to transmit disease has 
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Figure 2.9:  Schematic representation of the proposed PrP  synthesis and cell turn-over
pathway for the conversion of PrP  into PrP . Adapted from (Collins, Lawson et al. 2004).
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been investigated.  Rogers et al used in vitro mutagenesis studies to show that the 
deletion of residues 23-88 or the removal of the GPI-anchor did not alter the 
synthesis of PrPSc (Rogers, Yehiely et al. 1993). 
 
In contrast to previous studies (Caughey 1991), it has been observed that 
glycosylation of PrPC is not essential for the formation of PrPSc.  The presence of 
bulky oligosaccharides is thought to interfere with the conversion of PrPC to PrPSc.  
In circumstances where glycosylation was prevented, the rate of PrPSc synthesis 
actually increased (Lehmann and Harris 1997; Taraboulos, Scott et al. 1995) 
 
Figure 2.10:  Schematic representation showing the probable sites of PrPSc formation 
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Figure 2.10:  Schematic representation showing the probable sites of PrP  formation.
1. N-terminal of PrP  is cleaved
2. Glycosylation and GPI moiety added
3. Removal of the C-terminal domain
4. Transport to cell membrane
5. GPI-anchored to cell membrane and remains here between 3-6 hours before being recycled
6. Post-translation modification of PrP  to PrP
7. PrP  transportion into cell via caveolae and converted to PrP  or degraded
8. N-terminus trimmed to leave PrP27-30
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2.9.1 Models of conversion 
Two different models have been postulated for the conversion of PrPC to PrPSc with 
the exact mechanism still not fully understood.  Both models predict that the 
infectious protein interacts with endogenous PrPC to induce a conformational change 
generating PrPSc.   
 
2.9.2 Template-assisted model 
In this model the hypothesis is that PrPSc can act as a seed or template in the 
conversion of host PrPC to PrPSc (Jarrett and Lansbury 1993; Prusiner 1996; 
Weissmann 1996).  It is postulated that spontaneous fluctuations in the PrPC 
structure can form a partially folded protein intermediate named PrP* (Ceciliani and 
Pergami 2001; Weissmann 1999).  For partial unfolding to occur an external catalyst 
such as a chaperone or an unknown protein (referred to as protein X) may be 
required.  This metastable intermediate has potentially been identified, in the 
refolding of PrP 27-30 from a denatured state, by fluorescence and CD spectroscopy 
(Safar, Roller et al. 1994).  Exogenously introduced PrPSc can interact with this 
intermediate to induce a conformational change in PrPC to yield further PrPSc 
structures (see Figure 2.11a and b).  Mechanistic analyses have shown that the PrP 
conversion is induced by PrPSc aggregates or polymers and not by soluble, 
monomeric forms of PrP (Caughey, Kocisko et al. 1995).  The presence of the PrP* 
intermediate state is proposed to lower the activation energy required for a 
spontaneous conversion of the predominantly α-helical protein form to a β-sheet rich 
structure.  For this mechanism to be successful a small amount of PrP* would have 
to be present in normal brain tissue which would normally undergo an insignificant 
rate of conversion to PrPSc.  In the case of infectious prion diseases, exogenous PrPSc 
could act as a template for the reaction with the PrP* and promote the conversion of 
PrP* to PrPSc (Ceciliani and Pergami 2001).  In genetically inherited diseases such as 
familial CJD and GSS, mutations in the gene sequence could help destabilise the 
PrPC structure thereby increasing the population of the PrP* intermediate and 
enhancing the rate of the spontaneous PrPC to PrPSc conversion (Cohen, Pan et al. 
1994; Harrison, Bamborough et al. 1997; Huang, Gabriel et al. 1994).  This 
proposed model is a first-order reaction with the only rate limiting step being the 
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transition of PrPC to PrPSc.  It has been speculated that this conversion occurs by the 
initial binding of PrPSc to PrPC, via a localised site close in proximity to the C-
terminal end of the third helix.  This then slowly converts PrPC into the infectious 
form of PrPSc (Bessen, Raymond et al. 1997; Caughey, Kocisko et al. 1995; 
DebBurman, Raymond et al. 1997; Horiuchi and Caughey 1999).  There is evidence 
to support that this conversion is a first order reaction.  Scrapie incubation time 
period studies suggest that the level of PrPC expression is inversely proportional to 
the incubation period. (Carlson, Ebeling et al. 1994; Prusiner, Scott et al. 1990).   
 
2.9.3 Nucleated Polymerisation model 
In this model it is proposed that PrPC and PrPSc are in a reversible equilibrium with 
PrPC as the strongly favoured structure.  The PrPSc structure can be stabilised, and 
the equilibrium reversed, when additional monomeric PrPSc units are attached to 
create a crystal-like seed model (Weissmann 1999).  In the absence of this rare 
crystal-like seed or pre-existing aggregates the conversion between PrPC and PrPSc is 
reversible.  The crystal-like seed or complex aggregates can act as a stable nucleus 
and promote the rapid addition of further monomeric PrPSc units (Brown, Goldfarb et 
al. 1991; Jarrett and Lansbury 1993).  This addition of monomeric units continues 
until large aggregates are formed which can then fragment to create new crystal-like 
seeds and allow the reaction cycle to start again (see Figure 2.11b).  This rapid 
fragmentation process to create a new seed would account for the exponential 
conversion rate observed (Weissmann 1999).  The rate limiting step of this reaction 
would be the formation of the stable nucleus and therefore this conversion model 
would be a multi-step high order reaction (Jarrett and Lansbury 1993).  It is believed 
that yeast prion propagation and conventional amyloid fibril formation occur by this 
nucleated polymerisation mechanism (Caughey 2001). 
 
Conversion studies in vitro have shown the mechanism to have many similar 
features to the nucleation polymerisation model.  These similarities include the 
requirement to exceed a critical protein concentration prior to the formation of 
aggregates and the observation of a lag phase in kinetic experiments, equivalent to 
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the slow addition of monomeric PrPSc units, suggests a higher order reaction (Jarrett 
and Lansbury 1993). 
An alternative theory is that the conversion of PrPC to PrPSc could be a combination 
of both models.  Horwich et al, propose that the conversion mechanism could be a 
hybrid of both the template-assisted and the nucleation polymerisation model 
whereby a nucleation seed is initially formed which can then catalyse the 
conformational change in PrPC to PrPSc (Horwich and Weissman 1997).  
 
2.10 Prion strains 
The concept of the prion strain emerged when observations that distinct versions of 
prion diseases, which differ in their symptomatic and biochemical properties, could 
occur in the same species without a change in the PrP gene being detected 
(Dickinson and Meikle 1971).  It was speculated that strain-specific properties of 
prions could be encoded by the PrP genome but to date there has been no significant 
evidence to support this hypothesis (Weissmann 1991).  An alternative theory is that 
PrPSc can exist in a variety of distinct pathological conformations each of which can 
act as a template for the conversion of PrPC; this template can impart the new novel 
conformation resulting in an accumulation of the distinct pathological strain.  There 
is evidence from the yeast Sup35 prion model that strain phenotypes can be encoded 
in for a variety of different conformations all of which are stable against chaotropic 
salts and heat. (King and Diaz-Avalos 2004; Tanaka, Chien et al. 2004; Tanaka, 
Collins et al. 2006) 
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Figure 2.11:  Schematic representations of the various proposed models of conversion.  (a) 
The “refolding” model.  The conformational change is kinetically controlled, a high 
activation energy barrier preventing spontaneous conversion at detectable rates.  Interaction 
with exogenously introduced PrPSc causes PrPC to undergo an induced conformational 
change to yield PrPSc. This reaction may involve extensive unfolding and refolding of the 
protein to explain the postulated high energy barrier and could be dependent on an enzyme 
or chaperone.  Adapted from (Weissmann 1999).  Template assisted model.  1. In the initial 
step PrPC binds to protein X to form a complex.  2. PrPSc interacts with the new PrP*/protein 
X complex.  3. PrP* is converted to PrPSc, releasing protein X and forming a PrPSc dimer.  
Adapted from (Weissmann 1999).  Nucleated polymerisation model of PrPSc formation.  
PrPC and PrPSc are in a reversible equilibrium strongly favouring PrPC.  PrPSc is stabilised 
x
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when several monomeric PrPSc units add together to form aggregates or crystal-like seed 
structures.  Seed formation is a rare event; once a seed is present, monomer addition can 
ensue at a rapid rate.  It is believed that the aggregates are continuously fragmented to 
account for the exponential conversion rates.  Adapted from (Ceciliani and Pergami 2001; 
Weissmann 1999). 
2.11 Species barrier 
There are suggestions that differences in the PrP amino acid sequence are the major 
contributing factor to a transmission species barrier (Kocisko, Priola et al. 1995; 
Prusiner 1995; Prusiner, Scott et al. 1990; Raymond, Bossers et al. 2000; Scott, 
Kohler et al. 1992).  There is a high sequence identity between bovine and ovine PrP 
with differences in only seven amino acid positions; in comparison the differences 
between bovine and human differ by more than 30 amino acid positions (Figure 
2.12).  Two pairs of uniquely shared amino acid substitutions have been identified in 
the PrP gene sequence of cattle and great apes (including humans) (Krakauer, Pagel 
et al. 1996).  Speculations that these unique substitutions allow the successful 
transmission of BSE across the species barrier, in the form of v-CJD, and may also 
have prevented the transmission of scrapie to humans (Krakauer, Pagel et al. 1996).  
Alternatively, it is postulated that similarities in the secondary and tertiary structure 
of PrP molecules can enable a successful transmission of a TSE agent (Caughey, 
Raymond et al. 1998; Safar, Wille et al. 1998; Telling, Parchi et al. 1996).   
 
The apparent sporadic transmission of scrapie suggests there are limiting factors 
which prevent the successful transmission of PrP across the species barrier.  Scrapie 
in sheep can exist in a variety of strains, but only a select few can be readily 
transmitted to other sheep and goats.  In contrast, BSE appears to be caused by a 
single strain and can be transmitted to humans (v-CJD) as well as cattle.  It has been 
previously described that a single amino acid substitution in the host/donor PrP can 
have a profound effect on targeting the TSE strains in the CNS of the recipient 
species and can alter the disease pathology of a specific TSE agent (Barron, 
Thomson et al. 2001).  NMR structural analysis of recombinant human (Zahn, Liu et 
al. 2000), hamster (Donne, Viles et al. 1997) and mouse (Riek, Hornemann et al. 
1997) PrP identified significant sequence differences in the α-helix 3 region and the 
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loop residues 167-171 and it is has been suggested that these differences could alter 
the species specificity (see Figure 2.7b).  A small number of residues, located from 
codon 101 to 143, were found to be central to the prion species barrier (Schatzl, Da 
Costa et al. 1995).  Residues that are considered important for the species barrier 
have been mapped onto the three-dimensional structure of PrP (Riek, Hornemann et 
al. 1996).  These residues were found to be part of the hydrophobic core region or 
are located on the surface of the protein.  It was implied that the positions of these 
residues could destabilise the structure or influence the protein’s ligand binding 
properties.  Barron et al. (Barron, Thomson et al. 2001) demonstrated that a single 
mutation in the N-terminal flexible region of PrP could allow the efficient 
transmission of a strain of the agent across the species barrier to animals that would 
not have normally have succumbed to the disease.  It is likely that the key domain(s) 
within a protein and the strain of the infectious agent are important contributing 
factors to the species barrier.  Understanding prion strains and the species barrier is 
of paramount importance with respect to the BSE epidemic in Britain.   
2.12 Function 
The physiological role of PrPC is still debated, with data suggesting a number of 
possible functions including immunoregulation, signal transduction, synaptic 
transmission, antioxidant action, cell adhesion, copper binding and many others 
(Aguzzi and Polymenidou 2004; Choi, Kanthasamy et al. 2006).  Studies have 
shown that knockout mice lacking the PrP gene (Prnp0/0) develop and behave 
normally and showed no sign of scrapie clinical symptoms (Bueler, Fischer et al. 
1992).  In comparison to the control mice, PrP-null mice have shown brain 
abnormalities in the structure of the hippocampus (Collinge, Whittington et al. 
1994), have an altered circadian rhythm and disrupted sleep patterns (Tobler, Gaus et 
al. 1996).  Further Prnp0/0 studies showed that the synaptosomal fractions of the wild 
type mouse brain, and cultured cell lines, contained more copper than their knockout 
counterparts.  
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Figure 2.12:  Sequence alignment for human, bovine and ovine PrP.  Residues aligned using the nearest neighbour fit in Cluster. 
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One possible protective physiological function of PrPC is as an antioxidant.  It has 
been reported that Cu2+ can bind to the N-terminal of the protein, as a response to 
oxidative stress, to induce endocytosis of PrPC (Linden, Martins et al. 2008; Vassallo 
and Herms 2003).  Copper is an essential element for life and has numerous roles 
within the human body including acting as a catalyst in the transportation of iron, 
synthesis of collagen, coagulation of blood (Linder and Hazegh-Azam 1996) and, of 
particular significant to prion research, the synthesis of neurotransmitters (Georgieff 
2007).  Copper located in synapses  can play an important role in the gamma-
aminobutyric acid (GABA) feedback system and glutamate uptake (Gabrielsson, 
Robson et al. 1986).  It is widely accepted that PrPC can bind copper in a cooperative 
manner and there is some indication that it is involved in the homeostasis of copper 
within the body (Brown, Qin et al. 1997; Viles, Cohen et al. 1999).  In CJD patients, 
the levels of copper located in the brain are significantly decreased with similar 
effects/changes also observed in mice infected with scrapie.   
 
The highest concentration of PrPC is found in brain tissue.  If PrPC is consumed it is 
intestinally digested where it can be absorbed into the blood and transported to 
lymphoid fluids.  After this initial transportation, PrPC can be replicated at sites 
including the spleen, muscles, tonsils, appendix and a region in the intestines known 
as the Peyer’s patch (see Figure 2.13).  These newly replicated prions are then 
transported to the brain by the peripheral nerves where they cross the brain-blood 
barrier and accumulate in brain (Aguzzi and Heikenwalder 2006).  PrPC can also be 
expressed in neurons and glia, which would account for the high PrPC dosage located 
in brain tissues.  Due to its GPI-anchored location on the cell surface it is believed 
PrPC may have a functional role in cell adhesion and recognition, ligand uptake, or 
transmembrane signalling.   
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Figure 2.13:  Schematic representation of the human tissues and blood involved in the 
propagation and transport of prions.  Orally ingested prions are intestinally absorbed and 
transported to the blood and lymphoid fluids.  After a peripheral replication step prions are 
primarily transported to the brain via the peripheral nerves.  The prions cross the blood-brain 
barrier to accumulate in brain tissues.  Adapted from (Aguzzi and Heikenwalder 2006). 
2.13 What causes cell death? 
It is debated whether the accumulation of PrPSc or the loss of PrPC function is the 
actual cause of cell death in prion diseases.  Experiments show that PrPSc 
accumulation in the brain and the resulting extracellular aggregates/amyloid fibrils, 
can promote nerve cell loss and lead to neuronal death (Forloni, Angeretti et al. 
1993).  Conversely, it has been shown that PrP peptides can induce lipid vesicle 
fusion and it is believed that it is this PrP fusogenic property which causes neuronal 
death by destabilising the cellular membrane (Pillot, Lins et al. 1997).  There is also 
a hypothesis that PrPC can influence the activity of Cu/Zn superoxide dismutase 
which is important in the cell’s defence against oxidative stress (Brown, Schulz-
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Schaeffer et al. 1997).  The conversion of PrPC to PrPSc leads to this oxidative stress 
defence being lost allowing neurons to be exposed to increased oxidative stress 
levels.   
 
2.14 Clinical diagnosis 
2.14.1 PrP concentration in blood 
The concentration of PrPSc in plasma and red blood cells is estimated to be 
approximately 5-10 fold lower than in the buffy coat.  The buffy coat contains 
leukocytes and platelets and contributes to 1% of the whole blood cell and can be 
separated from the red and white blood cells by centrifugation.  Using rodent 
models, infectivity studies have shown that during the incubation period of prion 
disease the maximum concentration of PrPSc in the buffy coat, in circulating blood, is 
5-10 infectious units (IU) mL-1.  At the onset of disease the concentration of PrPSc 
increases to approximately 100 IU mL-1 (Soto 2004).  One picogram (pg) of PrPSc is 
estimated to contain 100 IU, therefore the estimated concentration of PrPSc in the 
buffy coat is expected to be 1 pg mL-1 (~3 x 10-14 M) and 0.1 pg mL-1 (~3 x 10-15 M) 
during the symptomatic and pre-symptomatic phases respectively (Soto 2004).  The 
concentration of PrPSc is an order of magnitude lower in whole blood, so that a blood 
test from pre-symptomatic patients would have to detect PrPSc in the femtomolar 
concentration range (Soto 2004).  For a feasible pre-symptomatic blood assay to be 
developed PrPSc would either have to be concentrated or amplified prior to analysis.  
 
2.14.2 Current post-mortem tests 
Brain histology assays are the most accurate method for identifying TSEs in post-
mortem samples; however, this procedure can be labour-intensive, expensive and has 
an extremely low throughput.  After the BSE crisis in Britain, the European 
Commission approved five tests for the post-mortem detection of BSE in cattle (see 
Table 2.3).  The majority of these tests are designed to detect PrP 27-30 after the 
sample has been subjected to proteinase K digestion.  A disadvantage of using this 
physical property as a diagnostic test is the evidence for a new proteinase-sensitive 
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prionopathy (PSPr) which is detergent insoluble but sensitive to protease digestion.  
The current approved tests cannot detect this new prionopathy which accounts for 
3% of all sporadic CJD cases in humans and an unknown number in cattle 
(Gambetti, Dong et al. 2008).  The majority of these tests are either labour–intensive 
or have a potentially high false-positive rate at the biologically relevant prion 
concentrations.  It is unlikely that these tests would successfully diagnose pre-
symptomatic disease due to their restricted detection limits.  An ante-mortem test is 
required to prevent pre-clinical BSE cattle from entering the food chain and to 
safeguard the blood supply from asympotomatic carriers donating blood.  
 
Table 2.3:  Summary of European Commission approved post-mortem tests for the 
detection of altered and infectious PrP isoforms in cattle brains (Soto 2004). 
Technique Principle Detection 
limit 
(pmol) 
Advantages Disadvantages 
Prionics-Check 
Western test 
Gel 
electrophoresis 
and Western 
blot 
5.0-20 Good 
reproducibility, 
low rate of 
false-positives 
Low 
throughput, 
low sensitivity.  
Dependent on 
proteinase K 
digestion 
Enfer test Enzyme-linked 
immunosorbent 
assay (ELISA) 
1.0-10 Rapid and 
simple 
Potential for 
false-positives. 
Dependent on 
proteinase K 
digestion 
CEA/Biorad test Sandwich 
ELISA using 
two different 
monoclonal 
antibodies 
0.5-2.0 High 
sensitivity 
Long and 
labour-
intensive.  
Potential for 
false-positives. 
Dependent on 
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proteinase K 
digestion 
Prionics-Check 
LIA test 
Sandwich 
ELISA using 
two different 
antibodies to 
detect 
proteinase K 
resistance 
1.0-5.0 Rapid, 
automated and 
simple 
Variability 
depending on 
sample 
preparation.  
Potential for 
false-positives. 
Dependent on 
proteinase K 
digestion 
Conformational-
dependent 
immunoassay 
Differential 
antibody-
binding to 
native and 
denatured PrP 
0.5-5.0 High 
sensitivity. 
Independent of 
proteinase K 
digestion 
Complicated, 
time 
consuming and 
labour 
intensive  
 
2.14.3 Pre-mortem tests 
The effective treatment of TSE sufferers requires a pre-clinical diagnostic test to be 
developed.  It is known that by the time a patient is exhibiting clinical symptoms the 
brain alterations are too extensive to be reversed and therapeutic treatment is no 
longer an option.  It has been shown in animal models that early treatment of TSEs 
can delay the onset of disease thereby extending their life expectancy (Soto 2004).  
Animal infectivity bioassays are methods which directly measure the presence of 
prions and the infectious PrPSc agent.  Widespread use of these invasive bioassays is 
limited as it can take months or years to obtain a result.  Recent developments have 
seen research into non-invasive diagnostic tests which include analysis of bodily 
fluids, tonsil tissue following a tonsillectomy, and screening of appendicectomy 
samples.  The screening of 16,703 patients revealed that three appendicectomy 
samples showed lymphoreticular accumulation of prion protein but this pathology 
could not be related to v-CJD (Hilton, Ghani et al. 2004).  Other research has led to 
the development of three putative PrPSc-specific antibodies that discriminate between 
PrPC and PrPSc (Paramithiotis, Pinard et al. 2003; Serbec, Bresjanac et al. 2004; Zou, 
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Zheng et al. 2004).  Further work is required to analyse the sensitivity and specificity 
of these antibodies before a diagnostic test can be developed.  An alternative strategy 
to increase the sensitivity for PrPSc is first to concentrate or amplify the sample prior 
to detection.  Protein misfolding cyclic amplification (PMCA) is an in vitro 
technique that mimics the replication of prions in vivo (Saborio, Permanne et al. 
2001).  Samples are subjected to cycles of incubation and sonication in the presence 
of PrPC which accelerates the replication of PrPSc in the sample and can lead to a 
several-million fold increase in sensitivity (Saa, Castilla et al. 2006).  PMCA 
experiments have been used successfully to detect PrPSc in pre-clinical hamster 
blood (Saa, Castilla et al. 2006).      
 
2.15 Aims 
The aim of this work is to develop and evaluate a mass spectrometry-based method 
to distinguish between the prion isoforms and assess the technique’s potential to be 
used as an ante-mortem diagnostic test.   
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This chapter is divided into two sections.  The first section describes the expression 
and purification of recombinant prion proteins and the characterisation methods used 
to study their structure.  The second section describes the materials and methods 
used to characterise synthetic polymers. 
3.1 Prions 
3.2 Material Suppliers 
All chemical reagents were of analytical grade and obtained from the following 
sources unless otherwise stated: 
• American Type Culture Collection (USA) • GE Healthcare (UK) 
• BHD Lab Supplies (UK) • Melford Laboratories Ltd (UK)  
• Bio-rad Laboratories (UK) • Merck kGaA (Germany) 
• Fisher Scientific (UK) • Qiagen (UK) 
• Fluka Chemika (UK) • Sigma Aldrich (UK) 
 
Dialysis tubing with a 7000 molecular weight cut-off was obtained from Medicell 
International Ltd (London, UK).  Spin columns with a 10,000 molecular weight cut-
off were obtained from Millipore Corporate (Watford, UK).  Coomassie protein 
assay reagents and molecular weight markers were obtained from Pierce (Illinois, 
USA).  All other chemicals were purchased from Sigma-Aldrich (Poole, UK) unless 
otherwise stated.   
 
3.3 Safety 
All recombinant PrP expression procedures were carried out in a containment level 
three laboratory.  Recombinant PrP was expressed in Escherichia coli and all cells 
were harvested and disrupted whilst in the containment level three laboratory.  The 
recombinant PrP was solubilised in 8 M GdnHCl and filtered through a 0.22 µM 
membrane before it was removed from the containment laboratory.  Further protein 
purification was carried out under a class II hood.  Decontamination and disposal of 
waste was carried out in accordance to the Health and Safety Executive guidelines 
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“Precautions for work with human and animal transmissible spongiform 
encephalopathies”.    
 
3.4 Expression, purification, and refolding SHaPrP(90-231) 
Recombinant Syrian hamster prion protein SHaPrP(90−231) was expressed using an 
alkaline phosphatase promoter in a protease-deficient strain of E. coli 27C7 as 
described by Mehlhorn et al (Mehlhorn, Groth et al. 1996).  The prion protein was 
purified from inclusion bodies and refolded into an α-helical structure (α-
SHaPrP(90-231)) under oxidising conditions, as previously described (Sanghera and 
Pinheiro 2002).   
 
The conversion of α-SHaPrP(90-231) to β-sheet-rich structures was carried out using 
a similar protocol to that described by Martins et al., (Martins, Frosoni et al. 2006).  
100 µM of recombinant α-SHaPrP(90-231) in 5 mM ammonium formate, pH 5.5 
buffer was incubated at 70 °C for 24 hr.    
 
3.5 Expression, purification, and refolding SHaPrP(23-231) 
The plasmid (pTrc) encoding full-length SHaPrP(23-231) was transformed into in E. 
coli strain BL21* Rosetta.  Transformed cells were grown in 1 L of Terrific Broth 
supplemented with 100 µg/mL ampicillin and 35 µg/mL chlorampenicol until an 
absorbance of 0.6 at 600 nm was reached.  Protein expression was induced by the 
addition of isopropyl thio-β-D-galactoside to a final concentration of 1 mM and the 
cultures were grown for a further 4 hours.  The recombinant protein accumulated in 
inclusion bodies within the cytoplasm.  The protocol for the purification of PrP was 
adapted from Bocharova et al., (Bocharova, Breydo et al. 2005).  Briefly, the cells 
were harvested by centrifugation at 4000 rpm for 30 min at 4 °C and re-suspended in 
cell lysis buffer; 50 mM Tris / 1 mM EDTA / 100 mM NaCl, pH 8.0 containing 0.2 
mg/mL lysozyme, 1 mg / mL deoxycholic acid and 10 µg / mL DNase.  Cells were 
lysed by stirring at 4 °C for 3 hours and centrifuged at 15000 rpm for 15 mins to 
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isolate the inclusion bodies containing PrP.  The inclusion bodies were solubilised in 
buffer consisting of 8 M urea / 10 mM TrisHCl / 100 mM sodium phosphate 
containing 10 mM β-mercaptoethanol, pH 8.0 and centrifuged at 15000 rpm for 15 
mins to remove insoluble material.  The solublised inclusion bodies were applied to 
a Ni-NTA column (Qiagen) and eluted with 8 M urea, 10 mM Tris / HCl, 100 mM 
sodium phosphate and 10 mM β-mercaptoethanol, pH 4.5.  Fractions containing PrP, 
as identified on SDS PAGE gels, were pooled and diluted 2 fold with 50 mM 
HEPES, pH 8.0 buffer containing 8 M urea and 10 mM DTT and incubated 
overnight at 4 °C.  PrP was further purified by application to a cation exchange 
column (SP-Sepharose, Amersham Biosciences) and eluted with a 50 mM HEPES 
buffer, pH 8.0 containing 8 M urea and 1.5 M NaCl.  Fractions containing PrP were 
pooled and diluted to 0.1 – 0.5 mg/mL with 50 mM HEPES buffer containing 8 M 
urea and oxidised using a 5 M excess of Cu2+.  The protein solution was stirred 
overnight and refolded the following day by dialysis into four changes of 5 mM 
MES, pH 5.0 containing 10 mM EDTA.  Protein was concentrated and PrP 
concentration was determined spectrophotometrically using an extinction coefficient 
of ε280 61,240 mol
-1 dm3 cm-1.   
 
3.6 Expression, purification, and refolding Mouse and Ovine PrP 
Expression and purification of MoPrP(90-231), MoPrP(23-231) and OvPrP(23-231) 
were carried out by Dr Narinder Sanghera (Department of Biological Sciences, 
University of Warwick, UK).  The plasmid (pET 23a) encoding MoPrP was 
transformed into in E. coli strain BL21* Rosetta and recombinant ovine prion protein 
was expressed using an alkaline phosphatase promoter in a protease-deficient strain 
of E. coli 1B 392.  The expression and purification procedure was the same as the 
full-length SHaPrP(23-231) described above.   
 
 
 101 
 
3.7 Synthesis and purification of bovine octapeptide (BovPrP(57-
101)  
The synthetic peptide was provided by Dr Andrew Gill (Neuropathogenesis 
Division, Roslin Institute, University of Edinburgh, UK).  All work was undertaken 
in the proteomics facility of the Institute for Animal Health and a brief description of 
the procedure is described below.  A model peptide mimicking the N-terminal 
octapeptide repeat region of PrP was synthesised by standard Fmoc-chemistry by 
means of an automated pioneer synthesiser (Perseptive Biosystems).  The peptide 
sequence was (GGGWGQPH)5GGGGW.  After synthesis, peptides were purified on 
a reversed-phase C18 HPLC column, lyophilised and checked for identity and purity 
by means of ESI-MS and ESI-MS/MS. 
3.8 Characterisation of purified recombinant PrP 
Various analytical methods were used to study the purity and secondary structure of 
the refolded recombinant samples.  
 
3.8.1 SDS-polyacrylamide gel electrophoresis 
The sample purity and molecular weight of the recombinant proteins were analysed 
by means of 15% mini polyacrylamide gels.  Each sample was mixed with sample 
buffer and heated to 100°C for 5 min until denatured.  All gels were visualised using 
Coomassie brilliant blue.  The presence of a single protein band on the gel, within 
the correct molecular weight range, suggested a high purity of the sample (see Figure 
3.1).  The exact molecular weight of the prion protein was determined by means of 
mass spectrometry.   
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Figure 3.1:  Coomassie stained 15% polacrylamide gel.  Lane: (1) Molecular weight 
standards.  (2) Purified SHaPrP(23-231). 
 
3.8.2 Infrared spectroscopy 
The secondary structure of the refolded proteins was analysed by means of infrared 
spectroscopy.  Attenuated total reflection (ATR) Fourier transform infrared (FTIR) 
spectra were acquired on a Bruker Vector 22 spectrometer equipped with a liquid 
nitrogen cooled mercury cadmium telluride (MCT) detector (Bruker, Coventry, UK).  
Spectra were recorded at room temperature at a nominal resolution of 4 cm−1 in the 
range 4000−1000 cm−1.  The spectral contribution of atmospheric water was 
minimised by the continuous purging of the sample chamber with dried air (Jun-Air; 
Kent, UK).  Residual water vapour peaks were subtracted using reference spectra 
and baseline correction was applied when necessary.  The internal reflection element 
was a germanium ATR plate (50 x 20 x 2 mm) with an aperture angle of 45°, 
yielding 25 internal reflections. 
 
A 50 µL aliquot of sample containing ~ 10 µM SHaPrP(90-231) in 5 mM 
ammonium formate buffer, pH 5.5 was deposited on the ATR plate.  A thin hydrated 
protein film was obtained by slowly evaporating the excess water under a stream of 
N2 gas.  All ATR FTIR spectra were collected after a short period of H2O/D2O 
exchange in order to aid the analysis of protein secondary structure (Goormaghtigh, 
Cabiaux et al. 1990).  Deposited protein films were subjected to a stream of D2O-
saturated nitrogen gas for 10 minutes.   
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3.8.3 Circular dichroism 
Far-UV (190–260 nm) CD spectra of SHaPrP(90-231), SHaPrP(23-231), MoPrP(90-
230), MoPrP(23-230), OvPrP(23-231) (10 µM) and were measured on a JASCO J-
815 spectropolarimeter using 1 mm pathlength quartz cuvettes.  Typically, a 
scanning rate of 100 nm/min, a time constant of one second, and a bandwidth of 1.0 
nm were used.  Spectra were measured at 20 ± 0.2 ˚C, with a resolution of 0.5 nm, 
and 16 scans were averaged per spectrum.  The buffer background was subtracted 
from the final spectra.  Samples were analysed immediately after recombinant α-
SHaPrP(90-231) and α-MoPrP(90-230) in 5 mM ammonium formate, pH 5.5 buffer 
were incubated at 70 °C for 24 hr to determine the secondary structure.  β-sheet rich 
SHaPrP(90-231) and MoPrP(90-230) spectra were recorded before and after 15 min 
sonication in a bath sonicator.  The direct CD measurements (θ, in millidegrees), 
were converted into molar ellipticity [θ]/deg cm2 dmol-1.  
 
3.8.4 Electron microscopy 
Stock solutions of β SHaPrP(90-231) were diluted to a protein concentration of 50 
µg/mL in 5 mM ammounium formate buffer, pH 5.0, applied to EM grids coated 
with carbon film, and stained with 2 % uranyl acetate.  The samples were viewed in 
a Philips CM120 electron microscope equipped with a LaB6 filament and a voltage 
of 100 kV.  Images were acquired at a magnification of 45,000. 
 
3.8.5 Mass Spectrometry  
All the parameters listed for mass spectrometry analysis of the prion protein and 
synthetic polymers are the optimised conditions.  The following parameters are for 
the analysis of recombinant truncated and full-length PrP only. 
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3.8.5.1 T-Wave Ion Mobility-Mass Spectrometry. 
All IM-MS experiments were performed in a hybrid quadrupole-ion mobility-
orthogonal acceleration time-of-flight (oa-ToF) mass spectrometer (Synapt HDMS, 
Waters, Manchester, UK).  The instrument was equipped with a nanoflow 
electrospray ion source and operated at a source temperature of 90°C.  The sample 
solutions were introduced into the source region of the instrument by direct infusion 
ESI.  The cone voltage was optimised at 40V for ESI-MS experiments.  A detailed 
explanation of the Synapt HDMS technology has been described elsewhere (Pringle, 
Giles et al. 2007).  Briefly, the machine comprises of three travelling wave (T-Wave) 
enabled stacked ion guides: trap; IM cell and transfer.  The trap ion guide is used to 
accumulate ions and releases these as ion packets into the IM cell for mobility 
separation.  The transfer ion guide is used to convey the mobility-separated ions to 
the oa-ToF mass analyser (Pringle, Giles et al. 2007).  The pressure in the T-Wave 
IM cell was 0.55 mbar in these experiments, with nitrogen employed as the mobility 
gas.  The T-Wave height and velocity were set at 9 V and 300 m/s respectively.  
 
After a release of a packet of ions from the Trap T-Wave the ToF analyser recorded 
200 orthogonal acceleration pushes (mass spectra) with the pusher frequency set at 
90 µs.  This resulted in each IM experiment being performed over an 18.0 ms time 
frame.  The ToF analyser was tuned in V-optic mode for an operating resolution of 
7,000 (FWHM).  Mass spectra were acquired at an acquisition rate of two spectra/s 
with an interscan delay of 100 ms.  Data acquisition and processing were carried out 
using MassLynx™ (v4.1) software (Waters Corp., Milford, MA, USA).  The 
resulting mass spectra were analysed and their corresponding masses were 
deconvoluted using maximum entropy (MaxEnt 1) which is an algorithm part of the 
MassLynx™ (v4.1) software. 
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3.8.5.2 Electrospray Ionisation-Mass Spectrometry 
All ESI-MS experiments were performed in a quadrupole orthogonal acceleration-
time-of-flight (Q oa-ToF) mass spectrometer (Q-ToF I, Waters, Manchester, UK).  
The instrument was equipped with a nanoflow electrospray ion source and operated 
at a source temperature of 90°C.  The sample solutions were introduced into the 
source region of the instrument by direct infusion.  The cone voltage was optimised 
at 40 V. 
 
The ToF analyser was tuned in V-optic mode for an operating resolution of 5,000 
(FWHM). Mass spectra were acquired at an acquisition rate of two spectra/s with an 
interscan delay of 100 ms. Data acquisition and processing were carried out using 
MassLynx™ (v4.0) software (Waters Corp., Milford, MA, USA). 
 
3.8.5.3 Sample Preparation (ESI) 
Ammonium formate was obtained from Sigma-Aldrich (Gillingham, UK).  All 
recombinant protein samples were diluted to a concentration of 10 µM in 10 mM 
ammonium formate pH 5.5.  The protein was analysed at two pH values pH 5.5 and 
pH 7.0.  The pH of each sample was increased to pH 7.0 using 0.1% ammonia 
solution.  ESI-MS analysis was performed by infusing a solution of recombinant PrP 
samples at pH 5.5 and pH 7.0.  Samples high in β-sheet content were sonicated for 
15 min prior to ESI-MS analysis and were sprayed immediately. 
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3.9 Metal ion coordination experiments 
Expression and purification of the recombinant proteins and peptide are described 
above. 
3.9.1 Circular dichroism 
Far-UV (190–260 nm) CD spectra of SHaPrP(23-231) (10 µM) and BovPrP (57-
101) (20 µM) were measured on a JASCO J-815 spectropolarimeter using 1 mm path 
length quartz cuvettes.  Typically, a scanning rate of 100 nm/minute, a time constant 
of one second, and a bandwidth of 1.0 nm were used.  Spectra were measured at 20 ± 
0.2 ˚C, with a resolution of 0.5 nm, and 16 scans were averaged per spectrum.  The 
buffer background was subtracted from the final spectra.  The direct CD 
measurements (θ, in millidegrees), were converted into molar ellipticity [θ]/deg cm2 
dmol-1.  
 
3.9.2 T-Wave Ion Mobility-Mass Spectrometry. 
All IM-MS experiments were performed in a hybrid quadrupole-ion mobility-
orthogonal acceleration time-of-flight (oa-ToF) mass spectrometer (Synapt HDMS, 
Waters, Manchester, UK).  The instrument was equipped with a nanoflow 
electrospray ion source and operated at a source temperature of 90°C.  The sample 
solutions were introduced into the source region of the instrument by direct infusion 
ESI.  The cone voltage was optimised at 40V for ESI-MS experiments.  A detailed 
explanation of the Synapt HDMS technology has been described elsewhere (Pringle, 
Giles et al. 2007).  The pressure in the T-wave IM cell was 0.55 mbar in SHaPrP 
(23-231) experiments and 0.64 mbar for BovPrP (57-101), with nitrogen employed 
as the mobility gas.  The T-Wave height and velocity were set at 9 V and 300 m/s, 
respectively.  
 
After a release of a packet of ions from the Trap T-Wave the ToF analyser recorded 
200 orthogonal acceleration pushes (mass spectra) with the pusher frequency set at 
90 µs.  This resulted in each IM experiment being performed over an 18.0 ms time 
frame.  The ToF analyser was tuned in V-optic mode for an operating resolution of 
7,000 (FWHM).  Mass spectra were acquired at an acquisition rate of two spectra/s 
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with an interscan delay of 100 ms.  Data acquisition and processing were carried out 
using MassLynx™ (v4.1) software (Waters Corp., Milford, MA, USA).  The 
resulting mass spectra were analysed and their corresponding masses were 
deconvoluted using a maximum entropy (MaxEnt 1) algorithm part of the 
MassLynx™ (v4.1) software. 
 
3.9.3 Electrospray Ionisation-Mass Spectrometry 
All ESI-MS experiments were performed in a quadrupole orthogonal acceleration-
time-of-flight (Q oa-ToF) mass spectrometer (Global, Waters, Manchester, UK).  
The instrument was equipped with a nanoflow electrospray ion source and operated 
at a source temperature of 90°C.  The sample solutions were introduced into the 
source region of the instrument by direct infusion.  The cone was optimised at 40 V 
for ESI-MS experiments. 
 
The ToF analyser was tuned in V-optic mode for an operating resolution of 7,000 
(FWHM). Mass spectra were acquired at an acquisition rate of two spectra/s with an 
interscan delay of 100 ms.  Data acquisition and processing were carried out using 
MassLynx™ (v4.1) software (Waters Corp., Milford, MA, USA).  The resulting 
mass spectra were analysed and their corresponding masses were deconvoluted using 
a maximum entropy (MaxEnt 1) algorithm part of the MassLynx™ (v4.1) software 
 
3.9.4 Sample Preparation (ESI) 
SHaPrP(23-231) samples were diluted to a concentration of 10 µM in 10 mM 
ammonium formate pH 5.5 and the pH of the protein sample was increased to pH 7.0 
using 0.1% ammonia solution.  BovPrP(57-101) samples were diluted to a 
concentration of 20 µM in 10 mM ammonium formate pH 7.0.  Copper sulphate 
solutions were prepared at three different concentrations 100 mM, 300 mM and 500 
mM in 10 mM ammonium formate pH 7.0.  These stock dilutions were mixed with 
the protein and peptide respectively to give a stoichiometric ratio of 1:1, 1:3 and 1:5 
PrP:Cu2+.  Manganese chloride solutions were prepared at three different 
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concentrations 100 mM, 500 mM and 1 M in 10 mM ammonium formate pH 7.0.  
These stock dilutions were mixed with the protein to give a stoichiometric ratio of 
1:1, 1:5, 1:10 and 1:20 PrP:Mn2+.  Nano-ESI-IM-MS analysis was performed by 
directly infusing a solution of SHaPrP(23-231) or BovPrP(57-101) pH 7.0 into the 
spectrometer. 
 
3.9.5 T-Wave cross-section calibration 
Methods to create a cross-section calibration for the T-Wave Synapt have been 
previously published (Ruotolo, Benesch et al. 2008; Ruotolo, Giles et al. 2005; 
Scarff, Thalassinos et al. 2008; Scrivens J. H 2006; Wildgoose J.L 2005).  The 
calibration was performed following an in-house procedure as described in 
Thalassinos et al. (Thalassinos, Grabenauer et al. 2009).  In brief, equine myoglobin 
and rabbit haemoglobin were diluted to a concentration of 10 µM in 50% aqueous 
acetonitrile/ 0.1% formic acid (Mallinckrodt Baker Inc., Phillipsburg, NJ, USA) and 
analysed against values obtained from drift-time ion mobility mass spectrometry 
(DTIMS) studies (Clemmer).  The arrival times obtained were corrected to exclude 
time spent outside of the T-Wave mobility cell.  Mass-independent time spent in the 
transfer region and mass-dependent time spent between the transfer region and time-
of-flight mass analyser were subtracted.  Normalised cross-sections (corrected for 
charge and reduced mass) were then plotted against corrected arrival times to create 
a calibration with a power series fit for myoglobin and a linear series fit for 
haemoglobin peptides.  The rotationally averaged collisional cross-sections were 
estimated for all recombinant proteins and peptides (with and without metal ions 
coordinated).  For the truncated and full-length prion proteins studied here, the 
relationship between corrected arrival times and published arrival times is best 
approximated by a power fit.  When calibrating the Synapt with smaller molecules 
such as peptides, BovPrP(57-101), a linear relationship has been found to be more 
appropriate (Thalassinos, Grabenauer et al. 2009).  An Excel spreadsheet, 
downloaded from (http://www2.warwick.ac.uk/fac/sci/bio/research/jscrivens/), was 
used to calculate the estimated cross-section of the proteins and peptide.   
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3.10 Polymers 
3.10.1 Ion Mobility-Mass Spectrometry/Mass Spectrometry  
All IM-MS/MS experiments were performed in a hybrid quadrupole-ion mobility-
orthogonal acceleration time-of-flight (oa-ToF) mass spectrometer (Synapt HDMS, 
Waters, Manchester, UK).  The instrument was equipped with a nanoflow 
electrospray ion source and operated at a source temperature of 90°C.  The sample 
solutions were introduced into the source region of the instrument by direct infusion 
ESI.  The cone voltage was optimised between 40 and 70 V for ESI-MS/MS 
experiments and the collision energy was ramped between 45 and 110 eV during the 
acquisition.  A detailed explanation of the Synapt HDMS technology has been 
described elsewhere (Pringle, Giles et al. 2007).  Ions were mass selected using the 
quadrupole prior to MS/MS experiments.  All MS/MS experiments were performed 
in the T-Wave transfer region after ion mobility separation.  The pressure in the T-
wave IM cell was 0.58 mbar for all PEG samples, with nitrogen employed as the 
mobility gas.  The T-Wave height and velocity were set at 9 V and 300 m/s 
respectively.  The pressure in the T-wave IM cell was 0.58 mbar for all PPG 
samples, with nitrogen employed as the mobility gas.  The T-Wave height and 
velocity were set at 11 V and 450 m/s respectively.   
 
The ToF analyser recorded 200 orthogonal acceleration pushes (mass spectra) with 
the pusher frequency set at 64 µs.  This resulted in each IM experiment being 
performed over a 12.8 ms time frame.  The total IM acquisition time for the data 
shown was combined and averaged over 1 minute.  The ToF analyser was tuned in 
V-optic mode for an operating resolution of 7,000 (FWHM).  Mass spectra were 
acquired at an acquisition rate of two spectra/s with an interscan delay of 100 ms.  
Data acquisition and processing were carried out using MassLynx™ (v4.1) software 
(Waters Corp., Milford, MA, USA). 
 
3.10.2 Electrospray Ionisation-Mass Spectrometry/Mass Spectrometry 
All ESI-MS/MS experiments were performed in a quadrupole orthogonal 
acceleration-time-of-flight (Q oa-ToF) mass spectrometer (Q-ToF I, Waters, 
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Manchester, UK).  The instrument was equipped with a nanoflow electrospray ion 
source and operated at a source temperature of 80°C.  The sample solutions were 
introduced into the source region of the instrument by direct infusion.  The cone was 
optimised at 70 V for ESI-MS/MS experiments.  Argon was used as the collision gas 
with a collision energy of 60 V for all spectra shown in Chapter 7. 
The ToF analyser was tuned in V-optic mode for an operating resolution of 5,000 
(FWHM). Mass spectra were acquired at an acquisition rate of two spectra/s with an 
interscan delay of 100 ms. Data acquisition and processing were carried out using 
MassLynx™ (v4.0) software (Waters Corp., Milford, MA, USA). 
 
3.10.3 Sample Preparation (ESI) 
PEG 1000, PEG mono-oleate, PEG bis(2-ethyl hexanoate), Brij 76 (stearyl alcohol 
initiated PEG), PPG monobutyl ether and PPG bis(2-aminopropyl ether) were all 
obtained from Sigma-Aldrich (Gillingham, UK).  Lithium chloride and methanol 
were also obtained from Sigma-Aldrich.  All samples were dissolved in 50% 
aqueous methanol to a concentration of 100 ng/µL.  Lithium chloride was dissolved 
in 50% aqueous methanol to a concentration of 1 mg/mL.  ESI-MS/MS analysis of 
individual polyether samples was performed by infusing a solution of a mixture of 
sample with lithium chloride at a ratio of 10:1 (sample:salt, v/v). 
 
PEG 1000 and PEG mono-oleate were dissolved in 50% aqueous methanol to a 
concentration of 200 ng/µL and 500 ng/µL respectively. PEG bis(2-ethyl hexanoate) 
and Brij 76 were dissolved in 50% aqueous methanol to a concentration of 100 
ng/µL and 500 ng/µL respectively.  PPG monobutyl ether and PPG bis(2-
aminopropyl ether) were dissolved in 50% aqueous methanol to a concentration of 
100 ng/µL.  ESI-IM-MS/MS analysis of polyether mixtures was performed by 
infusing a solution of samples with lithium chloride at a ratio of 10:10:1 
(sample:sample:salt, v/v/v). 
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3.10.4 MALDI-MS 
All samples were analysed, prior to ESI-MS characterisation, by MALDI-MS.  
MALDI-MS experiments were performed in a MALDI micro MX instrument 
(Waters MS Technologies, UK).  The instrument was operated in reflection mode to 
obtain a resolution of 9000 FWHM.  
 
3.10.5 Sample Preparation (MALDI) 
Sodium trifluoroacetate, DCTB (trans-2-3-(4-tert-butylphenyl)-2-methyl-(2-
propenlidene)-malononitrile) and anhydrous tetrahydrofuran were obtained from 
Sigma-Aldrich (Gillingham, UK).  All solutions were prepared at a concentration of 
10 mg/mL.  The polymer and matrix were dissolved in anhydrous tetrahydrofuran 
and mixed in a 1:20 ratio (v/v).  This solution was then mixed with sodium 
trifluoroacetate in tetrahydrofuran, in a 100:1 ratio (v/v), prior to deposition of 
approximately 0.5 µL on the sample stage. 
 
3.10.6 NMR 
NMR spectra were recorded for PEG 1000, PEG mono-oleate, PEG bis(2-ethyl 
hexanoate), Brij 76, PPG monobutyl ether and PPG bis(2-aminopropyl ether) in an 
Eclipse 500 MHz NMR spectrometer (JEOL, Welwyn, UK), operating at 500 MHz 
and 125 MHz for acquisition of 1H and 13C spectra respectively.  The solvent used 
for all experiments was deuterated chloroform (CDCl3) and the data were generated 
in 5 mm (external diameter) NMR tubes.  The data from all six samples indicated 
that the structures of those polymers were as expected from the supplier.   
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3.10.7 On-line GPC-NMR Measurements 
A detailed explanation of the on-line GPC-NMR conditions has been described 
elsewhere (Robertson, Heron et al. 2004).  Briefly, the gel permeation 
chromatography (GPC) equipment consisted of a Gilson 305 pump, a Rheodyne 
injector provided with a 100 µL sample loop and two PLgel columns in series; firstly 
a PLgel 7.5 mm i.d. x 300 mm column particle size 5 µm pore type 500 Å followed 
by a PLgel 7.5 mm i.d. x 300 mm column particle size 5 µm pore type 100 Å 
(Polymer Laboratories Ltd, Shropshire, UK).  Degassed CDCl3 was employed as the 
mobile phase and solvent for the sample preparation.  The 2H resonance of CDCl3 
was utilised as the field frequency lock.  The eluent flow rate was optimised at 0.7 
mL min-1. 
 
Figure 3.2:  Schematic representation of the 5 mm diameter NMR flow cell (Robertson, 
Heron et al. 2004).   
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On-line NMR measurements were performed by means of a JEOL-Eclipse 500 MHz 
NMR spectrometer (JEOL, Welwyn, UK).  A 5 mm quartz NMR tube was used as 
the flow cell with a detection cell volume of approximately 220 µL (see Figure 3.2) 
(Robertson, Heron et al. 2004).  The flow cell was connected to the GPC outlet by a 
PEEK capillary (0.25 mm i.d. x 2.7 m).  The temperature of the flow cell was set at 
20 °C.  A summary of the NMR experimental conditions can be found in Table 3.1. 
 
Table 3.1:  Summary of NMR experimental conditions 
Parameter Value 
Sample Temperature 20 °C 
Frequency 500 MHz 
Pulse width ~ 45° tip angle 
Spectral width 5000 Hz 
Pulse delay 0.1 s 
Acquisition time 0.17 s 
Typical number of scans per slice 4 
X points 8192 
Typical Y points 200-400 
Observation nucleus 
1H 
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Chapter 4 
Results: Structural Studies of Prion 
Proteins 
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4.1 Introduction 
Various analytical methods have been used for the structural characterisation of 
prions extracted from in vivo material and recombinant proteins.  Spectroscopic 
techniques such as CD, FTIR, NMR spectroscopy and electron paramagnetic 
resonance (EPR) spectroscopy are widely used in prion research.  The use of mass 
spectrometry to analyse the primary structure of PrP and post-translational 
modifications is well documented (Back, Sanz et al. 2002; Maras B. 2004; Onisko, 
Dynin et al. 2007; Principe, Maras et al. 2008; Pushie, Ross et al. 2007; Qin, Yang 
et al. 2002; Requena, Groth et al. 2001; Whittal, Ball et al. 2000).  When MS is 
combined with soft ionisation methods, such as ESI, detailed molecular structural 
information can be obtained.  An additional analytical challenge is introduced when 
MS is used to analyse proteins that are differing in structure, but isobaric in 
molecular weight.  Recent developments in the field of MS have seen the coupling of 
ion mobility spectrometry (IMS) to MS instruments (Thalassinos and Scrivens 
2009).  This has led to the development of a powerful methodology which provides a 
potential technique to investigate the different structures of PrP with the prospect of 
developing a future diagnostic test for prion diseases. 
 
A combination of ESI with ion mobility has been used to generate information on 
the conformations of recombinant prion proteins.  Prions from three different 
mammalian species were studied: Syrian hamster, mouse and ovine.  The truncated 
prion samples were either α-helical in structure, representative of PrPC, or refolded to 
a β-sheet rich construct; a property similar to PrPSc.  Separation of α-helical and β-
sheet rich PrP 27-30 isomers, with the same nominal m/z ratio but differing 
secondary structure, was possible using ion mobility.  In conjunction with the 
Bowers Group (UCSB, California, US), computer modelling studies of full-length 
proteins were performed and the theoretical cross-sections were compared to 
experimental data.  The α-helical full-length proteins were analysed and a 
comparison of the stabilities and unfolding mechanisms of the various species was 
made.   
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4.2 Results and Discussion 
For all materials and methods please refer to Chapter 3. 
 
4.3 Syrian hamster PrP (SHaPrP) 
During its short life span (3-6 hours) (Borchelt, Scott et al. 1990; Caughey, Race et 
al. 1989; Caughey and Raymond 1991; Yedidia, Horonchik et al. 2001) the prion 
protein can experience two different pH environments; a mildly acidic environment, 
whilst cycling within the cell, and a neutral environment when it is GPI-anchored to 
the cell membrane.  The prion conformational isoforms studied were α-helical 
SHaPrP(90-231) and β-sheet rich SHaPrP(90-231) at physiological pH 5.5 and pH 
7.0.  Both conformational isoforms have the same nominal m/z ratio but differ in 
their secondary structure.  MS alone is not able to resolve oligomers with the same 
nominal m/z ratio, regardless of their shape.  Figure 4.1 shows the mass spectra of α-
helical SHaPrP(90-231) and β-sheet rich SHaPrP(90-231) at pH 5.5.  A comparison 
of the MS spectra indicates the charge state envelope distributions of the two data 
sets are similar and that the samples are devoid of contamination.  The labels on the 
peaks (7+, 8+ etc) indicate the m/z ratio of the ion species.  The deconvoluted peak 
(see insets) derived from each sample corresponded to the predicted molecular mass 
of oxidised SHaPrP(90-231), 16240 Da.  This is considered to be more biologically 
relevant than its reduced counterpart (Hosszu, Trevitt et al. 2009; Prusiner 1998).  
This is because the oxidised construct is structured due to the presence of a 
disulphide bond.  This disulphide bond has been observed in both conformational 
isoforms.  
 
The conversion of PrPC, a protein that is predominantly α-helical, to a β-sheet-rich 
isoform that has a propensity to aggregate, is the key molecular event in prion 
diseases.  Recombinant prion protein can be refolded into a monomeric α-helical 
conformer α SHaPrP(90-231) or to a β-sheet-rich structure.  Refolding of PrP under 
oxidising non-denaturing conditions at pH 5.5 yields an α SHaPrP(90-231) isoform.  
This isoform shows a characteristic far-UV CD spectrum with well defined minima 
at 208 nm and 222 nm (Figure 4.2a) and also a FTIR spectrum containing a 
symmetrical amide I band with a maximum at ~1660 cm–1 (Figure 4.2b).  The CD 
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and FTIR results are consistent with a protein containing a significant amount of α-
helical structure.  Incubation of α SHaPrP(90-231) at 70 °C for 24 hrs induces a  
 
 
Figure 4.1(a):  Mass spectrum of α SHaPrP(90-231) at pH 5.5.  Inset:  Deconvoluted mass 
of the oxidised protein.  (b)  Mass spectrum of β SHaPrP(90-231) at pH 5.5.  Inset:  
Deconvoluted mass of the oxidised protein. 
 
structural transition from a protein that is mainly α-helical to one that has increased 
β-sheet structure (Martins, Frosoni et al. 2006).  In contrast to α SHaPrP(90-231), 
the β-sheet-rich SHaPrP(90-231) isoform produced a far-UV CD spectrum has a 
minimum at ~ 217 nm (Figure 4.2a), which is indicative of a substantial increase in 
β-sheet structure.  CD data are a representation of the average structure in solution.  
The β-sheet structure observed by means of CD could contain a variety of 
monomeric structures as well as β-sheet rich oligomers.  The amide I band in the 
FTIR spectrum of β SHaPrP(90-231) is also significantly different from that of α 
SHaPrP(90-231), the appearance of a distinct band at 1627 cm–1 is characteristic of 
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β-sheet structure (Figure 4.2b).  Examination of the β-sheet-rich isoform of 
SHaPrP(90-231) under the electron microscope revealed the presence of ordered 
aggregates.  Electron microscopy showed flexible fibrillar type structures of varying 
lengths with an average diameter of 10 nm (Figure 4.2c).  Direct analysis of these β-
sheet-rich SHaPrP(90-231) structures by means of ESI-IM-MS was challenging due 
to the difficulty of obtaining a stable spray.  To overcome this problem the sample 
was sonicated for 15 minutes in a bath sonicator, resulting in lower molecular weight 
molecules which could then be directly infused into the IM-MS.  Analysis of the 
sonicated β SHaPrP(90-231) sample by means of CD showed no change in the 
secondary structure of the protein upon sonication (Figure 4.2a) although the EM 
images suggested that the large protein aggregates were broken into smaller 
structures (Figure 4.2c). 
 
Several hypotheses have been outlined which suggest that the α-helical PrP can 
undergo a conformational change to form a variety of β-sheet rich isoforms 
(Gambetti, Dong et al. 2008).  The monomeric β-sheet rich PrP sample prepared for 
this experimental data set is likely to be one of a number of possible structures 
observed in vitro and in vivo.  It has been observed, by means of CD and EM (Figure 
4.2), that the β-sheet rich PrP sample had a propensity to aggregate and form high 
order oligomers.  Monomeric/low oligomeric material is required for nanoflow mass 
spectrometry analysis, as it was observed that higher order oligomers blocked the 
sample tip.  The formation of monomeric β-sheet rich PrP (after 15 minute 
sonication) could be considered a transient form of the aggregating protein.  
Sonication of the prion is used in high order oligomeric seeding experiments such as 
prion misfolding cyclic amplification (PMCA) experiments which were first 
described by Castilla et al., 2005 (Castilla, Saa et al. 2005).  A fast and sensitive 
approach is required to capture the monomeric β-sheet form, under near native 
conditions, when the PrP sample has been sonicated.   
 121 
 
 
Figure 4.2:  Conformational properties of different PrP states.  Secondary structure of PrP; 
(a) Far-UV CD spectra of α-helical PrP (solid line), β-sheet-rich PrP (dashed line) and 
following sonication (dotted line) and (b)  ATR FTIR spectra of α-helical PrP (solid line) 
and β-sheet-rich PrP (dashed line).  (c) Morphology of β-sheet-rich PrP aggregates.  Electron 
micrographs of negatively stained β-sheet-rich PrP aggregates before (left panel) and after 
sonication (right panel).  The bar scale is 50 nm. 
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The SHaPrP(90-231) samples, rich in β-sheet content, had a propensity to aggregate 
and were analysed immediately after their conversion from the α-helical form.  It 
was observed that, on average, the sonicated β SHaPrP(90-231) sample started to 
aggregate after a few minutes of spraying.  These aggregates blocked the sample tip 
and prevented further data from being collected.  An advantage of the Synapt is its 
ability to simultaneously collect mass spectral data and arrival time distribution 
(ATD) information.  This allows data to be collected in a relatively short time scale.  
The total Synapt IM acquisition time for the data shown was combined and the data 
were averaged over five minutes enabling high quality data to be obtained before the 
sample tip blocked.  The MS experimental time period is crucial in the maintenance 
of solution-phase structure.  It has been shown that, within a time scale of 30-60 ms, 
the gas-phase structures of proteins can rearrange as a result of their change in 
environment (Badman, Myung et al. 2005).  The Synapt experiments operate within 
a 15-30 ms time frame (Wyttenbach, Grabenauer et al. 2009), which limits the 
opportunity for the protein solution-phase structures to rearrange within the gas 
phase.  
 
The conformational isoforms at pH 5.5 were directly infused after ionisation by 
means of ESI into the Synapt mass spectrometer.  Figure 4.3 shows the estimated 
cross-sections for the +6 to +17 charge states at pH 5.5 and the enlargement is of the 
data of the +15 to +17 charge states (see inset).  Separation of the two isobaric 
conformational isoforms and their corresponding mass spectra were derived in the 
same experiment.  There are small differences in the estimated cross-sections 
between the α-helical SHaPrP(90-231) and the β-sheet rich SHaPrP(90-231) from 
charge states +13 to +17.  The charge states of α-helical SHaPrP(90-231) appear to 
have a smaller rotationally averaged cross-section than that of the β-sheet rich 
SHaPrP(90-231).  Upon the sequential addition of protons the conformational 
isoforms become less compact in structure.  This can be representative of the 
unfolding structure.   
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Figure 4.3:  Comparison of estimated cross-sections from charge state +6 to +17 for the α-
helical (red) and predominantly β-sheet (blue) SHaPrP (90-231), at pH 5.5.  Inset:  Enlarged 
image of the +15 to +17 charge states showing the differences in the estimated cross-
sections between the α-helical and predominantly β-sheet conformational isoforms. 
 
At the lower charge states, no significant differences in the rotationally-average 
cross-section were observed.  The ATD profiles for individual charge states were 
examined and showed a clear distinction between the two isomeric samples.  Figure 
4.4 shows a comparison of the α-helical and β-sheet rich SHaPrP(90-231) ATDs at 
pH 5.5 for the +9 and +10 charge states.  The peaks labelled * were not included in 
the estimated cross-section plot in Figures 4.3 or 4.5.  The ATD for the α-helical PrP 
charge state +9 (Figure 4.4a) is 60% broader at full-width half-height maximum 
(FWHM) than that of the β-sheet form.  There is also a 40% increase in the intensity 
of the secondary peak in α-helical species relative to that of the β-sheet ATD.  These 
differences are particularly noticeable when the individual ATDs are overlaid.  
Similar observations have been made for the +10 charge state see Figure 4.4b.  The 
relatively large width of the α SHaPrP(90-231) ATD suggests that there are multiple 
conformations present which may have a difference in cross-section of <5%.  It is 
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expected that cross-sections that are greater than 5% in difference would be resolved 
by this ion mobility approach (Hilton, Jackson et al. 2008). 
 
 
Figure 4.4:  Comparison of α-helical (red) and predominantly β-sheet (blue) SHaPrP(90-
231) selected arrival time distributions (ATDs) for the +9 and +10 charge state. (a)  Overlaid 
ATDs for the +9 charge state at pH 5.5.  (b)  Overlaid ATDs for the +10 charge state at pH 
5.5.  (c)  Overlaid ATDs for the +9 charge state at pH 7.0.  (d)  Overlaid ATDs for the +10 
charge state at pH 7.0.   
 
The pH of each sample was increased to pH 7.0 by the addition of a 0.1% ammonia 
solution and infused into the Synapt mass spectrometer.  Figure 4.6 shows the 
estimated cross-sections for the +6 to +17 charge states obtained at pH 7.0 and the 
enlargement is of the data of the charge states +15 to +17 (see insets).  The degree of 
protein unfolding, as sequential protons are added, is indicated by an increase in 
estimated cross-section with increasing charge state.  The unfolding of the prion is 
similar under the two physiological pH conditions.  Multiple stable conformations 
are observed under both pH conditions from charge states +6 to +11.  Two 
conformations were observed for the +8 charge state at pH 7.0 but one conformation 
dominated and was the only one considered here.  At charge states ≥ +12 it was 
observed that the FWHM of individual ATDs decreased as sequential protons were 
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added.  An instrument performance validation was performed, using equine 
myoglobin and α-helical SHaPrP(90-231) at pH 7.0, to check the reproducibility and 
precision of the ATD profiles and estimated cross-sections throughout all the 
experiments (see Figure 4.5 for myoglobin reproducibility).  These validation 
experiments were performed before any IM-MS conformational isoform studies.  
The measured experimental variation indicated that the differences observed 
between α-helical SHaPrP(90-231) pH 5.5 and β-sheet rich SHaPrP(90-231) pH 5.5 
were because of differences in the sample conformation rather than experimental 
error.  The differences observed in the conformation disappeared when the pH of the 
sample was increased.   
 
 
Figure 4.5:  Arrival time distributions (ATDs) of equine myoglobin (50% aqueous 
acetonitrile/ 0.1% formic acid) for charge states +13 (a), +14 (b) and +15 (c).  The different 
colours represent three different instrument performance validation checks over a three 
month time period.  All the ATDs are within ±1 scan number of one another.  This 
reproducibility and precision of the ATD profiles suggests that the differences observed 
between α-helical SHaPrP(90-231) pH 5.5 and β-sheet rich SHaPrP(90-231) pH 5.5 were 
because of differences in the sample conformation rather than experimental error.   
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Figure 4.6:  Comparison of estimated cross-sections from charge state +6 to +17 for the α-
helical (red) and predominantly β-sheet (blue) SHaPrP(90-231), at pH 7.0.  Inset:  Enlarged 
image of the +15 to +17 charge states shows no differences in the estimated cross-sections 
between the α-helical and β-sheet rich conformational isoforms. 
 
Figure 4.6 shows there is no significant difference in the estimated cross-sections 
between the α-helical and β-sheet rich conformers at pH 7.0.  At the higher charge 
states, +15 to +17, ~100 Å2 separate the two isoforms at pH 5.5, whereas ≤ 10 Å2 
separates the α- and β- SHaPrP(90-231) at pH 7.0.  Examination of the individual 
ATDs at pH 7.0 revealed there were no differences in the shape, size or intensity of 
the peaks.  Figure 4.4c and d shows a comparison of ATDs for the +9 and +10 
charge states which suggest that both isoforms at pH 7.0 have similar conformations 
to the β-sheet rich SHaPrP(90-231) at pH 5.5.    
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4.4 Mouse PrP (MoPrP90-230) 
Truncated α-helical- and β-sheet-rich mouse prion proteins were studied at pH 5.5 
and pH 7.0 by means of IM-MS.  Both conformational isoforms have the same 
nominal m/z ratio but differ in their secondary structure, and therefore cannot be 
separated by MS alone.  The same refolding methods and secondary structure 
characterisation techniques used to monitor the SHaPrP(90-231) isoforms were 
applied to the mouse protein.  Far-UV CD was used to observe the changes in 
secondary structure between the prion isoforms.  The spectra show typical 
characteristics of an α-helical structure, minima at 208 nm and 222 nm, and a β-sheet 
structure, minimum at 218 nm, for the refolded isoforms (data not shown).  A 
comparison of the mass spectra for α MoPrP(90-230) and β-sheet rich MoPrP(90-
230) at pH 5.5 and pH 7.0 showed that both data sets have a similar charge state 
envelope distribution observed in all four spectra (data not shown).  The resulting 
data were deconvoluted and revealed that the molecular mass of the sample was 
16012 Da.  This corresponds to the predicted molecular weight of oxidised 
MoPrP(90-230) (disulphide bond intact). 
 
The physical properties of the SHaPrP(90-231) and MoPrP(90-230) samples were 
similar.  In both sample sets the β-sheet rich isoform had a propensity to aggregate 
and was analysed immediately after its conversion from the α-helical form.  All 
samples were pH sensitive and could precipitate if the pH was greater than pH 7.8.  
Figure 4.7 shows the plot of the estimated cross-sections of α MoPrP(90-230) and β-
sheet MoPrP(90-230) at pH 5.5 and pH 7.0.  The estimated cross-sections at pH 5.5 
range from ~1380 Å2 for the +6 charge state to ~3400 Å2 for the +20 charge state.  
The ATD for charge state +9 has at least two distinct conformations and the +10 
charge state has at least three different conformations in the ATD (see Figure 4.8).  
All other charge states have one distinct peak in their corresponding ATD.  The 
FWHM at the lower charge states (+6 to +8) was greater than that of the higher 
charge states (+16 to +20) which suggests that multiple disparate conformations 
populate the lower charge states.  There are small differences in the estimated cross-
sections between the α-helical MoPrP(90-230) and the β-sheet rich MoPrP(90-230) 
in all of the charge states in Figure 4.7.  The β-sheet rich MoPrP(90-230) appear to 
have smaller rotationally averaged cross-sections than the α-helical MoPrP(90-230); 
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the opposite was observed for the Syrian hamster samples.  As was observed for the 
SHaPrP(90-231) isoforms at pH 5.5, the individual ATDs for MoPrP(90-230) 
suggest larger differences in their conformations than represented in the estimated 
cross-section plot.  Figure 4.8 shows the individual ATDs for the +7 and +10 charge 
states for both the α-helical and β-sheet rich MoPrP(90-230) at pH 5.5.  Figure 4.8a* 
were not included in the estimated cross-section plot.  When the ATDs of the +7 
charge state of the β-sheet rich isoform and the α-helical counterpart were overlaid, it 
was clear that the former ATD is much narrower (FWHM 29 scans) than the latter 
(FWHM 38 scans).  This suggests that β MoPrP(90-230) is either more compact in 
structure and/or has fewer disparate conformational populations than α MoPrP(90-
230).  In contrast the FWHM of the +10 charge state peaks are similar; the notable 
difference in these ATDs is the arrival time of each conformation.  The 
conformations belonging to the α MoPrP(90-230) have a shorter arrival time and 
must, therefore, have a smaller cross-section than their β-sheet rich equivalents.   
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Figure 4.7:  Estimated cross-section plot for charge states +6 to +20.  (a)  Comparison of α 
MoPrP(90-230) (red) and β-sheet rich MoPrP(90-230)(blue) at pH 5.5.  (b) Comparison of α 
MoPrP(90-230) (red) and β-sheet rich MoPrP(90-230)(blue) at pH 7.0.   
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The estimated cross-sections for α MoPrP(90-230) and β-sheet rich MoPrP(90-230) 
at pH 7.0 are shown in Figure 4.7b.  They range from ~1450 Å2 for the +6 charge 
state to ~3500 Å2 for the +20 charge state.  These are larger than the cross-sections 
calculated at pH 5.5 and suggest that the conformations can change because of their 
pH environment.  The number of distinct conformations for each charge state and the 
unfolding pattern of the protein are similar to those observed in Figure 4.7a.  There is 
an average 5% difference in the estimated cross-section between the α MoPrP(90-
230) and β MoPrP(90-230) samples; this is considered significant.  From these data 
it has been deduced that the α-helical isoform has a larger rotationally-averaged 
cross-section than β-sheet rich MoPrP(90-230).  These differences at pH 7.0 were 
also evident in the individual ATDs (data not shown). 
 
 
Figure 4.8:  The individual arrival time distribution of MoPrP(90-230) at pH 5.5  (a) Charge 
state +7 β-sheet rich MoPrP(90-230) (blue), α MoPrP(90-230) (red) overlaid α and β-sheet 
ATD.  (b) Charge state +10 β-sheet rich MoPrP(90-230) (blue), α MoPrP(90-230) (red) 
overlaid α and β-sheet ATD.   
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4.5 Comparison of SHaPrP(90-231) with MoPrP(90-230) 
Both SHaPrP(90-231) and MoPrP(90-230) have been characterised by means of IM-
MS.  The PrP sequence is highly conserved between the two mammalian species 
with a difference of only eight different amino acid residues between the sequences.  
These differences give rise to a difference of 228 Da (1.4%) in mass.  Figure 4.3 
reveals that the β-sheet rich SHaPrP(90-231) conformation is larger in cross-section 
than the α-helical isoform at pH 5.5, whereas the opposite observation was made in 
the mouse data (Figure 4.7a).  At pH 7.0, there were no differences between the 
estimated cross-sections of the α or β-sheet rich SHaPrP(90-231) (Figure 4.6); 
significant differences, however, were observed between the mouse conformational 
isoforms with the α-helical conformation, again, having the larger cross-section 
(Figure 4.7b).  Figure 4.9a shows a direct comparison of the α-helical SHaPrP(90-
231) and MoPrP(90-230) samples at pH 5.5.  On average SHaPrP(90-231) is 5% 
larger in cross-section, for all charge states, when compared to MoPrP(90-230).  This 
observation is surprising because of the small difference in their primary sequences.  
SHaPrP(90-231) gives rise to more distinct conformations at the lower charge states, 
+6 to +10, than the mouse equivalent.  A similar observation is reflected in the β-
sheet rich samples (see Figure 4.9b) in which a 6% average difference in the 
estimated cross-sections between the mouse and hamster PrP β-sheet rich samples 
were measured.  There are data to suggest that hamster and mouse PrP fold via 
different mechanisms (Robinson and Pinheiro 2009).  It is believed that the hamster 
PrP folds via a framework mechanism.  This occurs by diffusion-collision and 
requires the secondary structure to be initially formed, followed by the tertiary 
structure arrangement.  In comparison, the mouse PrP folds because of a nucleation 
condensation mechanism in which the secondary and tertiary structure form 
simultaneously and without the presence of a detectable intermediate (Robinson and 
Pinheiro 2009).  The difference between the folding mechanisms, and presumably 
unfolding mechanisms, could account for the differences in estimated cross-section 
observed. 
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Figure 4.9:  Estimated cross-section plot for charge states +6 to +17.  (a)  Comparison of α 
MoPrP(90-230) (red) and α SHaPrP(90-231)(blue) at pH 5.5.  (b) Comparison of β 
MoPrP(90-230) (red) and β SHaPrP(90-231)(blue) at pH 5.5.   
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4.6 Comparison of full-length PrP with truncated PrP 
IM-MS was used to observe the estimated cross-sections of recombinant full-length 
Syrian hamster (SHaPrP(23-231)) and mouse (MoPrP(23-230)).  Several attempts 
were made to convert the full-length α-helical PrP into a β-sheet rich structure; all 
methods, however, proved unsuccessful (see Table 4.1).  Figure 4.10 shows the 
estimated cross-section plot of α SHaPrP(23-231) at pH 7.0.  The estimated cross-
sections range from 1871 Å2 for the +9 charge state to 4915 Å2 for the +26 charge 
state; these are larger than the truncated cross-sections.  The lowest and most 
biologically relevant charge state, +9, has at least two distinct conformations.  
Charge states +12 to +15 also give rise to at least two distinct conformations.  For all 
the other charge states only one peak was observed in the corresponding ATD.  
Three different conformational families are observed in Figure 4.10 illustrated by a 
dotted, solid and dashed box.  It is believed that the conformations in each individual 
family are related, and that the increase in cross-section, with increased charge state, 
is because of long range Coulombic repulsion (Sinelnikov, Kitova et al. 2007).  The 
differences between the conformational families could be related to the different 
degrees of unfolding.  It is likely that the +9 to +15 charge states (dotted box) are the 
most thermally stable and compact conformations, and that the conformational 
family illustrated by the solid box could represent a transition-state or partially 
unfolded protein.  Conformational structures of the fully unfolded protein could 
constitute the third conformational family (dashed box), charge states +20 to+26.     
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Table 4.1:  A list of conditions used to try to convert full-length α-helical PrP into a 
β-sheet rich structure.  All the samples were analysed by means of far-UV CD.  A 
minimum at 217 nm in the far-UV CD spectrum would be indicative of a substantial 
increase in β-sheet structure. 
Conversion conditions 217 nm 
minimum? 
Incubation of α SHaPrP(23-231) at 65 °C for 24 hrs X 
Incubation of α SHaPrP(23-231) at 70 °C for 24 hrs X 
Incubation of α SHaPrP(23-231) at 75 °C for 24 hrs X 
Incubation of α SHaPrP(23-231) at 75 °C for 3 hrs repeated 
twice 
X 
Incubation of α SHaPrP(23-231) at 85 °C for 1 hr X 
Incubation of α SHaPrP(23-231) at 85 °C for 1 hr repeated four 
times 
X 
Incubation of α SHaPrP(23-231) at 85 °C for 24 hrs X 
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Figure 4.10:  Estimated cross-section plot for α SHaPrP(23-231) for charge states +9 to +26.  
Boxes indicate different conformational families present. 
 
Figure 4.11 shows a comparison of truncated and full-length estimated cross-sections 
of the hamster PrP at pH 5.5 and pH 7.0.  The difference in molecular weight 
between the two constructs is 6862 Da.  Under the two physiological pHs, both 
constructs show a similarity in their estimated cross-sections from charge states +9 
to +15.  It has been previously published that the N-terminal region has features of a 
flexible random coil-like polypeptide which is dissociated from the core truncated 
structure (Riek, Hornemann et al. 1997).  At charge states +9 to +15 there are small 
differences in the estimated cross-section between the truncated and full-length 
proteins.  If both proteins have near-identical structures, it is believed that the 
estimated cross-section of the full-length construct would proportionally increase in 
size relative to the truncated protein.  The relatively small differences in the 
estimated cross-sections, for charge states +9 to +15, observed in Figure 4.11 suggest 
that the N-terminal tail associates with the truncated core.  This tail-core association 
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flexible tail were not associated with core, it is likely that the rotationally-averaged 
cross-section would be larger than that observed.  A similar observation was made 
for the comparison of the truncated and full-length mouse PrP constructs and the 
same tail-core association conclusion was drawn. 
 
A comparison has been made between the experimentally derived estimated cross-
sections and theoretical approximations from published NMR structures and in-
house computer modelling structures (see Figure 4.11).  The structures of truncated 
Syrian hamster prion and truncated mouse prion determined by means of NMR 
spectroscopy, which were used for the calculations, are held in the Protein Data 
Bank (PDB) (Berman, Westbrook et al. 2000).  All computer modelling studies were 
performed by UCSB collaborators and their methods are briefly outlined below.  The 
AMBER suite of programs were used to create model structures of SHaPrP(90-231), 
SHaPrP(23-231), MoPrP(90-230) and MoPrP(23-230) based on information found in 
the PDB (1b10) and (1AG2) respectively.  A simulated annealing protocol was used 
to minimise these structures and their theoretical cross-sections were calculated by 
the use of the program MobCal (Mesleh, Hunter et al. 1996; Shvartsburg and Jarrold 
1996).  The computer model structures are shown in Figure 4.12 and as an inset in 
Figures 4.11.  Cross-sections were calculated by means of two different theoretical  
 137 
 
 
 
Figure 4.11:  Estimated cross-section plot for α SHaPrP(90-231) (blue) and α SHaPrP(23-231) (red).  (a) Charge states +6 to +26 estimated cross-sections at 
pH 5.5.  Red dashed and dotted lines theoretical EHSS and PA cross-sections for SHaPrP(23-231), blue dashed and dotted lines theoretical EHSS and PA 
cross-sections for SHaPrP(90-231).  Inset computer model structures used to determine theoretical cross-sections.  (b) Charge states +6 to +26 estimated 
cross-sections at pH 7.0.  Red dashed and dotted lines theoretical EHSS and PA cross-sections for SHaPrP(23-231), blue dashed and dotted lines theoretical 
EHSS and PA cross-sections for SHaPrP(90-231).   
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approximation approaches, the projection approximation (PA) and the exact hard 
sphere scattering (EHSS) method.  The PA replaces the cross-section of an ion with 
its projection (shadow) and averages the projections created by every orientation of 
the ion.  This method does not take into account protein-buffer gas interactions and 
can therefore under-estimate the cross-section of a protein.  The EHSS method is 
similar to the PA method.  The EHSS method includes the protein-buffer gas 
interactions in the cross-section calculation but excludes any electrostatic 
interactions.  It has been observed that the EHSS model can over-estimate a protein’s 
cross-section (Scarff, Thalassinos et al. 2008).  The PA and EHSS cross-sections for 
all the hamster and mouse constructs are listed in Tables 4.2 and 4.3.  The PA and 
EHSS cross-sections for hamster PrP are represented as dotted and dashed lines in 
Figure 4.11.  The experimental estimated cross-sections for the lower charge states 
lie between the PA and EHSS theoretical values.  At pH 5.5 three truncated 
conformations are in agreement with the theoretical values; when the pH is increased 
two conformations lie in-between the theoretical values at pH 7.0.  It is observed 
from the data set for the full-length prion that the +9 charge state has a compact 
conformation that is in agreement with the theoretical cross-sections.  These 
observations support the hypothesis that the lowest/lower charge states (under near-
native conditions) are representative of the native protein structure.  It is believed 
that the lower charge state conformations are more compact because they have fewer 
basic residues exposed on the surface when compared to the unfolded conformations 
of the same protein.  Previous work has shown that a gaseous protein’s conformation 
is more compact in cross-section than conformations that have been measured by the 
means of X-ray crystallography and NMR spectroscopy (Scarff, Thalassinos et al. 
2008) (Shelimov, Clemmer et al. 1997a).  The lower charge state estimated cross-
sections are smaller than the EHSS model value.  In the absence of solvent, polar 
amino acid side chains can collapse onto the protein surface because of 
intramolecular interactions (Shelimov, Clemmer et al. 1997b).  In the gas-phase 
these interactions can reduce the overall rotationally averaged cross-section of a 
protein.  The gas phase ions are therefore smaller in cross-section than the solution 
phase EHSS model cross-sections.   
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Figure 4.12:  Cartoon representation of SHaPrP and MoPrP computer model structures.  (a) 
SHaPrP.  Red structure SHaPrP(90-231), green structure SHaPrP(23-231) residues 90-231 
only and blue structure SHaPrP(23-231) residues 23-89.  (b) MoPrP.  Red structure 
MoPrP(90-230), green structure MoPrP(23-230) residues 90-230 only and blue structure 
MoPrP(23-230) residues 23-89.  (c) Structural alignment of cartoon representations.  
SHaPrP(23-231) red and MoPrP(23-230) yellow. 
 
ba
c
 140 
 
Tables 4.2 and 4.3 show that the estimated experimental cross-sections for the 
hamster and mouse PrP constructs are in good agreement with the calculated 
theoretical cross-sections.  A comparison of the hamster and mouse theoretical 
values suggests that the mouse PrP protein is larger in cross-section than that of the 
hamster.  The opposite is observed in the experimental estimated cross-sections (see 
Figure 4.9 and Figure 4.16).  The simplistic computer modelling studies did not 
energy minimise the conformational space surrounding each atom.  This suggests 
that the calculated values could be unrealistically high in energy and, at present, do 
not represent the prion protein structure in its lowest energy state.  The energy states 
of the individual models have not been optimised which suggests that the model 
hamster structure could be in a different energy state than the mouse.  The potential 
difference in the modelling energy parameters could explain the opposing 
observations made between the cross-sections in the experimental and theoretical 
data.  The model structures have compact cross-sections because they are based on 
the folded PDB NMR core structures.  The agreement between the experimental and 
theoretical data further supports that hypothesis that the lowest experimental charge 
states are representative of the protein’s native structure.   
 
Table 4.2:  Theoretical and experimental estimated cross-sections for the lowest 
charge state at physiological pH for Syrian hamster PrP. 
Constructs SHaPrP(90-231) SHaPrP(23-231) 
Calculated cross-section pH 5.5 pH 7.0 pH 5.5 pH 7.0 
PA 1302 Å2 1302 Å2 1641 Å2 1641 Å2 
EHSS 1626 Å2 1626 Å2 2065 Å2 2065 Å2 
Experimental 1466 Å2 1496 Å2 1784 Å2 1871 Å2 
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Table 4.3:  Theoretical and experimental estimated cross-sections for the lowest 
charge state at physiological pH for Mouse PrP. 
Constructs MoPrP(90-230) MoPrP(23-230) 
Calculated cross-section pH 5.5 pH 7.0 pH 5.5 pH 7.0 
PA 1335 Å2 1335 Å2 1703 Å2 1703 Å2 
EHSS 1676 Å2 1676 Å2 2158 Å2 2158 Å2 
Experimental 1431 Å2 1467 Å2 1895 Å2 2151 Å2 
 
Figure 4.13:  Cartoon representation of SHaPrP(23-231) computer model structure.  Red 
structure SHaPrP(90-231), green structure SHaPrP(23-231) residues 90-231 only and blue 
structure SHaPrP(23-231) residues 23-89.  (b) and (c) Previously published proposed 
structure for full-length PrP.  Taken from (Riek, Hornemann et al. 1997) and (Donne, Viles 
et al. 1997) respectively. 
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4.7 Models 
Figure 4.12 shows the model structures used to calculate the theoretical cross-section 
of the hamster and mouse PrP protein as listed in Tables 4.2 and 4.3.  In Figure 4.12a 
and b the red structure represents the truncated protein amino acid residues 90-231, 
the green structure represents the residues 90-231 in the full-length protein (23-231) 
and the blue structure represents residues 23-89 in the flexible N-terminal tail.  The 
red and green structures are very similar.  This suggests that the addition of the N-
terminal flexible tail does not affect the position or structure of the core protein 
residues.  The full-length protein models, for both the hamster and mouse PrP, show 
that the flexible N-terminal tail can associate with the core structure.  These models 
are in stark contrast to previous speculations which imply that the flexible N-
terminal tail is unstructured and do not associate with the core structure (see Figure 
4.13 for model comparison) (Donne, Viles et al. 1997; Riek, Hornemann et al. 
1997).  It is postulated that if the structure of the full-length protein was similar to 
that proposed by Riek et al, (Riek, Hornemann et al. 1997) and Donne et al, (Donne, 
Viles et al. 1997) (Figure 4.13), then the rotationally averaged cross-section of the 
protein would be considerably larger than that of the truncated protein.  
Experimental data suggest that the estimated cross-section of the two protein 
constructs are similar.  The models in Figure 4.12 also suggest that the N-terminal 
flexible tail has some structure.  The tail in both protein models appear to be twisted 
and contain several loop regions – the latter observation is particularly notable in the 
hamster model.  Figure 4.12c shows a comparison of the hamster and mouse prions 
full-length model structures.  The full-length hamster structure is illustrated in red 
and the corresponding mouse structure is shown in yellow.  It is observed that the 
model structures are highly conserved and the individual N-terminal flexible tails 
have a similar ordered structure.  As previously discussed these are simplified model 
structures and may differ from the protein’s in vivo structure.   
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Figure 4.14:  Sequence alignment for Syrian hamster, mouse and ovine PrP.  Residues aligned using the nearest neighbour fit in Cluster. 
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4.8 Species structural stability 
T-Wave ion mobility was used to investigate the structural differences between full-
length Syrian hamster, mouse and ovine (OvPrP(23-230)) PrP.  Figure 4.14 shows 
the aligned primary sequences of these three species.  The PrP sequence is highly 
conserved throughout the mammalian species with ten different amino acid residues 
between the full-length hamster and mouse, 14 between hamster and ovine, and 15 
between ovine and mouse.  Figure 4.15 shows the mass spectra of OvPrP(23-230), 
MoPrP(23-230) and SHaPrP(23-231) at pH 5.5.  Inset is the deconvoluted molecular 
mass of the corresponding oxidised sample: ovine 22872 Da, mouse 23059 Da and 
hamster 23102 Da.  A comparison of the MS spectra indicates the charge state 
envelope distribution, between all three data sets, is similar.  The exception to this 
observation is the presence of additional peaks in the OvPrP(23-230) spectrum 
which are a result of methionine oxidation (labelled accordingly).   
 
Figure 4.15(a):  Mass spectrum of α OvPrP(23-230) at pH 5.5.  Inset. Deconvoluted mass of 
the oxidised protein.  (b) Mass spectrum of α MoPrP(23-230) at pH 5.5.  Inset. 
Deconvoluted mass of the oxidised protein.  (c) Mass spectrum of SHaPrP(23-231) at pH 
5.5.  Inset. Deconvoluted mass of the oxidised protein. 
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Figure 4.16 shows the estimated cross-sections for charge states +9 to +26 of the 
full-length prion proteins at pH 5.5 and pH 7.0.  Only ATDs that are greater than 
50% in relative intensity are represented in the estimated cross-section plot.  Upon 
the addition of sequential protons the estimated cross-section of the protein increases 
and the higher charge states represent an extending/unfolding structure.  Charge 
states +9, +12 to +14 and +17 to +18 have two or more distinct stable conformations 
whereas the remaining charge states have only one.  A comparison of the three 
species reveals there are no significant differences in estimated cross-section at 
charge states +9 to +14 at pH 5.5 or between the +9 to +12 charge states at pH 7.0 
(Figure 4.16 a and b).  This implies that the most biologically relevant conformations 
are similar.  The program PyMOL was used to make a comparison of the 
corresponding structures based on NMR spectroscopy.  It showed that there was a 
structural similarity between the species (data not shown).  No notable differences 
were observed between the estimated cross-section of mouse and ovine prion at 
either pH.  This is despite the 15 different amino acid residues in their sequence and 
a 187 Da difference in the molecular weights.  The estimated cross-sections of 
mouse and ovine prions are smaller than those of hamster prions of similar charge.  
This suggests that the hamster prion structure can adopt a more open conformation in 
the gas-phase.  At charge states ≥ +15 small but distinct differences in the estimated 
cross-section were observed between hamster prion and mouse prion.  These 
differences are exemplified at charge states +20 to +26 in which a 5% difference in 
cross-section was observed.  There are data to suggest that hamster and mouse PrP 
fold via different mechanisms despite their high sequence and three-dimensional 
structure homology (Robinson and Pinheiro 2009).  These mechanisms have been 
previously discussed in section 4.5.  This difference in folding mechanisms, and 
presumably unfolding mechanisms, could account for the differences observed in the 
estimated cross-sections at higher charge states between SHaPrP(23-231) and 
MoPrP(23-230) in Figure 4.16.  The similarity between the estimated cross-sections 
of mouse and ovine PrP, across the charge state distribution, suggests that ovine PrP 
folds via a nucleation condensation mechanism. 
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Figure 4.16:  Estimated cross-section plot for α SHaPrP(23-231) (blue),α MoPrP(23-230) 
(red) and α OvPrP(23-231) (green) charge states +9 to +26.  (a) pH 5.5.  (b) pH 7.0. 
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Syrian hamster SHaPrP(23-231), mouse MoPrP(23-230) and ovine OvPrP(23-230) 
differ in their primary structure in the positions believed to be key in the structure’s 
stability as shown in Figure 4.14.  In order to investigate the hypothesis that key 
amino acid residues are required to stabilise the prion protein’s tertiary structure, the 
three different recombinant mammalian prion proteins were subjected to a wide 
range of activating conditions.  Several hypotheses have been outlined which show 
that the Q171R mutation present in the ovine prion can destabilise the secondary and 
tertiary structure of PrP (Paludi, Thellung et al. 2007; Robinson and Pinheiro 2009) 
(see Figure 4.17 magenta residue).  Studies have shown polymorphisms at amino 
acid residues 136, 154 and 171 (ovine numbering) are associated with different 
degrees of scrapie susceptibility.  Sheep with the genotype PrP(ARQ) 
[PrP(Ala136/Arg154/Gln171)] are vulnerable to scrapie, whereas those with the PrP 
(ARR) genotype [PrP(Ala136/Arg154/Arg171)] are scrapie resistant (Paludi, 
Thellung et al. 2007).  This suggests that the amino acid residue Q171 plays an 
essential role in disease resistance.  From co-crystallisation studies of these two 
variants it is believed that a hydrogen bond exists between R167 and Q171 in the 
ARQ variant.  It is believed this interaction can stabilise the loop region between β-
strand two (S2) and helix 2.  This stabilisation mechanism could also be present in 
Syrian hamster and mouse PrP as both have the ARQ genotype.  In contrast, the 
R167 and R171 residues in the scrapie resistant variant ARR destabilise the loop 
region because of electrostatic repulsion (Eghiaian, Grosclaude et al. 2004).  
Molecular dynamic stimulations have shown that destabilisation in this loop region 
can stimulate the opening of other domains to destabilise the overall tertiary structure 
(DeMarco and Daggett 2007).   
 
The stability of a conformation in the gas-phase can be investigated by increasing the 
amount of energy with which the ions are injected into the mobility cell (Grabenauer, 
Sanghera et al. 2009).  The injection energy studies performed by means of DCIM 
instrument can be mimicked in the T-Wave technology by increasing the trap 
voltage.   
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Figure 4.17:  Cartoon representation of the NMR structure of recombinant SHaPrP(121-
231) in aqueous solution highlighted residues and those that differ from mouse and sheep.  
Magenta residue R171 key mutation in sheep sequence (Q in sheep) believed to destabilise 
the structure.  Green stick residue I184 (V in sheep) possibly essential to create interactions 
between helix 2 and 3.  Different residues may change the kinetic pathway of folding. 
 
The conversion from folded conformations to extended/unfolded conformations was 
monitored for charge state +9 by means of IM-MS for all three proteins.  Figure 
4.18a shows the ATDs for the +9 charge state of OvPrP(23-230) for a range of trap 
collision voltages.  At low trap collision voltages there is a broad peak with three 
defined apexes corresponding to the estimated cross-sections 1624 Å2, 1928 Å2 and 
2142 Å2.  As the trap collision energy was increased a number of broad but discrete 
peaks were observed at longer drift times.  These latter peaks, assigned D and E in 
Figure 4.18a, can be related to the extended/unfolded conformations of the prion 
protein (estimated cross-section 2356 Å2 and 2535 Å2 respectively).  The intensity of 
the peaks that correspond to the more compact structure, (A, B and C) begins to 
decrease at trap collision voltages 20 V, 20 V and 40 V respectively.  At 60 V 
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onwards the extended species D is the most intense peak and at 50 V the most 
unfolded conformation (E) can be observed.  The signal to noise ratio in the mass 
spectrum of charge state +9 OvPrP(23-230) decreased dramatically at a trap collision 
energy of 80 V and no further measurements could be obtained beyond this point.  
The width of the C and D peaks are considerably broader than the widths of the other 
peaks.  This suggests that there may be multiple disparate conformations 
contributing to these peaks in contrast to A, B and E.  Similar ATDs with 
conformational ensembles of analogous cross-section were observed for SHaPrP(23-
231) and MoPrP(23-230) (data not shown).   
 
A comparison of the gas-phase unfolding of SHaPrP(23-231), MoPrP(23-230) and 
OvPrP(23-230) is shown in Figure 4.18b.  The relative stability of the hamster, 
mouse and ovine PrP conformations follow the same trend.  In all three mammalian 
species the conformational ensemble C is dominant at 30 V.  The intensities of the 
unfolded/extended conformations D and E rise in abundance at 50 V, as 
conformation C diminishes, and D becomes the dominant species.  In the hamster 
and mouse sample the most unfolded form, E, is not observed until the compact A 
conformation has disappeared and conformation B accounts for less than 10% of the 
ion count.  All conformations have similar intensities at 80 V with the notable 
exception of conformations B and D in ovine.  The relative intensity of the D peak 
for ovine prion is approximately 10% lower than that of hamster and mouse PrP, 
whereas the intensity for conformation B is approximately 10% higher.  This implies 
that the compact conformations are more stable in the ovine PrP than they are in the 
other two proteins.  This is a surprising result because the ovine ARR genotype, as 
discussed above, contains steric hinderance between residues R167 and R171 which 
have the potential to destabilise the structure.  Recent kinetic folding studies have 
shown that core mutations within human PrP have a profound effect on the protein’s 
stability - of note were mutations in the amino acid residues V108, located in helix 2 
and M206 within helix 3 (human numbering) (Hart, Hosszu et al. 2009).  These two 
residues are located on the interface of the respective helices and can interact to 
create structural constraints (see Figure 4.17 green and red stick residues).  In all the 
mammalian species studied here the equivalent V108 and M206 residues are  
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Figure 4.18:  (a) The arrival time distribution of the +9 charge state of OvPrP23-230 monomer acquired at the corresponding trap collision voltage show a 
conformational transition from compact to extended ion conformations.  The centroid estimated cross-sections of peaks are labelled A to E.  (b) The relative 
intensities of the individual peaks calculated from the arrival time distribution of 9+ charge state of monomer SHaPrP(23-231) (circle), MoPrP(23-230) 
(diamond) and OvPrP(23-231) (triangle). 
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conserved and therefore cannot account for the difference in stability.  Hart et al, 
observed that the I184V mutation had a dramatic effect on the human PrP protein’s 
folding kinetics.  Isoleucine is the equivalent amino acid residue in the hamster and 
mouse PrP primary sequence whereas valine is the equivalent in ovine PrP (see 
Figure 4.14).  This mutation could account for the differences in stability observed 
for conformation D.  The residue is located within helix 2 and has the ability to 
interact with helix 3 and S2 (see Figure 4.17 green stick residue).  Kinetic 
experiments suggest that this single mutation can distort the native-folded structure 
of PrP and change the equilibrium pathway between the folded and unfolded 
structure, without significantly changing the global structure of the protein (Hart, 
Hosszu et al. 2009).  The difference in the folding pathway may energetically favour 
the folded structure; hence the higher intensity of conformation B and the lower 
intensity of conformation D observed for ovine compared to hamster and mouse 
prions. 
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4.9 Conclusions 
ESI-IM-MS has been used to study recombinant isobaric prion conformational 
isoforms at relevant physiological pHs: α-SHaPrP(90-231), β-sheet rich SHaPrP(90-
231), α-MoPrP(90-230) and β-sheet rich MoPrP(90-230) at pH 5.5 and pH 7.0.  CD 
and ATR FTIR information characterised the secondary structure of the proteins 
whilst the protein aggregations were observed by means of EM.  The presence of the 
β-sheet rich SHaPrP(90-231) and MoPrP(90-230) was further suggested by the ready 
aggregation of the samples necessitating each sample solution to be sonicated prior 
to any IM-MS experiments.  The use of ion mobility as a shape-selective separation 
technique has made possible the differentiation of the recombinant α-helical 
SHaPrP(90-231) and β-sheet rich SHaPrP(90-231) conformational isoforms at pH 
5.5.  While the differences in cross sections were small (~3%) the resulting ATD 
profiles were significantly different at this pH.  No differences in cross-sections or 
ATD profiles were observed when the analyte was at pH 7.0.  In contrast, the 
estimated cross-sections of the truncated mouse isoforms were distinctly different at 
pH 7.0 (≥ 5%) but were difficult to distinguish under the mildly acidic pH 
conditions.  Significant differences were observed between the individual ATDs of 
the α MoPrP(90-230) and β-sheet rich MoPrP(90-230) at both physiological pHs.  A 
comparison of the truncated Syrian hamster PrP cross-sections with those of mouse 
PrP showed that the hamster isoforms were larger in cross-section than those of the 
mouse PrP.  It was reasoned that the differences in the folding mechanisms could 
account for the differences in the estimated cross-section.   
 
The structure of full-length PrP was probed by the means of IM-MS.  The estimated 
cross-section of α SHaPrP(23-231) indicated the presence of three different 
conformational families.  The difference between the families was attributed to the 
difference in the proteins’ unfolding.  The first family contained the lower charge 
states and were considered the most compact conformations, the second family 
suggested that the conformations were in the folded/unfolded transition stage and the 
third family incorporated conformations which were fully unfolded.  Further 
evidence that the first family contained the most compact or native-like 
conformations came from a comparison between the Syrian hamster constructs 
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SHaPrP(90-231) and SHaPrP(23-231).  At the lower charge states the estimated 
cross-section of both constructs were similar.  This similarity suggested that the N-
terminal flexible tail was associated with the core structure rather than, as previous 
studies had suggested, being unstructured and dissociated.  A comparison between 
the theoretically calculated and experimentally derived cross-sections also supported 
the hypothesis that the flexible N-terminal tail was associated with the core PrP 
structure.  These simplistic computer model structures supported the findings of 
previously published work that the lowest/lower charge states are similar to the in 
vivo structure (Scarff, Thalassinos et al. 2008). 
 
Three different mammalian PrP species were studied by means of IM-MS.  Previous 
studies have shown that a species barrier exists between the three species despite 
their highly conserved primary sequences (Prusiner, Scott et al. 1990; Scott, Kohler 
et al. 1992).  The estimated cross-section for the lower charge states was similar 
between all the species of PrP but at the higher charge states significant differences 
in the cross-section between hamster and mouse PrP, and hamster and ovine PrP 
were observed.  The estimated cross-section of mouse PrP and ovine PrP were 
similar at all of the charge states under both physiological conditions.  The lowest, 
most biologically relevant, charge state of each species was subjected to increasing 
trap collision energies and the stability of the conformations was monitored.  The 
most compact conformations in ovine PrP were more stable than the corresponding 
conformations in Syrian hamster and mouse PrP.  The differences in stability suggest 
that the I184V amino acid mutation plays an important role in the tertiary structures 
stability.  The occurrence of the species barrier between hamster and mouse PrP, and 
hamster and ovine PrP, could be because of the differences in their tertiary structure 
and folding mechanisms.  The species barrier between ovine PrP and mouse PrP 
could be because of the differences in the proteins’ stability and the mutation of 
amino acid I184V in their primary sequence.  
 
ESI-MS alone cannot distinguish between the isobaric conformational isoforms.  The 
T-Wave device is able to operate at biologically relevant sample concentrations and 
with its speed and ease of use it has the ability to be used in an automated fashion.  
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ESI-IM-MS provides an extra dimension of fast, sensitive, gas-phase, ion separation 
enabling conformational changes in the protein structure to be probed.  
Consequently, the technique is worth evaluating as a potential method of providing 
an ante-mortem screening assay of bodily fluids for protein misfolding diseases such 
as TSEs.  The T-Wave device can also be used to study the differences in structural 
stability of a protein and T-Wave cross-section data is comparable to NMR 
spectroscopy cross-section data and computer model structures.    
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Chapter 5 
Results: Conformational Studies of 
Metal Ion Coordination to the Prion 
Protein 
 160 
 
5.1 Introduction 
5.1.1 Role of Copper  
Copper is an essential element for life.  It has numerous roles within the human body 
including acting as a catalyst in the transportation of iron, in the synthesis of 
collagen, in the coagulation of blood (Linder and Hazegh-Azam 1996) and of 
particular significance to prion research in the synthesis of neurotransmitters 
(Georgieff 2007).  A deficiency of copper can lead to a variety of diseases ranging 
from the common blood disorder anaemia to the rarer Wilson’s disease.  Wilson’s 
disease is an autosomal recessive disorder characterised by the toxic accumulation of 
copper in the liver and brain.  The brain pathology of deceased Wilson’s disease 
sufferers resembles the spongiform degeneration observed in PrP diseases (Tanzi, 
Petrukhin et al. 1993).  It is widely accepted that PrPC can bind copper in a 
cooperative manner with some indication that it is involved in the homeostasis of 
copper within the body (Brown, Qin et al. 1997; Viles, Cohen et al. 1999).  In CJD 
patients, the levels of copper found in the brain are significantly decreased (Wong, 
Chen et al. 2001).  Similar effects/changes were also found in mice infected with 
scrapie.   
 
5.1.2 Copper Transport 
Copper uptake, sequestration and excretion in living systems are highly regulated 
processes which eliminates the need for copper storage.  In blood, the major protein 
that transports copper is ceruloplasmin.  This protein is stimulated by ascorbate and 
other reducing agents to take up copper which it then readily deposits into tissues 
(Linder and Hazegh-Azam 1996).  Copper can act as an electron transfer agent or as 
a cofactor for specific enzymes such as superoxide dismutase (SOD).  The Cu/Zn 
SOD enzyme catalyses the disproportionation reaction of superoxide (O2
-) to 
hydrogen peroxide and oxygen to protect the cell against oxygen radical damage (as 
described in Figure 5.1).  Recombinant mouse and chicken PrP can also act as SOD 
enzymes but their activity is approximately 10% of the extremely potent Cu/Zn-SOD 
enzyme.  Although low, this PrP SOD activity is believed to be significant and is 
observed only in the full-length species (Thompsett and Brown 2004).  SOD activity 
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in the octarepeat peptides alone was found to be insufficient (Wong, Pan et al. 2000).  
It has been shown that knockout Prnp mice have lower levels of copper in their 
brains and reduced Cu/Zn-SOD activity (approximately 50%) compared to their wild 
type counterparts (Brown 2001; White, Bush et al. 1999).  This implies that the 
lower SOD activity in knockout mice is due to the absence of the PrP protein.  It is 
believed that PrPC can behave as a sacrificial antioxidant resulting in oxidative 
chemical modification of the methionine and histidine residues in PrPC (Nadal, 
Abdelraheim et al. 2007).  In proteins, methionine residues can act as a reactive 
oxygen species (ROS) sink which scavenge for harmful ROS before they can 
damage the cell.  The toxicity of ROS is strongly increased in the presence of 
copper.  In Fenton chemistry, copper ions act as a catalyst to transfer a single 
electron and aid the formation of a free radical (see Figure 5.2) (Fenton 1995).  This 
newly formed free radical (˙OH) is toxic to the cell and can cause damage to the 
DNA or initiate lipid peroxidation cascades (Fernaeus, Reis et al. 2005).  The short 
half life of PrP (3-6 hours) (Borchelt, Scott et al. 1990; Caughey, Race et al. 1989; 
Caughey and Raymond 1991; Yedidia, Horonchik et al. 2001) coupled with its high 
copper binding affinity implies that the PrPC functional role is to act as a sacrificial 
quencher of free radicals, thereby protecting the cell from the Cu2+ toxic effects 
(Viles, Klewpatinond et al. 2008).   
 
 
Figure 5.1:  Cu/Zn-SOD reaction with superoxide. 
 
Cu(II)SOD + O2
-   Cu(I)SOD + O2
 
Cu(I)SOD + O2
- + 2H+   Cu(II)SOD + H2O2
 162 
 
 
Figure 5.2:  Proposed mechanism for the action of BESOD.  Mechanism thought to be 
similar in the PrP protein (Fenton 1995).  The bound superoxide reduces the copper(II) to 
copper (I) with simultaneous cleavage of the bond between the copper and His (this is the 
bridging His in Cu/Zn-SOD).  Dioxygen is released and a second superoxide binds to the 
copper (I) positioning an oxygen atom to form a hydrogen bond with the protonated 
imidazole of His.  Electron transfer from the copper (I) coupled with proton transfer from 
the His gives copper hydroperoxide which picks up the second hydrogen from the active site 
water to release hydrogen peroxide (Fenton 1995).  
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5.1.3 PrP metal binding 
PrPC may specifically bind copper, but similarities in ionic strength, hydration size 
and valence allow other metal ions to bind to PrPC if present in sufficient 
concentrations.  It has been shown that oxidative impairment in scrapie-infected 
mice is associated with lower levels of divalent copper, zinc, manganese, iron and 
calcium in the brain (Choi, Kanthasamy et al. 2006).  This suggests that metal 
imbalances in infected brains can affect the structural and antioxidant functional 
properties of the protein.  Fernaeus et al, have demonstrated that iron regulation is 
disturbed in scrapie-infected mouse neuroblastoma cells with the infected cells 
having a lowered intracellular iron concentration than that of their wild type cousins 
(Fernaeus and Land 2005).  Further studies showed that an increase in excess iron 
weakens the cell’s cytoprotective defence and leads to an increase in ROS formation 
and eventually cell death (Fernaeus, Reis et al. 2005).  There is evidence to suggest 
that manganese, like copper, can bind to PrPC at two distinct binding sites (Brown, 
Hafiz et al. 2000).  This manganese binding results in the conversion of PrPC to an 
abnormal isoform which is high in β-sheet content and has the ability to aggregate.  
These features are reminiscent of PrPSc.  Studies of PrP manganese coordination 
suggests that manganese can drive the conversion of PrPC to PrPSc in vivo by aiding 
the formation of a β-sheet rich PrP intermediate or a PrP seed (see Figure 5.3 and 
Chapter 2.9.1) (Brown, Hafiz et al. 2000; Choi, Kanthasamy et al. 2006).  An 
alternative theory suggests that other divalent transition metals can inhibit the 
ubiquitin proteasomal pathway, causing it to be inactivated thereby leading to an 
increase in the concentration of PrPSc (see Figure 5.3). 
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Figure 5.3:  Schematic representation of the proposed metal-induced changes in the 
structure and function of PrPC.  Transition metals such as manganese, cadmium and zinc 
could inhibit the proteasomal activity thereby increasing the concentration of PrPSc.  
Manganese can induce a conformational change in PrPC to create the intermediate PrP*, this 
reaction can be reversed with the introduction of copper.  In the presence of excess 
manganese PrPSc can form aggregates.  Adapted from (Choi, Kanthasamy et al. 2006). 
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5.1.4 PrP binding affinities 
The concentration of copper varies dramatically throughout the body with the 
highest concentration being found in the muscles and brain (see Figure 5.4).  These 
findings are complementary to the distribution of the prion protein.  Cu2+ 
concentrations in the cerebrospinal fluid (CSF) and extracellular brain interstitial 
fluid are typically 0.1 µM.  Concentrations of serum albumin are found at much 
lower levels in the CSF than in blood plasma (typically 3 µM), but much of the Cu2+ 
is still found to be in the serum albumin, which has a picomolar affinity for Cu2+ ions 
(Viles, Klewpatinond et al. 2008).  PrPC is found concentrated at the synaptic cleft 
with the Cu2+ concentration ranging from 100-250 µM depending on the cleft size 
(Kardos, Kovacs et al. 1989). 
 
Figure 5.4:  Summary of nutritional biochemistry of copper in adult humans.  Values for 
copper indicate average daily amounts of copper concentrations in fluids and tissues.  
Diagram modified from (Aguzzi and Heikenwalder 2006), copper values obtained from 
(Linder and Hazegh-Azam 1996). 
Muscle 
26 mg
Blood 6 mg
Plasma 1.2 mg/L
7 mg
Liver 
10 mg
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Spleen
Lymphoid system
Brain
Peyer’s patches
Appendix
Stomach
4-5 mg
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There is no general agreement concerning the binding affinities, sites and extents of 
copper binding within PrP (Brown 2004; Jackson, Murray et al. 2001).  There is 
evidence to suggest that PrP binds up to four copper ions in the highly conserved 
octarepeat, and possibly a further copper at a fifth site outside this region (Brown 
2004).  The octarepeat is located in the N-terminal region and is rich in histidine 
residues.  Binding of copper to the N-terminal fragment of human PrP (23-98) 
suggested a saturation stoichiometry of one copper per histidine residue (Brown, Qin 
et al. 1997), with dissociation constants in the micromolar range.  An alternative 
binding mode in which four octarepeat His residues bind to one Cu2+ ion 
simultaneously has been reported with the corresponding dissociation constants 
ranging from 8 fM (Jackson, Murray et al. 2001) to 3 nM (Viles, Klewpatinond et al. 
2008).  In addition, Cu2+ can bind to the amyloidogenic region (residues 90-126) 
which, comprises His96 and His111 in humans, with binding affinities between 1-
100 nM being recorded (Klewpatinond, Davies et al. 2008; Viles, Klewpatinond et 
al. 2008).   
 
PrP can also bind two manganese ions, in conjunction with Cu2+, to the 
amyloidogenic region with binding affinities of 63 µM for one Mn2+ ion and ~200 
µM for two Mn2+ ions (Brazier, Davies et al. 2008; Jackson, Murray et al. 2001).  
The concentration of manganese in heathly human blood is approximately 22 ppb 
and is even lower in serum with typical values ranging from 3-18 ppb (Hesketh, 
Sassoon et al. 2008).  Upon the onset of TSE diseases it has been shown that 
manganese levels are elevated in blood and brain tissues (Hesketh, Sassoon et al. 
2007) but still remain within ppb range.  The binding dissociation constants and the 
low concentration of manganese in the blood imply that PrP cannot bind manganese 
in vivo.  If this observation were true, very few manganese-binding proteins would 
successfully chelate the metal ion.  It is therefore assumed that manganese binding to 
proteins is regulated in a manner that is currently not understood (Brazier, Davies et 
al. 2008). 
 
In contrast to numerous studies of Cu2+ binding to fragments of PrP fewer structural 
studies of Cu2+ binding to full-length PrP are available.  These studies have been 
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restricted by the solubility of PrPC at physiological pH required for Cu2+ binding.  
Spectroscopic techniques such as CD (Klewpatinond, Davies et al. 2008), NMR 
spectroscopy (Wells, Jackson et al. 2006) and EPR spectroscopy (Burns, Aronoff-
Spencer et al. 2003) have been used to study structural details of Cu2+ binding to 
full-length and other large recombinant PrP fragments.  These techniques are limited 
to the measurement of the average structure in solution and often require high 
sample concentrations and volumes.  In comparison, IM-MS is able to operate at 
biologically relevant concentrations (as low as femto molar) and when combined 
with soft ionisation methods, such as ESI, detailed molecular structural information 
can be obtained on individual conformations in a complex mixture.  Mass 
spectrometry is gaining in popularity as a technique for prion characterisation (Back, 
Sanz et al. 2002; Maras B. 2004; Onisko, Dynin et al. 2007; Pushie, Ross et al. 
2007; Qin, Yang et al. 2002; Requena, Groth et al. 2001; Whittal, Ball et al. 2000) 
and it can be especially useful in determining the stoichiometric ratio of metal ions 
bound to proteins, (Becker and Jakubowski 2009) for which other techniques give 
ambiguous results.   
 
5.2 Results and Discussion 
For all materials and methods please refer to Chapter 3. 
 
T-Wave ion mobility was used to investigate the structure of PrP in the presence and 
absence of cooper and manganese coordination.  Two different constructs were 
studied; full-length Syrian hamster prion protein containing a structured C-terminal 
domain and an N-terminal fragment containing the unstructured octarepeat region.  
The N-terminal region of mammalian PrP contains a highly conserved sequence of 
five or six octapeptide repeats (PHGGGWGQ)n.  Previous studies have shown that 
copper binds to the histidine residues in the octarepeat motif with a saturation 
stoichiometry of one copper per histidine residue (Brown, Qin et al. 1997), and 
manganese can bind in the amyloidogenic region (Brazier, Davies et al. 2008).  
Bovine PrP and Syrian hamster PrP have complete sequence identity in their 
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octarepeat regions with the addition of one extra octarepeat motif in the bovine 
protein.   
 
5.2.1 Copper coordination to BovPrP(57-101) 
The interaction of copper with the N-terminal peptide of bovine PrP BovPrP(57-
101), was studied for different stoichiometric ratios of Cu2+ (PrP:Cu2+) at near-
physiological pH 7.0.  Figure 5.5 shows the deconvoluted mass spectra for apo-
BovPrP(57-101) [1], BovPrP(57-101): Cu2+ [2], BovPrP(57-101): 3Cu2+ [3] and 
BovPrP(57-101): 5Cu2+ [4].  The deconvoluted peak derived from sample [1] 
corresponds to the predicted molecular mass, 4313.8 Da, of BovPrP(57-101), 
labelled PrP.  Upon the addition of copper, unbound PrP is no longer observed which 
is indicative of the protein’s high affinity for copper.  At the 1:1 PrP:Cu2+ molar ratio 
(sample [2]) the peak at 4377 Da indicates the binding of one copper ion, in addition 
further peaks at 4438 Da and 4502 Da suggest binding of a further one and two Cu2+ 
ions.  The masses reflect that two H+ atoms are displaced upon Cu2+ coordination to 
the peptide.  It was found that as the concentration of Cu2+ was increased the number 
of Cu2+ ions attached to the peptide also increased with up to three Cu2+ ions bound 
in [2] compared to five Cu2+ ions, inclusive, in samples [3-4].  It is observed that 
increasing stoichiometric ratios of Cu2+ decreases the relative abundance, in the gas-
phase, of PrP + 1Cu2+.   
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Figure 5.5:  Deconvolution of the ESI spectrum for (a) BovPrP(57-101), (b) BovPrP(57-
101): Cu2+ (c) BovPrP(57-101): 3Cu2+ and (d) BovPrP(57-101): 5Cu2+. 
 
All experiments were repeated three times over different days and the ATDs were 
measured for the +3 to +5 charge states.  Figure 5.6a shows the estimated cross-
sections for the biologically relevant +5 charge state with 0, 1, 2, 3, 4, and 5 Cu2+ 
ions bound at physiological pH 7.0.  The relatively small estimated cross-section of 
apo BovPrP(57-101) at the +5 charge state suggests this has a more globular 
structure than its copper bound counterparts.  When 1-3 Cu2+ ions are coordinated to 
PrP, an increase in the estimated cross-section was observed with a 15 Å2 difference 
measured between the average estimated cross-section of BovPrP and 
BovPrP+2Cu2+.  This increase in estimated cross-section suggests a more extended 
structure compared to the apo peptide.  The coordination of three Cu2+ ions results in 
a structure that is more extended than the apo peptide but more compact than that 
with one and two Cu2+ ions bound.  The observation of the attachment of a fourth 
and fifth Cu2+ ion suggests the peptide becomes more globular as a decrease in 
estimated cross-sections is seen (from 774 Å2 to 769 Å2 respectively).  These 
findings are in good agreement with previous reports in which molecular dynamics 
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(Riihimaki, Martinez et al. 2008) and NMR studies (Zahn 2003) indicate that 
binding of copper ions to the human PrP octarepeat peptide can induce a 
conformational transition.  The FWHM of the individual ATDs (Figure 5.6b) also 
suggests that at higher Cu2+ coordination the peptide becomes less flexible/more 
rigid.  The FWHM of BovPrP is 15 scans and is reduced to 9 scans when one copper 
is coordinated.  The width of an ATD can be related to the number of conformations 
contributing to the area of that peak.  The relatively large width of the BovPrP ATD 
suggests that there are multiple conformations present which have a difference in 
cross-section of <5%.  It is expected that individual cross-sections that are greater 
than 5% in difference would be resolved by this ion mobility instrument (Hilton, 
Jackson et al. 2008).  In comparison, the ATD for BovPrP+1Cu2+ is narrower 
indicating fewer conformations are present when one copper ion is bound.  Upon 
increasing the number of Cu2+ ions coordinated to the peptide the FWHM of the 
respective ATDs increases and it can therefore be presumed that the number of 
different conformations per ATD also increases. 
 
Secondary structural changes of the N-terminal peptide upon Cu2+ coordination were 
determined by means of CD.  CD data are a representation of the average structure in 
solution, whereas IM-MS can analyse individual conformations in the gas-phase.  
Far-UV CD spectra of BovPrP(57-101) show a single minimum at 198 nm which 
represents an essentially unstructured protein.  This is in good agreement with 
previously published NMR structures which show that the amino acid residues 23-
124 have features of a flexible random coil-like polypeptide (Riek, Hornemann et al. 
1997).  In the presence of copper, samples [2-4], the relative abundance of random 
coil is reduced suggesting a profound structuring of the peptide from the 
unstructured conformation.  This has been previously observed elsewhere (Garnett 
and Viles 2003) and is in good agreement with the IM-MS data.   
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Figure 5.6a:  Comparison of estimated cross-sections for charge state 5+ of BovPrP(57-
101), BovPrP(57-101)+Cu2+, BovPrP(57-101)+2Cu2+, BovPrP(57-101)+3Cu2+, BovPrP(57-
101)+4Cu2+ and BovPrP(57-101)+5Cu2+.  Inset:  Far-UV CD spectrum of BovPrP(57-101) 
(red), BovPrP(57-101): Cu2+ and BovPrP(57-101): 3Cu2+ (blue) and BovPrP(57-101): 5Cu2+ 
(green).  Figure 5.6b:  Comparison of full-width half-height maximum (FWHM) of the 
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individual arrival time distributions (ATDs) for BovPrP(57-101) (black), BovPrP+Cu2+ 
(red), BovPrP+2Cu2+ (green), BovPrP+3Cu2+ (blue) and BovPrP+4Cu2+ (orange) at the 
biologically relevant charge state [M+5H]5+.  The FWHM of BovPrP is 15 scans and is 
reduced to 9 scans when one copper is coordinated. 
 
It is widely accepted that PrPC can bind copper in a cooperative manner with several 
structural models suggesting that the Cu2+ ion stoichiometry can influence the 
binding mechanism of copper coordination (Burns, Aronoff-Spencer et al. 2003; 
Chattopadhyay, Walter et al. 2005; Riihimaki, Martinez et al. 2008; Viles, Cohen et 
al. 1999).  It can therefore be postulated that the binding of one copper ion can 
change the conformation of PrP to allow the coordination of the further copper ions.  
The estimated cross-section plot for BovPrP(57-101) with Cu2+ attached, shown in 
Figure 5.6a, indicates that the shape of the peptide changes depending on the number 
of Cu2+ ions coordinated to BovPrP(57-101).  It is observed that the apo BovPrP(57-
101) has a more compact structure than that of the species with 1-3 copper ions 
bound.  It has been previously noted that the structure of the apo octarepeat is 
strongly influenced by the interaction of the aromatic rings in tryptophan, histidine 
and proline residues (Riihimaki, Martinez et al. 2008).  Ring-stacking initially 
occurs between the consecutive histidine and tryptophan residues which apply 
structural constraints to the peptide.  These structural constraints allow further ring 
interactions to occur between the proline residues.  It is proposed that this ring-
stacking gives the octarepeat peptide a more globular structure as observed for 
BovPrP in Figure 5.6a.  See Figure 5.7 for a schematic representation of the ring-
stacking mechanism.  In the presence of copper, however, the extent of ring-stacking 
is diminished to allow for a more extended structure, as observed in the cross-
sections of PrP+1Cu2+ and PrP+2Cu2+.  The estimated cross-section of BovPrP(57-
101) decreases when ≥3 Cu2+ ions are coordinated, whereas an increase in the 
FWHM of the respective ATDs has been observed.  This apparent ring stacking 
phenomena that gives the peptide structure was not observed by means of far-UV 
CD and NMR spectroscopy.  This could be because these techniques measure the 
average structure in solution and therefore cannot select a single conformation.  The 
use of near-UV CD to characterise the peptide could show evidence for the aromatic 
ring interactions.   
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Figure 5.7:  Schematic representation of the octarepeat peptide ring-stacking.  (a) The 
indole rings of the first and second octarepeat sequence interact through ring-stacking.  The 
proline residue has folded to the axial region of the first coordination site.  (b) Globural 
structure formed as the indole rings of the third and fourth octarepeat sequence are in well-
defined positions.  Taken from (Riihimaki, Martinez et al. 2008) 
 
A unique feature of IM-MS is its ability to measure individual cross-sections, 
calculated from the ATD, as well as the overall conformation of a protein or peptide.  
The width of an ATD can be related to the number or spread of conformations 
present at a particular charge state.  An increase in the FWHM of the ATDs upon 
Cu2+ coordination implies that there are also an increased number of different 
conformations contributing to these peaks (Figure 5.6b).  Several hypotheses have 
been outlined to explain copper coordination binding modes.  A crystal structure has 
been postulated by Chattopadhyay et al, which shows Cu2+ coordinated to the 
octarepeat motif (HGGGW).  The Cu2+  coordinates to three nitrogen atoms and one 
oxygen atom, in an equatorial plane, and an axial water oxygen atom to form a 
square-pyramidal coordination complex (Burns, Aronoff-Spencer et al. 2002; 
a b
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Millhauser 2004) (see Figure 5.8a).  These and other studies (Jackson, Murray et al. 
2001) further showed that a change in coordination geometry can occur as a function 
of the relative Cu2+ concentration, suggesting that an alternative binding mechanism 
could take place at different copper levels.  Figure 5.8b shows a further alternative 
binding mode in which copper can coordinate to nitrogen provided by the octarepeat 
histidine imidazole as well as the nitrogen present in the exocyclic backbone 
(Chattopadhyay, Walter et al. 2005).  It has also been proposed that at low copper 
concentrations (stoichiometric equivalents <1.0 Cu2+) three or four sequential 
HGGGW motifs are required to coordinate to one Cu2+ with the neutral imidazoles 
(see Figure 5.8c).  Recent studies have shown that Cu2+ initially binds to full-length 
PrP in the amyloidogenic region at His95 and His110 inducing yet another binding 
mode (Klewpatinond, Davies et al. 2008).  It is believed that Cu2+ ions preferentially 
bind to the amyloidogenic region, before the octarepeat region, until each histidine 
residue in the repeat is saturated with copper (Viles, Klewpatinond et al. 2008).  The 
overall cross-section of the three different binding mechanisms, shown in Figure 5.8, 
to the octarepeat region could be similar (<5% difference in cross-section) and 
therefore, it would be difficult to resolve individual conformations when using ion 
mobility (Chattopadhyay, Walter et al. 2005; Malmström and Vänngård 1960).  This 
similarity is reflected in the individual ATDs.  If the cross-sections of conformations 
contributing to the ATD were different, greater than 5%, then several resolvable 
peaks would be observed.  This suggests that the binding mode conformations are 
too similar to be fully resolved but different enough to increase the number or spread 
of conformations contributing to each ATD.  It is unclear, at different copper 
concentrations, which of the three binding modes described above would be 
dominant; consequently all three could be present and contribute to the increased 
width at FWHM of the respective individual ATDs.   
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Figure 5.8:  Models of the three proposed different copper binding modes.  (a) Cu2+ ions 
coordinate with three nitrogen atoms and one oxygen atom, in an equatorial plane, preferred 
binding mode for high Cu2+ occupancy.  (b) Cu2+ ions coordinate to nitrogen provided by the 
octarepeat histidine imidazole and nitrogen present in the exocyclic backbone.  (c). Three 
sequential HGGGW motifs coordinate to one Cu2+ via the neutral imidazoles.  X may 
represent either a fourth neutral imidazole or a water molecule.  This binding mode provides 
the highest binding affinity.  Taken from (Chattopadhyay, Walter et al. 2005).   
 
5.2.2 Copper coordination to SHaPrP(23-231)  
The coordination of copper with the full-length hamster PrP SHaPrP(23-231) was 
studied using different stoichiometric ratios of Cu2+ at physiological pH 7.0.  Figure 
5.9 shows the mass spectra of SHaPrP(23-231) and SHaPrP(23-231): Cu2+ at pH 7.0.  
The insets are an enlargement of the +11 charge state ([M+11H]11+), with masses 
attributed to [M+9H+Cu]11+ and [M+7H+2Cu]11+, respectively.  A comparison of the 
MS spectra indicates the charge state envelope distribution of the two data sets is 
similar.  The exception to this observation is the presence of extra dimer peaks in the 
SHaPrP(23-231): Cu2+ spectrum.  It was noted that upon increasing the concentration 
of copper relative to that of the prion, the sample became increasing difficult to 
spray.  In samples with a stoichiometric ratio greater than 1:5 PrP:Cu2+ visible 
c
a b
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aggregates were formed and blocked the sample tip.  This prevented further mass 
spectrometry studies of higher stoichiometric ratios being performed.  The 
appearance of dimer peaks in the mass spectrum supports the proposal that when 
copper interacts with PrPC it can promote the protein to oligomerise (Qin, Yang et al. 
2000).  The concentration of copper used in the stoichiometric ratio experiments was 
biologically relevant with the highest concentration of Cu2+ ions not exceeding 150 
µM.  Kardos et al, calculated the concentration of copper in the synaptic cleft to be 
in the range of 100 – 250 µM (Kardos, Kovacs et al. 1989).  .   
 
A comparison of the deconvoluted mass spectra for all four samples, SHaPrP(23-
231) [5], SHaPrP(23-231): Cu2+ [6], SHaPrP(23-231): 3Cu2+ [7] and SHaPrP(23-
231): 5Cu2+ [8], is shown in Figure 5.10.  The dominant peak (23102 Da) derived 
from sample [5] in Figure 5.10a corresponded to the predicted molecular mass of 
oxidised SHaPrP(23-231), labelled PrP.  The second lower intensity peak observed is 
due to sodium salt adducts and has not been labelled.  With 1:1 PrP:Cu2+ (sample 
[6]) the presence of unbound SHaPrP(23-231) was still observed as well as PrP+Cu2+ 
and PrP+2Cu2+.  When the stoichiometric ratio of copper was increased to 1:3 and 
1:5 (PrP:Cu2+) the unbound SHaPrP(23-231) and PrP+Cu2+ were no longer observed.  
The masses deconvoluted from sample [7] and [8] can be attributed to PrP+2Cu2+, 
PrP+3Cu2+ and, in sample [8] only, PrP+4Cu2+.  This observation of an increase in 
the number of copper ions coordinated to the protein as the concentration of copper 
is increased is in good agreement with that obtained for copper binding to 
BovPrP(57-101).  This again agrees with previous studies which suggest copper can 
coordinate to the prion protein in a cooperative manner (Brown, Qin et al. 1997; 
Viles, Cohen et al. 1999).   
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Figure 5.9:  (a) Mass spectrum of SHaPrP(23-231):Cu2+ at pH 7.0.  The spectrum shows 
two series of peaks corresponding to multiply charged ions from monomer and dimer.  Inset:  
Enlargement of the +11 charge state showing m/z peaks due to [M+11H]+11, [M+9H+Cu]+11, 
[M+7H+2Cu]+11.  (b)  Mass spectrum of SHaPrP(23-231) at pH 7.0.  The spectrum shows 
one series of peaks corresponding to multiply charged ions from monomer.  Inset:  
Enlargement of the +11 charge state showing m/z peaks due to [M+11H]+11. 
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Figure 5.10:  Deconvolution of the ESI spectrum for (a) SHaPrP(23-231), (b) SHaPrP(23-
231): Cu2+, (c) SHaPrP(23-231): 3Cu2+ and (d) SHaPrP(23-231): 5Cu2+.   
 
Figure 5.11 shows the estimated cross-sections of the charge states of PrP, with and 
without Cu2+ ions coordinated, from (+9 to +25 charge states) obtained at pH 7.0.  
The samples with a higher concentration of Cu2+, namely 1:3 and 1:5 PrP:Cu2+ 
(samples [7 and 8]) had a propensity to aggregate and were analysed immediately 
after the Cu2+ had been mixed with the prion protein.  The estimated cross-section 
plot shows that protonation of the protein increases the cross-section measured and 
therefore higher charge states represent an extending/unfolding structure.  Charge 
states +9, +12 to +14 and +17 to +19 have two or more stable conformations 
whereas the remaining charge states have only one conformation.  Figure 5.11 also 
shows that there are no significant differences in the estimated cross-sections 
between SHaPrP(23-231) and its respective copper bound forms which suggests that 
copper coordination has little influence on the degree of the prion protein folding.  
This observation is in agreement with far-UV CD data (see inset Figure 5.11) from 
which a structural similarity was also detected.  There is a significant difference in 
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the lower estimated cross-section value of charge state +12 between PrP, PrP+Cu2+ 
and PrP+≥2Cu2+.  This difference is greater than the ±3% expected from 
experimental error.  The ATDs at this charge state (see Figure 5.12) indicate there is 
a significant difference in the intensity on the second conformational peak (see 
Figure 5.12b *) between unbound SHaPrP(23-231), PrP+Cu2+ and the ATDs of 
PrP+2Cu2+, PrP+3Cu2+ and PrP+4Cu2+.  The relative intensity of the ATD suggests 
that when zero or one Cu2+ ion is coordinated to the prion protein two stable 
conformations are preferred, compared with one significant stable conformation at 
higher Cu2+ ion concentrations.   
 
 
Figure 5.11:  Comparison of estimated cross-sections for different charge states of 
SHaPrP(23-231), PrP+Cu2+, PrP+2Cu2+, PrP+3Cu2+ and PrP+4Cu2+.  Inset:  Far-UV CD 
spectrum of SHaPrP(23-231) (green), SHaPrP(23-231): Cu2+ and SHaPrP(23-231): 3Cu2+ 
(blue) and SHaPrP(23-231): 5Cu2+ (red). 
 
In Chapter 4, it was observed that differences can be detected between ATDs of the 
same m/z when no significant differences were present in the estimated cross-section 
plots.  Figure 5.12 shows a comparison of the ATDs of SHaPrP(23-231) unbound 
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and PrP+Cu2+,PrP+2Cu2+, PrP+3Cu2+ and PrP+4Cu2+ at charge states +10, +12, +14 
and +22.  There are no significant differences between the ATDs at any charge state 
(except +12 charge state see above) indicating that the estimated cross-sectional plot, 
in this case, is an accurate representation of this data set.  As the charge state 
increases the ATD baseline width and FWHM decreases.  For the +10 charge state 
the FWHM is 29 scans compared to 13 scans FWHM at charge state +22.  The width 
of an ATD can be related to the number of conformations contributing to the area of 
that peak.  The large width at charge state +10 suggests that there is more than one 
conformation, of a similar shape, present which is unable to be fully resolved in the 
ion mobility cell.  At the +22 charge state the sharp, narrow ATD suggests fewer 
conformations are present.  This observation can be rationalised as at lower charge 
states, such as +10, a more native like structure is detected (Scarff, Thalassinos et al. 
2008) (in this case globular) whereas, at higher charge states, +22, the protein has 
unfolded becoming denatured in structure. 
 
 
Figure 5.12:  Comparison of SHaPrP(23-231) (pink), PrP+Cu2+ (blue), PrP+2Cu2+ (green), 
PrP+3Cu2+ (orange) and PrP+4Cu2+ (red) selected arrival time distributions (ATDs) for the 
+10, +12, +14 and +22 charge states.(a)  Overlaid ATDs for the +10 charge state at pH 7.0.  
(b)  Overlaid ATDs for the +12 charge state at pH 7.0.  (c)  Overlaid ATDs for the +14 
charge state at pH 7.0.  (d)  Overlaid ATDs for the +22 charge state at pH 7.0.   
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An X-ray crystal structure or molecular model of the complete full-length prion has 
not been published.  The NMR structure of recombinant full-length prion protein 
reveals residues 125-228 comprise a global domain and the N-terminal fragment, 
residues 23-120, shows features of a flexible random coil-like polypeptide (Riek, 
Hornemann et al. 1997).  The actual positions/structure of this flexible tail has never 
been defined because of missing residue assignments and exchange-broadening in 
the NMR spectrum.  The majority of copper coordination conformational studies for 
PrP have used octarepeat fragments.  The limited size of these fragments permits the 
peptides to be more flexible allowing them to fold and interact with the copper more 
readily than if constrained by the rest of the protein.  Zahn observed a structural 
change in the octarepeat motif under different pH conditions and postulated that the 
induced conformational transition modulated PrP aggregation (Zahn 2003).  In these 
experiments, the estimated cross-sections of the octarepeat region peptide, 
BovPrP(57-101) suggests that upon the addition of copper a change in estimated 
cross-section occurs.  The most significant difference observed is between 
BovPrP(57-101) and BovPrP(57-101)+2Cu2+ with a difference of 15 Å2.  This 
difference is less than 1% in the overall estimated cross-section.  In Figure 5.11, the 
estimated cross-sections of SHaPrP(23-231) suggests that, upon the addition of 
copper, no discernible change in the estimated cross-section occurs.  If a similar 
change in cross-section, i.e. ± 15 Å2, occurred when copper coordinated to full-
length prion the difference in estimated cross-section between SHaPrP(23-231) and 
SHaPrP(23-231)+2Cu2+ would be <0.1%.  This difference is too small to be detected 
by means of current IM-MS instrumentation.   
 
It is believed that binding of copper could stimulate endocytosis by altering the 
conformation of PrPC.  Putative endocytic receptors that localise PrPC in clathrin-
coated pits could be stimulated by the conformational change, thereby increasing the 
binding affinity (Pauly and Harris 1998).  Pauly et al, hypothesise that the 
attachment of PrPC to the cell surface by a GPI anchor, results in the loss of a 
cytoplasmic domain which can directly bind to the intracellular components of a 
clathrin-coated pit.  Pauly postulates, that a copper induced structural change in PrPC 
could enable the protein to bind to a transmembrane receptor whose cytoplasmic 
domain contain signals for interacting with adapter molecules and clathrin (Harris, 
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Gorodinsky et al. 1996; Shyng, Moulder et al. 1995); this could aid endocytosis.  
These results suggest that the relatively small changes in the estimated cross-section 
when copper coordinates to the N-terminal fragment BovPrP(57-101) do not induce 
significant conformational changes in the C-terminal domain.  This suggests that 
endocytosis is stimulated by Cu2+ binding that is triggered by extremely small 
changes in conformational structure.   
 
Brown et al, have demonstrated for the prion protein to display SOD activity a 
minimum number of two coordinated copper ions are required (Brown, Hafiz et al. 
2000).  In the full-length protein the SOD activity can be increased when a further 
two copper ions are bound.  It is postulated that the more ordered structure observed 
in the octarepeat peptide when up to five copper ions are coordinated (see Figure 
5.6a) can account for the increase in the protein’s SOD activity.  The conformational 
change in the peptide was not detected in the full-length protein.  Again, if this 
hypothesis is true, these experiments suggest that SOD activity can be induced by 
minor changes in the overall conformation of the full-length prion protein. 
 
5.2.3 Manganese coordination to SHaPrP(23-231)  
Recent literature indicates that manganese coordinates only to the amyloidogenic 
region in the prion protein (Brazier, Davies et al. 2008; Gaggelli, Bernardi et al. 
2005), therefore manganese binding to the octarepeat peptide was not studied.  The 
coordination of manganese with SHaPrP(23-231) was studied using different 
stoichiometric ratios of Mn2+ at physiological pH 7.0.  Figure 5.13 shows the mass 
spectra of SHaPrP(23-231) and SHaPrP(23-231): 20Mn2+ at pH 7.0.  The insets are 
an enlargement of the +11 charge state ([M+11H]11+), with masses attributed to 
[M+9H+Mn]11+ and [M+7H+2Mn]11+, respectively.  A comparison of the MS 
spectra indicates the charge state envelope distribution, between the two data sets, is 
similar.  Manganese coordination was not observed to promote aggregation; this is in 
stark contrast to copper coordination.  It was noted, however, that upon increasing 
the concentration of manganese with respect to prion the sample became 
increasingly difficult to spray.  Stoichiometric ratios greater than 1:20 PrP:Mn2+ 
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greatly reduced data quality, and prevented further mass spectrometry studies of 
higher stoichiometric ratios being performed.   
 
 
Figure 5.13:  (a) Mass spectrum of SHaPrP(23-231):20Mn2+ at pH 7.0.  The spectrum 
shows a series of peaks corresponding to multiply charged ions from monomer.  Inset:  
Enlargement of the +11 charge state showing m/z peaks due to [M+11H]+11, [M+9H+Mn]+11, 
[M+7H+2Mn]+11.  (b)  Mass spectrum of SHaPrP(23-231) at pH 7.0.  The spectrum shows 
one series of peaks corresponding to multiply charged ions from monomer.  Inset:  
Enlargement of the +11 charge state showing m/z peaks due to [M+11H]+11. 
 
A comparison of the deconvoluted mass spectra for all three samples, SHaPrP(23-
231) [9], SHaPrP(23-231): 10Mn2+ [10], and SHaPrP(23-231): 20Mn2+ [11], is 
shown in Figure 5.14.  The dominant peak (23,102 Da) derived from sample [9] in 
Figure 5.14a corresponds to the predicted molecular mass of oxidised SHaPrP(23-
231), labelled PrP.  The second and third lower intensity peaks observed are due to 
ammonium and sodium salts adducts respectively and have not been labelled.  The 
samples PrP: Mn2+, and PrP: 5Mn2+ were also analysed but manganese coordination 
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was not observed.  In contrast to the copper experiments, the deconvoluted mass 
spectra for all three samples ([9-11]) shows a continual presence of unbound 
SHaPrP(23-231).  The masses deconvoluted from sample [10] can be attributed to 
PrP and PrP+1Mn2+ (23,155 Da), whereas sample [11] has an additional peak at 
mass 23,208 Da which corresponds to PrP+2Mn2+.  The continual presence of PrP 
suggests that manganese does not bind to PrP in a cooperative manner.  The Mn2+ 
binding constant, to PrP, is 10 orders of magnitude lower than for copper (femto 
molar dissociation constant) (Jackson, Murray et al. 2001), this is reflected in the 
higher stoichiometric ratios required to coordinate the metal to the protein.  Figures 
5.5 and 5.10 indicate that as the concentration of copper is increased, with respect to 
prion, the peak intensities of the copper coordinated species (PrP+≥2Cu2+) also 
increase.  In contrast, Figure 5.14 illustrates that apo-SHaPrP(23-231) is the 
dominant peak in the spectra whatever the manganese ion concentration used.  These 
striking differences could be caused by the difference in binding modes and 
affinities. 
 
Figure 5.15 shows the estimated cross-sections of the charge states of PrP, with and 
without Mn2+ ions coordinated, from (+9 to +25 charge states) obtained at pH 7.0.  
Charge states +9, +12 to +14 and +17 to +19 have only two or more stable 
conformations whereas the remaining charge states only have one conformation.  
This unfolding pattern is similar to that observed in Figure 5.11.  Figure 5.15 also 
shows that there are no significant differences in the estimated cross-sections 
between SHaPrP(23-231) and those forms in which manganese is bound to the prion.  
This suggests that manganese coordination to the amyloidogenic region has no 
influence on the degree of the prion protein folding. 
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Figure 5.14:  Deconvolution of the ESI spectrum for (a) SHaPrP(23-231), (b) 
SHaPrP(23-231): 10Mn2+, (c) SHaPrP(23-231): 20Mn2+. 
Figure 5.15:  Comparison of estimated cross-sections for different charge states of 
SHaPrP(23-231), PrP+1Mn2+, PrP+2Mn2+. 
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5.2.4 Copper coordination vs manganese coordination to SHaPrP(23-
231)  
The coordination chemistry of Cu2+ and Mn2+ to the prion protein have been 
previously characterised and studies reveal that both metal ions coordinate to the His 
111 imidazole ring at the fifth binding site (Burns, Aronoff-Spencer et al. 2002; 
Chattopadhyay, Walter et al. 2005; Gaggelli, Bernardi et al. 2005; Jackson, Murray 
et al. 2001; Klewpatinond, Davies et al. 2008; Millhauser 2004).  Copper and 
manganese bind to the prion protein in two different regions; the structure of the N-
terminal region is affected by Cu2+, while Mn2+ first anchors to the Gly126 
carboxylate and involves the preceding carbonyl residues from Leu125, Gly124 and 
His111 in the metal ion coordination (Gaggelli, Bernardi et al. 2005).  A comparison 
of the estimated cross-sections for the copper and manganese coordinated species 
can be found in Figure 5.16.  There are no significant differences in the estimated 
cross-sections between apo-SHaPrP(23-231) and PrP+Cu2+, PrP+Mn2+, PrP+2Cu2+ 
and PrP+2Mn2+.  This implies that the different binding sites for Cu2+ and Mn2+ do 
not induce a major conformational change in the protein.  The difference in the prion 
cross-section upon metal coordination could be as small as 0.1%, as described above, 
and therefore IM-MS would not detect these differences. 
 
Brown et al demonstrated that when the recombinant full-length prion protein is 
refolded in the presence of 5 mM MnCl2, the protein is resistant to proteinase K 
digestion (Brown, Hafiz et al. 2000).  These PrP constructs also became less stable 
upon manganese binding and were quickly converted to a misfolded form.  From 
these findings Brown hypothesised that incorporation of manganese ions into PrPC 
could produce a proteinase-resistant PrP seed which catalysed the conversion of PrPC 
to PrPSc.  In these experiments, the recombinant full-length PrP remained stable 
throughout and did not produce high order oligomers.  A comparison of the 
estimated cross-sections showed there was no significant change in the overall 
conformation. 
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Figure 5.16:  (a) Comparison of estimated cross-sections for different charge states of 
SHaPrP(23-231), PrP+1Cu2+, PrP+1Mn2+.  (b) Comparison of estimated cross-sections for 
different charge states of SHaPrP(23-231), PrP+2Cu2+, PrP+2Mn2+.   
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5.3 Conclusions 
ESI-IM-MS has been used to measure the interaction of copper and manganese with 
recombinant bovine peptide, BovPrP(57-101) and full-length recombinant Syrian 
hamster prion, SHaPrP(23-231), using different stoichiometric ratios of Cu2+ and 
Mn2+ at physiological pH, pH 7.0.  Bovine peptide experiments show that at high 
copper concentrations (1:≥3 PrP: Cu2+) all five octarepeat histidine residues 
coordinate to Cu2+ ions resulting in five Cu2+ attached to the peptide.  The estimated 
cross-sections of the peptide suggest that the apo form may be globular in shape due 
to electrostatic interactions between the aromatic rings in consecutive tryptophan, 
histidine and proline residues.  At low copper occupancy the peptide becomes less 
globular, as up to two Cu2+ ions can coordinate.  The peptide becomes more globular 
when all five Cu2+ ions coordinate; this observation is also reflected in far-UV CD 
data as the relative abundance of random coil structure decreases upon increasing 
copper concentration.  The largest difference in estimated cross-section upon copper 
coordination is 15 Å2 which is observed between BovPrP(57-101) and BovPrP(57-
101)+2Cu2+.  IM-MS can successfully detect small differences (≥1%) in the cross-
section of the N-terminal octarepeat peptide. 
 
Analysis of SHaPrP(23-231) ESI-MS data with and without ion mobility separation 
is in good agreement.  At low Cu2+ ion concentrations (1:≤1 PrP:Cu2+ equivalents) a 
maximum of two Cu2+ are coordinated to the protein.  At higher Cu2+ ion 
concentrations (1:>3 PrP:Cu2+ equivalents) it was observed that four Cu2+ coordinate 
to the prion in a cooperative manner.  Copper binding affinities have been published 
elsewhere and it is noted that different binding modes occur at different copper 
concentrations.  The mass spectrum of apo SHaPrP(23-231) shows a single series of 
multiply charged peaks suggesting only monomer is present and the prion sample is 
of a high purity.  In comparison, the mass spectrum of SHaPrP(23-231):Cu2+ shows 
the presence of dimer peaks indicating that copper can induce aggregation of the 
prion.  There are no significant differences between the estimated cross-sections of 
PrP, PrP+Cu2+, PrP+2Cu2+, PrP+3Cu2+ and PrP+4Cu2+; the same observation can be 
made when comparing individual ATDs. 
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Manganese binding experiments to SHaPrP(23-231) show that a high excess of the 
metal ion is required for Mn2+ coordination to occur.  Up to two Mn2+ ions 
coordinate to the protein at ratios PrP:≥20 Mn2+.  Apo SHaPrP(23-231) was 
observed in all the deconvoluted spectra and the mass spectra reveal a single series 
of peaks arising from multiply-charged ions throughout the sample set.  Manganese 
binding to the protein did not induce the sample to aggregate.  A comparison of Cu2+ 
and Mn2+ coordinated species shows there is no significant difference in the 
estimated cross-section between apo SHaPrP(23-231) and its metal bound 
counterparts. 
 
It has been observed that copper coordination to the N-terminal fragment can induce 
conformational changes in the octarepeat fragment.  These changes are relatively 
small and cannot be measured in the full-length prion protein.  This suggests that 
minor structural changes in the N-terminal could stimulate endocytosis via a minor, 
undetected, conformational change in the C-terminal domain.  It also implies that 
SOD activity in the full-length protein is sensitive to extremely small conformational 
changes.  
 
The T-Wave device is able to operate at biologically relevant sample concentrations 
and with its speed and ease of use it has the ability to be used in an automated 
fashion.  ESI-IM-MS provides an extra dimension of fast, sensitive, gas phase, ion 
separation enabling conformational changes in the protein structure to be probed.  T-
Wave technology is still in the early stages of development and it is likely that 
further improvements in the resolution of the technique will extend the approach into 
a fast, sensitive, information-rich method.  This provides a technique with the 
potential to probe small but significant changes in structure of biological molecules.  
 
The aim of this work was to develop and evaluate a mass spectrometry-based 
method to distinguish between the prion isoforms and access the technique’s ability 
to be used as an ante-mortem diagnostic test.  The work described in chapters four 
and five suggests that the IM-MS technique has the potential to be used as an ante-
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mortem test.  It was discussed that, in principle, the IM-MS technique could be used 
to distinguish between PrPC and PrPSc and IM-MS was a useful tool to discriminate 
between small conformation changes in the gas-phase.  Extensive further studies 
would, however, be required before this approach could be recognised as an effective 
ante-mortem test.  Such studies include an amplification method of PrP in 
mammalian blood, de-glycosylation of the extracted PrP protein and the re-
assessment of the IM-MS technique to detect PrPC and PrPSc from healthy and 
diseased blood samples.   
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Chapter 6 
Introduction to Synthetic Polymers 
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6.1 Introduction 
Synthetic polymers are an integral part of everyday life.  Plastic bags, medical 
implants, textile fibres, automobiles and children’s toys are a few examples of the 
diverse applications of modern polymeric materials.  Polymer systems can exhibit a 
wide range of properties.  It is the differences in these physical properties that have 
resulted in the polymers being used for a variety of different applications.  The 
performance of these materials is dependent on a number of factors including the 
initiating and/or terminating end groups, the molecular weight distribution and more 
importantly the monomeric units.  As a consequence, there is great interest in 
characterising the detailed microstructure of synthetic polymers and to relate this 
information to their structural and functional properties (Koenig 2004).     
 
6.2 What is a polymer? 
A polymer can be a naturally-occurring, an artificially-modified or a synthetic 
compound.  The most common and generally accepted definition of a polymer is: “a 
system formed by an assembly of macromolecules – that is a system of molecular 
entities with large dimension which are obtained by the covalent linking of a large 
number of constitutional repeat units, more commonly called monomeric units” 
(Gnanou and Fontanille 2008).  The polymeric repeat units are composed from 
sequentially reacted monomers which are typically capped by end groups.  A 
polymer can be characterised by the chemical composition of its repeat units, the end 
groups and the molecular weight distribution of the oligomers.   
 
6.3 Function 
Synthetic polymeric materials are used throughout the industrial world for a variety 
of different purposes within chemical, pharmaceutical and manufacturing commerce 
(see Table 6.1 for examples).  They range from high-value commodity products such 
as poly(propylene) (PP) and poly(ethylene) (PE), to low tonnage speciality products 
such as poly(ether ether ketone) (PEEK) and carbon fibre reinforced resins (Scrivens 
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and Jackson 2000).  Traditional polymer systems such as poly(methyl methacrylate), 
cellulose acetate and poly(ether urethane) are commonplace within the medical field 
and are regularly used as false teeth, dialysis tubing or in artificial hearts respectively 
(Peppas and Langer 1994).  These polymer materials have helped to usher in new 
medical treatments but critical problems in biocompatibility, mechanical properties, 
degradation and numerous other areas still remain (Langer and Tirrell 2004).  
Developments in manufacturing and in biomedical materials have been the catalysis 
for the creation, and synthesis, of thousands of specialised products.  For example a 
new polyether copolymer has been synthesised that, once formed into nanospheres, 
can circulate around the body mimicking the movement of cells (Langer and Tirrell 
2004).  This application has the potential to revolutionise drug delivery systems.  
The new specially synthesised polymeric materials tend to be more chemically 
complex and can be difficult to analyse.   
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Table 6.1:  Examples of synthetic polymers and their function (Nicholson 2006) 
Polymer class Example Uses 
Acrylic Poly(methyl methacrylate) • Shatter-proof glass 
• Heat-proof material 
• Paints 
Polyamide Nylon • Textile fibres 
• Engineering 
applications 
Polycarbonate Polycarbonate of bisphenol 
A 
• Shatter-proof glass 
• Reading spectacles 
Polyester Poly(ethylene terephthalate) • Textile fibres 
• Food & drink 
containers 
Polyether Poly(ethylene glycol) • Electrical insulation 
• Cosmetics 
• Building and 
construction 
Polyurethane Elastane (Spandex/Lycra) • Rigid or flexible foam 
• Protective coatings 
• Textile fibres 
Polyvinyl Poly(vinyl chloride) • Adhesives 
• Pipes 
• Textile fabrics 
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6.4 Polymer formulations 
A polymer formulation can contain several components in addition to the synthetic 
polymer itself.  These components range from contaminants of the synthetic process 
which include un-reacted catalyst, low molecular weight oligomers and intact 
monomers, to components deliberately added to the polymer system that modify the 
properties of the polymeric material.  These deliberately added components, known 
as polymer additives, can enhance the performance of a polymer system.  Different 
types of additives can be mixed with a synthetic polymer to change its function.  For 
example Table 6.1 shows that poly(ethylene glycol) (PEG) can be used as both an 
electrical insulator and in cosmetic products.  The properties required for these two 
manufactured goods are dramatically different.  An electrical wire insulator should 
be flexible, protect the wire from environmental factors and protect the user from 
receiving an electrical shock.  Polymer additives such as plasticizers, flow enhancers 
and heat stabilisers are added to the PEG formulation to improve its insulation 
properties.  In cosmetic applications the polymer is added as a bulk reagent to the 
formulation; it should be stable when exposed to light, creamy in texture and inert.  
Antioxidants, lubricants and fragrances are the types of additives added to cosmetic 
PEG formulations.  Polymer additives can be complex mixtures and a variety of 
different analytical techniques is often required to help identify and quantify them.   
 
6.5 Polymerisation 
Synthetic polymers can be classified according to their method of synthesis.  The 
two main methods are either step-growth or chain-growth polymerisation.  Step 
polymerisation describes the mechanism in which the polymer backbone is generated 
by a step-wise reaction between two independent molecular species.  Most step-
growth polymers, such as Nylon 66, are produced by a reaction between two 
difunctional monomers (see Figure 6.1a).  The majority of step-growth 
polymerisation mechanisms occur by simple one step condensation/addition 
reaction.  In contrast, chain polymerisation typically consists of three phases: namely 
initiation; propagation and termination (see Figure 6.1b).  In some cases a chain 
transfer agent is used to control the functionality and molecular weight of the 
polymer system.  In the initiation stage a reactive centre is generated.  These reactive 
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centres are usually free radicals and are formed when an initiator is heated or excited 
by UV light.  The newly formed free radical can react with a monomer unit to create 
a reactive intermediate.  In the propagation phase, the reactive intermediate reacts 
with successive monomers to create a growing polymer chain.  This chain continues 
to grow until all the monomer units have been reacted or the end groups undergo a 
termination reaction.  Free radical polymerisation reactions can be terminated either 
by combination or disproportionation.  The combination mechanism involves the 
reaction of two radical species which form a single bond and one reaction product.  
In the disproportionation reaction two radical species react to yield a saturated and 
unsaturated reaction product (see Figure 6.1b).  The polymerisation mechanisms can 
influence the properties of the resulting polymer.  Polymers created by chain-growth 
polymerisation tend to have a low polydispersity and be higher in molar mass.  A 
long chain-growth reaction time tends to increase the yield of the polymer rather 
than the molar mass of the individual oligomers.  In contrast, a longer step-growth 
reaction time is required for higher molar mass oligomers to be created; during this 
reaction varying oligomer lengths are created which affects the polydispersity value 
(Montaudo and Lattimer 2002). 
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Figure 6.1:  Schematic of step-growth and chain-growth polymerisation.  (a) Step-growth 
mechanism for the formation of Nylon 66.  (b) Chain-growth mechanism.  Free radical 
reaction of a commonly used initiator azobisisobutyronitrile (AIBN).  Propagation and 
termination stages of the chain-growth polymerisation.   
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6.6 Copolymers 
A homopolymer is a polymer formed from polymerisation of monomer units that 
have the same structure; for example polyethylene is formed by polymerisation of 
ethylene.  Copolymers are obtained from polymerisation of two different monomer 
units.  Copolymers can be synthesised by means of step-growth polymerisation, such 
as Nylon 66 (see Figure 6.1a), or by chain-growth polymerisation.  The propagation 
step in a free radical copolymerisation reaction (see Figure 6.1b Propagation) is the 
only step that differs from that of homopolymerisation.  Copolymers can be 
classified by their statistical properties.  The statistics of copolymers is defined by 
the distribution of monomeric units along the chain backbone (Gnanou and 
Fontanille 2008).  The distribution of monomers can be described as alternating, 
block or random (see Figure 6.2).  Alternating copolymers contain regular 
alternating comonomers (A and B).  Block copolymers comprise of two or more 
homopolymer subunits linked together by covalent bonds.  These copolymers can be 
further classified by the number of repeating block units each polymer contains such 
as di-block or tri-block.  Random copolymers occur if the probability of finding a 
given type of monomer residue, at a particular point in the chain, is equal to the mole 
fraction of that monomer residue in the chain (Gnanou and Fontanille 2008).  The 
characteristics of a copolymer are dependent on its statistical properties.  
 
The analysis of copolymers can be considerably more challenging than that of 
homopolymers.  In particular, the characterisation of block and random copolymers 
can be complex because of the additional information content.  The information that 
can be determined from a copolymer includes the average molecular weight of the 
polymer, the structure of the repeat units (both A and B), the estimation of the 
relative abundance of macromolecular chains terminated with one type of end group 
or another, the average molar fraction of A and B units in the copolymer, the average 
length of long AAAA and BBBB blocks, the weight of copolymer chains that 
possess a given composition and the variation of copolymer composition as the 
molar mass of the macromolecular chain grows (Montaudo 2002).  A variety of 
spectroscopic and spectrometric techniques have been used to characterise the 
structural properties and functions of copolymer systems (Mark, Ngai et al. 2004). 
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Figure 6.2:  Schematic representation of statistical copolymers. 
 
6.7 Analysis of Polymers 
Assessing the performance of a polymeric material, after preparation and in its 
working environment, requires a fundamental understanding of the relationship 
between the molecular and bulk properties of a polymer system.  The 
characterisation method chosen to analyse the polymer system depends on the 
information content required.  The macroscopic/bulk properties of the polymeric 
material are typically determined by means of mechanical testing, rheology and 
thermal analysis.  Techniques such as light scattering and microscopy are used to 
analyse the microscopic properties of a polymer (Nicholson 2006).  The performance 
of a polymeric material can also be influenced by the nature of its surface and 
interface.  Secondary ion mass spectrometry (SIMS) has been used to monitor the 
changes in interfacial properties (Harton, Stevie et al. 2006).  Other techniques such 
as X-ray photoelectron spectroscopy (XPS) have also been used to characterise the 
surface defects and imperfections of a polymeric material (Briggs, Brewis et al. 
1976).   
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6.7.1 Molecular Mass Distribution 
Knowledge of the molecular weight distribution of a polymer is very important as a 
variation in this mean value and the distribution can affect the physical properties of 
the material.  Two common measurements for the average molecular weight of a 
polymer are the number-average molecular weight (Mn) and the weight-average 
molecular weight (Mw).  Equations 6.1 and 6.2 show how to calculate these 
parameters where mi is the mass of an observed ion and Ni is the number of ions 
observed. 
 
The number-average molar mass Mn is given by: 
B<   ∑ : #:∑ #:  
Equation 6.1 
The weight-average molar mass Mw is defined as: 
BD   ∑ :#:∑ :#:  
Equation 6.2 
 
The polydispersity (D) of the polymer can be calculated from the Mn and Mw values 
(see Equation 6.3). 
E   BDB<  
Equation 6.3 
 
In general, the value for Mw is always larger than that of Mn except for a 
monodisperse system.  This implies that the value for D cannot be less than 1.  
Narrow molecular weight distributions are characterised by D values close to 1, 
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whereas broad molecular weight distribution are characterised by D values ≥ 2 
(Montaudo and Lattimer 2002).   
 
6.8 Characterisation methods 
Various analytical methods are available for the characterisation of synthetic 
polymer structures.  Techniques such as gel permeation chromatography (GPC, also 
known as size exclusion chromatography, SEC), light scattering, osmometry, NMR 
spectroscopy and end group titration are used to measure the average molecular 
weight of the polymer.  Spectroscopic techniques such as IR spectroscopy and NMR 
spectroscopy measure the overall average features of a polymer system rather than 
an individual molecular structure.  In some cases, however, end group functionality 
can be deduced.  Mass spectrometry is an established analytic tool for the 
characterisation of various polymer systems. 
 
6.8.1 NMR Spectroscopy 
NMR spectroscopy is frequently used to characterise polymers because of its high 
resolution, sensitivity and the ability to quantify polymer repeat units from the 
spectrum.  NMR provides information on polymer structures including main-chain 
and microstructures (stereochemistry, regioisomerism and geometric isomerism), co-
monomer composition, end- and side-group analysis, cross-linking, branching and 
side-chain tacticity (Mark, Ngai et al. 2004).  Both 1H and 13C NMR are typically 
used to analyse the polymer system but the lower sensitivity of the latter means 
longer acquisition times are often necessary.  An advantage of employing NMR 
spectroscopy to characterise synthetic polymers is that most polymeric phases can be 
analysed by means of solid-state, solution-state or hyphenated solution-state NMR 
methods. 
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6.8.2 GPC-NMR 
GPC is a widely applicable chromatography technique that can help determine the 
molecular weight distribution of synthetic polymers.  The technique is based on the 
separation of solvated samples based on their molecular size and shape.  A sample is 
injected on to the GPC column, where the various components are separated 
according to their size and shape, and eluted from the column in order of decreasing 
size.  The molecular size of these samples can be calculated by comparing the 
elution times of components of the unknown sample with the elution times of GPC 
calibrants.  The GPC equipment should ideally be calibrated with a compound 
similar to that being analysed.  A problem with this approach is that calibration 
compounds for many polymers are not available.  The disadvantages of GPC are that 
the data generated are dependent on the calibration curve used, and the molecular 
shape of the compound.  A difference in molecular shape can affect the elution order 
of a compound.  For example, in a low molecular weight polymer, substitution of an 
aromatic end group to a long aliphatic end group could have a dramatic affect on the 
overall shape of the polymer.  This difference could change the elution order of the 
polymer and therefore the predicted molecular weight of the compound (Choi, 
Chong et al. 2001; Rader, Spickermann et al. 1995).   
 
The first report of GPC coupled on-line to a NMR detector was in 1988.  In this 
initial study Hatada and co-workers demonstrated that the number-average molecular 
weight of isotactic poly(methyl methacrylate) (PMMA) could be directly measured 
by GPC-NMR (Hatada, Ute et al. 1988).  The use of NMR as a detector removed the 
need to perform a GPC calibration step.  Two decades later, several publications 
suggest that GPC-NMR is an invaluable tool for the deformulation of complex 
polymer mixtures (Hatada, Ute et al. 1990; Hatada, Ute et al. 1989; Kitayama, Janco 
et al. 2000; Kitayama and Ute 2006; Kramer, Pasch et al. 1999; Robertson, Heron et 
al. 2004; Ute, Kashiyama et al. 1990; Ute, Niimi et al. 2001).  Hiller et al, have 
shown that on-line GPC-NMR can be used to analyse blends of homopolymers and 
copolymers at ambient and high temperatures (Hiller, Pasch et al. 2006).  They 
revealed it was possible to separate a mixture of poly(ethylene) (PE) and PMMA 
based on their molecular masses and different chemical compositions.    
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6.8.3 Mass Spectrometry 
Mass spectrometry is gaining in popularity as a technique that can be used to 
investigate the structure of polymers in the gas phase.  This technique was originally 
used to determine the fundamental energetic and structural properties of small 
molecules.  In more recent years, it has been applied to characterise the chemical 
composition and molar mass distribution of certain polymer classes.  The 
development of soft ionisation techniques such as ESI and MALDI has permitted 
relatively large macromolecules to be analysed intact.   
 
The desire for new materials and technologies has led to the creation of more 
complex polymer systems and mixtures.  The complexity of these polymers systems 
makes it difficult to characterise the polymer by MS alone.  To overcome this 
analytical challenge, many new ionisation techniques and hyphenated analytical 
approaches have been employed including ion mobility mass spectrometry (IM-MS) 
(Weidner and Trimpin 2008).    
 
6.8.3.1 Matrix-assisted laser desorption/ionisation (MALDI) 
Successful polymer analysis by means of MALDI-MS requires the polymer sample 
to be co-crystallised with salt and matrix molecules.  The nature of synthetic 
polymers makes it difficult to achieve a uniform sample:salt:matrix crystal.  
Different sample preparation techniques are therefore required for different polymer 
systems or different molecular weight ranges (Peacock and McEwen 2006; Zenobi 
and Knochenmuss 1998).  A typical MALDI mass spectrum of a low polydisperse 
synthetic polymer is relatively simple.  The spectrum consists of peaks 
predominantly from singly charged, cationised polymer ions with few or no 
fragmentation ions present.  Structural and compositional information on the 
polymer system can be deduced from the MALDI–MS data.  This information 
includes repeat unit and end group identification, structural analysis of linear and 
cyclic oligomers, tracking of polymerisation kinetics and the determination of 
molecular weight distributions (Montaudo and Lattimer 2002).   
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Most mass spectrometry studies of synthetic polymers involve cationisation rather 
than protonation.  Alkali metals are the preferred cationising agents but in some 
cases transition metals, such as silver and copper, are required.  Research has shown 
that the molecular weight distribution of certain polymer classes can vary depending 
on the cation used for ionisation (Deery, Jennings et al. 1997; Dogruel, Nelson et al. 
1996; Jackson, Yates et al. 1997a).  This variation is observed because the larger 
cations interact less favourably with small oligomers and vice versa.  For example, 
polyethers can be readily ionised when coordinated to small alkali cations such as 
lithium or sodium, whereas polystyrenes are more favourably ionised when they 
interact with larger cations such as silver (Chen and Li 2001; Deery, Jennings et al. 
1997; Polce, Ocampo et al. 2008a; Polce, Ocampo et al. 2008b).   
 
In recent years MALDI has developed into an invaluable tool for determining the 
molecular weight distributions of synthetic polymers (Bahr, Deppe et al. 1992; Dey, 
Castoro et al. 2002; Montaudo, Montaudo et al. 1995b; Montaudo, Montaudo et al. 
1997).  The advantage of analysing polymers by means of MALDI, over techniques 
such as SEC or light scattering techniques, is that molecular weights and molecular 
weight distribution can be obtained however, these values can be inaccurate.  The 
disadvantage of the MALDI-MS technique is that the molecular weight values for 
polydisperse polymers (polymers with a polydispersity > 1.2 (Martin, Spickermann 
et al. 1996)) differ from known SEC values (Montaudo, Garozzo et al. 1995; 
Montaudo, Montaudo et al. 1995a).  A number of suggestions have been made to 
explain these discrepancies including the mass spectrometer detector design, laser 
power and analyser performance (Scrivens and Jackson 2000).  Hyphenation of SEC 
and MALDI-MS can overcome these limitations and has been demonstrated as a 
powerful tool for polymer characterisation (Nielen 1998). 
 
MALDI-ToF has been used to characterise a number of copolymer systems (Malik, 
Trathnigg et al. 2009; Montaudo 2002; Van Rooij, Duursma et al. 1998).  The 
analysis of copolymers is considerably more challenging than that of homopolymers.  
This is because, in addition to the molecular weight and end group information, 
copolymers can exhibit a different topological distribution.  MALDI-ToF can be 
 211 
 
used to determine the topology (either block, alternating or random) of a copolymer 
(Montaudo 2002).  The mass spectra of copolymers can be complex and oligomeric 
information can be lost if ion peaks overlap.  The composition of a copolymer can be 
determined from the m/z peak intensities provided that significant ion fragmentation 
has not taken place (Montaudo, Samperi et al. 2006; Montaudo 2002).  Novel 
complex copolymer systems often require a combination of liquid chromatography 
separation methods and other spectroscopic techniques for complete structural 
analysis to be possible (Weidner and Trimpin 2008).   
 
6.8.3.2 Electrospray ionisation (ESI) 
Multiply charged species can be formed by means of ESI.  The main advantage of 
ESI is that for instruments of limited m/z range the multiple charges allow one to 
observe ions of a higher mass at lower m/z values.  This permits mass spectrometer 
systems which have limited m/z range analysers to characterise the polymer of 
interest.  Separation techniques such as liquid chromatography (LC) and GPC can 
also be coupled to ESI.  This extra dimension of separation, prior to MS analysis, 
can aid identification and interpretation of the data.  The ESI mass spectra of 
synthetic polymers can be complex because of the numerous multiply charged 
species that are present.  The interpretation of the spectra can be aided if the 
experiments are performed in high resolution instrumentation such as FT-ICR-MS or 
Orbitrap.  An advantage of using FT-ICR-MS to characterise synthetic polymers is 
its high mass accuracy and high mass resolving power.  FT-ICR-MS experiments 
performed in high resolution mode can provide resolutions >106 and a mass accuracy 
of < 1 ppm (Alber, Marshall et al. 1993).  The high resolution enables ion peaks to 
be unambiguously assigned and the isotope peaks of oligomers can be distinguished 
in polymer systems up to 23,000 Da (O'Connor and McLafferty 2002).  FT-ICR-MS 
is, however, usually coupled with MALDI for the analysis of synthetic polymers 
rather than with ESI (Buback, Frauendorf et al. 2007; Dey, Castoro et al. 2002; 
Easterling, Amster et al. 1999; Mize, Simonsick et al. 2003; Robinson, Garcia et al. 
2006; Van der Hage, Duursma et al. 1997; Van Rooij, Duursma et al. 1998; van 
Rooij, Duursma et al. 1996).  This is because, like MALDI, FT-ICR-MS has a 
limited m/z dynamic range and can typically characterise low polydisperse synthetic 
polymer systems only.   
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An alternative and more popular approach, to analyse synthetic polymers, is to 
couple ESI with an orthogonal ToF (oa-ToF) analyser (Weidner and Trimpin 2008).  
ESI is a soft ionisation technique and as a consequence, little or no fragmentation of 
the analyte molecules occurs.  It is considered a softer ionisation technique than 
MALDI which is important for the characterisation of labile polymer systems.  The 
advantage of coupling ESI to a Q-ToF analyser is that tandem MS experiments can 
be performed.  These experiments enable end group and sequence information to be 
determined.  The added advantage of ESI is that the orientation and end-group 
sequence can be determined from the tandem MS data.  This is in contrast to MALDI 
data which can only suggest what the overall mass of the end-groups are. 
 
Until recently, the majority of polymer mass spectrometry research focused on 
measuring the molecular weight distributions of a polymer of interest (Bahr, Deppe 
et al. 1992; Dey, Castoro et al. 2002; Montaudo, Montaudo et al. 1995b; Montaudo, 
Montaudo et al. 1997), identifying its end groups (Buback, Frauendorf et al. 2007; 
Jackson, Green et al. 2006; Jackson, Scrivens et al. 2000a; Jackson, Slade et al. 
2004; Jackson, Yates et al. 1996), determining the sequence and composition of 
copolymers, and confirming the monomer structure in homopolymer systems 
(Nuwaysir, Wilkins et al.; Van Rooij, Duursma et al. 1998; Wilczek-Vera, Yu et al. 
1999).  These studies have provided information on the primary and secondary 
structure of the polymer, but they do not help one to deduce the tertiary structure or 
conformation.  New methods such as tandem mass spectrometry and IM-MS can 
provide information on the fragmentation patterns of the polymer and the gas phase 
conformation respectively.   
 
6.8.3.3 Tandem Mass Spectrometry 
Most MS/MS experiments use collision-induced dissociation (CID) to induce 
fragmentation of the selected precursor ion (Crecelius, Baumgaertel et al. 2009).  A 
different technique, namely electron capture dissociation (ECD), can also be used to 
achieve the fragmentation of peptides and certain types of polymers (Cerda, Horn et 
al. 1999; Syka, Coon et al. 2004).  The production of fragment ions by means of 
ECD is, however, limited to FT-ICR-MS instruments.  An MS/MS experiment 
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which makes use of metastable ion decay, called post-source decay (PSD), can be 
performed in MALDI-ToF instruments.  This technique suffers from low selectively 
of the precursor ion and a lack of control of the ion activation conditions, which has 
prevented its widespread use in the polymer field 
 
Pioneering tandem mass spectrometry work was first published by Craig and Derrick 
as a tool to analyse the microstructure of polystyrene systems (Craig and Derrick 
1986).  Tandem mass spectrometry experiments were  originally shown by Lattimer 
and coworkers to be a viable method for characterising polyethers such as PEG and 
PPG (Lattimer 1992a; Lattimer 1992b; Lattimer 1994; Lattimer, Munster et al. 
1989).  In MS/MS experiments a specific precursor ion is mass selected, fragmented 
and the resulting product ions are detected to create the product ion MS/MS mass 
spectrum.  ESI-MS/MS and MALDI-MS/MS experiments of various polymer 
systems have shown that valuable structural information can be gained from the 
fragmentation patterns observed (Jackson, Bunn et al. 2000; Jackson, Jennings et al. 
1997; Jackson, Scrivens et al. 2000a; Jackson, Scrivens et al. 2000b; Jackson, Slade 
et al. 2004; Lattimer 1992a; Lattimer 1992b; Lattimer 1994; Lattimer, Munster et al. 
1989; Polce, Ocampo et al. 2008a; Polce, Ocampo et al. 2008b).  The m/z values in 
the fragment ion series produced by MS/MS experiments often enable one to identify 
the initiating and terminating end groups.  In some polymer systems the mass of the 
end group can be a significant proportion of the overall molecular weight of the 
polymer system, especially in low molecular weight polymers.  End-group analysis 
by means of CID has the added benefit that the orientation of the polymer can be 
detected; this is in contrast to high resolution mass spectrometry data.  
Characterisation of the end groups is therefore very important, as changes to the end 
group functionality could lead to significant changes in the properties of the 
polymer. 
 
6.8.3.4 Fragmentation pathways  
The fragmentation series produced by MS/MS experiments can enable one to 
determine both the sum of and the individual masses of the initiating and terminating 
end groups.  This allows both end groups to be identified.  In general, the MS/MS 
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spectrum of a polymer contains a series of fragment ion peaks which have either 
experienced the loss of repeat units containing the initiating end group (α) or have 
sequentially lost repeat units that contain the terminating end group (ω). 
 
It has been demonstrated that lithiated precursor ions can generate more structural 
information, from the tandem mass spectra of polyethers, than other alkali metal 
cations (Chen and Li 2001; Lattimer 1992a; Lattimer 1994; Selby, Wesdemiotis et 
al. 1994; Williams, Hilton et al. 2007).  Polyethers ionised by other alkali metals, 
such as potassium and cesium, can lead to the formation of bare cations as the 
dominant fragment ions.  MS/MS spectra with these bare cations enable little (if any) 
structural information to be derived.  The majority of polyether fragmentation studies 
have therefore used lithium ions to ionise the polymer (Chen and Li 2001; Chen, Yu 
et al. 2002; Jackson, Slade et al. 2008; Lattimer 1992a; Lattimer 1994; Lattimer, 
Munster et al. 1989).  Figure 6.3 shows the proposed annotated fragmentation 
pathways for polyethers.  Polyether MS/MS mass spectra are dominated by ions, 
which have retained the cation, from the Ax, Bx and Cx series (where x represents the 
partial or whole number of monomer units in the product ions).  The A series 
describes product ions that contain newly-generated alcohol end groups, the B series 
contain vinyl end functionalities and the C series contains an aldehyde end group 
(Jackson, Green et al. 2006; Lattimer 1992a; Lattimer 1994).  The apostrophes 
present in the annotation scheme in Figure 6.3 denote fragment ions that contain 
either the initiating end group (R’) or the terminating end group (R”).  Apostrophes 
are not used when the initiating and terminating end functionalities are the same e.g. 
di-hydroxyl end-capped PEG.  A further series of ions have been proposed for 
esterified polyethers (Jackson, Green et al. 2006).  This new series of ions Aax,
 Bax 
and Cax describes the loss of an acid from the remaining original end group of the Ax, 
Bx and Cx ion series respectively (where the superscript “a” denotes the loss of an 
acid).  It has been shown that low-energy CID fragment ions of PPG diesters are  
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Figure 6.3:  Proposed annotated fragmentation pathway for polyethers.  Taken from (Jackson, Green et al. 2006) 
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analogous to high-energy CID ions of PEG diesters and that the presence of these ions 
are diagnostic for polyether diesters (Jackson, Slade et al. 2008).  Additional fragment 
ions observed in the CID mass spectrum of 1,2-epoxide derived polyethers can be 
associated with the creation of the Y and Z ion series.  The Yx series is similar to the Cx 
ion series and the Zx series shows similarities to the Bx ion series.  The exception to this 
observation is that the two new ion series account for the loss of a side chain 
functionality from the polyether backbone.  It has been proposed that the presence of the 
Yx and Zx ion series can help to differentiate between structurally similar polyethers 
such as poly(butylene glycol) and poly(tetramethylene glycol) (Jackson, Green et al. 
2006).  Jackson et al, postulated that when observing the Ax, Bx and Cx series, fragments 
at the higher m/z are the most structurally informative for the generation of end group 
information (Jackson, Green et al. 2006).  
 
The ion series nomenclature for polymethacrylates is similar to that for polyethers.  In 
polymethacrylates and acrylics the A series describes fragment ions which retain the 
cation and the terminating end group, whereas the B series retain the cation and the 
initiating functionality (see Figure 6.4) (Jackson, Slade et al. 2004).  These fragment ion 
series tend to be the dominant fragment ion peaks in the MS/MS spectrum.  There are 
two proposed mechanisms for the formation of the A and B ion series.  The first is 
believed to be charged induced, with cleavage of the polymer backbone preferentially 
being induced in close proximity to the cation (Gidden, Jackson et al. 1999).  This 
mechanism accounts for the low molecular weight fragment ions observed in 
polyacrylate MS/MS mass spectra (Gidden, Jackson et al. 1999; Jackson, Slade et al. 
2004).  The less abundant fragment ions observed in the MS/MS spectra belong to the 
C, D, E and F ion series (see Figure 6.4).  These series of fragment ions arise from 
fragments that contain an intact functionality group from either the initiating- (C and F 
series) or terminating- (D and E series) end group.  It has been demonstrated that ions 
from the C-F series can be used to differentiate between random and block copolymers 
(Jackson, Scrivens et al. 2000b).  The second mechanism is random homolytic cleavage 
of the polymer backbone followed by depolymerisation.  This mechanism has recently 
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been used to describe the fragmentation pathways of polystyrene systems (Polce, 
Ocampo et al. 2007a; Polce, Ocampo et al. 2007b). 
 
 
Figure 6.4:  Proposed fragmentation scheme and structures for the A-E series of PMMA.  
Adapted from (Jackson, Slade et al. 2004) 
 
Figure 6.5:  Proposed structure for ions from the G series observed for polystyrenes.  (Jackson, 
Yates et al. 1998) 
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Another polymer that has been extensively studied by means of MS/MS is polystyrene 
(Jackson, Bunn et al. 2000; Jackson, Yates et al. 1998; Scrivens, Jackson et al. 1997).  It 
was demonstrated that polystyrenes with a variety of different end-group functionalities 
could be differentiated by the intense series of peaks in the low m/z range (Jackson, 
Bunn et al. 2000; Polce, Ocampo et al. 2007a; Polce, Ocampo et al. 2007b).  The 
styrene notation is similar to that used in describing the spectra of polyacrylates.  The Ax 
and Bx polystyrene series are analogous to those noted for methacrylate polymers (see 
Figure 6.4).  These two series dominate the mass spectrum and have been proposed to 
be the most useful for the identification of polystyrene end groups.  The G series 
contains other fragment ions that are also intense in the mass spectrum from polystyrene 
(see Figure 6.5).  These fragment ions retain the cation and are formed by rearrangement 
reactions rather than direct backbone cleavages.  This internal fragment series is thought 
to be formed by a two hydrogen rearrangement reaction which is analogous to the that 
observed for poly(alkyl methacrylates) (Jackson, Bunn et al. 2000; Jackson, Yates et al. 
1997b).  The remaining series of ion fragment peaks (C, D, E and F) are proposed to be 
generated by means of a 1,5-hydrogen rearrangement.  These reactions involve cleavage 
of the polymer backbone, loss of a benzene group and formation of neutrals with 
unsaturated end groups, and fragment ions.  These ions are equivalent to the 
polyacrylate ion series in Figure 6.4.  Recently a new mechanistic rationale has been 
proposed to describe the formation of CID polystyrene fragments (Polce, Ocampo et al. 
2007b).  The mechanistic rationale described above does not account for the origin of 
abundant internal fragments.  Polce et al, describe a free radical chemistry mechanism 
that accounts for the appearance of the previously characterised, and some 
uncharacterised, fragment ions commonly observed in the polystyrene product ion 
MS/MS mass spectrum.  This mechanism is referred to as random homolytic cleavage 
followed by depolymerisation.  They propose all MS/MS polystyrene fragments, that 
have silver as the cation, are formed by random, charge-remote homolytic cleavages 
along the polymer chain, followed by typical radical site reactions (Polce, Ocampo et al. 
2007b).  The radical reactions involve a β C-C bond scission and hydrogen atom 
rearrangements (also known as backbiting).  In the backbiting mechanism, a terminal 
radical can abstract a hydrogen atom from an interior position of the chain to create a 
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more stable radical (see Figure 6.6).  Polce and co-workers believe the two mechanistic 
pathways, β scission and backbiting, are in competition with one another and the 
preferred mechanism is dependent on the chain end groups.  For example it has been 
demonstrated that fragmentation of poly(α-methyl styrene) occurs via the β scission 
mechanism only.  This is because hydrogen rearrangement of the benzylic hydrogen 
atoms cannot occur (Polce, Ocampo et al. 2007a).  .    
 
 
 
Figure 6.6:  Proposed polystyrene fragmentation scheme.  Adapted from (Polce, Ocampo et al. 
2007a) 
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In comparison to peptides, relatively few polymer fragmentation pathways have been 
characterised.  Possible reasons for this observation are that polymers can either undergo 
re-arrangement(s) after dissociation or a complex range of covalent bonds are present in 
the polymer system backbone.  These rearrangement reactions can produce additional 
fragment ions or a new ion series which can make elucidation of the mass spectrum 
even more complicated.  Tandem experiments performed by means of MALDI-MS have 
the added analytical challenge that the singly charged fragment ions, preferentially 
produced in MALDI, can be of low intensity and can lack the information-rich backbone 
cleavages.  The majority of research has focussed on polyether, polyacrylate or 
polystyrene systems (as described above).   
 
6.8.3.5 Software development 
Software and databases are an inherent tool for the identification of peptides and 
proteins from tandem MS data (Craig and Beavis 2003; Eng, McCormack et al. 1994; 
Geer, Markey et al. 2004; Ma, Zhang et al. 2003; Perkins, Pappin et al. 1999; Zhang, 
Aebersold et al. 2002).  Until recently, there was no development in computational 
programs which could aid the interpretation of MS/MS data from synthetic polymers.  
Thalassinos et al, describe the development and application of a software program that 
can annotate MS/MS data of synthetic polymers (Thalassinos, Jackson et al. 2007).  
This software aids the interpretation of MS/MS spectra from polymers with known 
fragmentation pathways (such as those described above) and can significantly reduce the 
spectral interpretation time.  Exact mass MS/MS data were assigned by means of the 
Polymerator software to validate the suggested structures and to give further confidence 
in the interpretation of end-group structures (Thalassinos, Jackson et al. 2007).  Figure 
6.7 shows a screenshot from the Polymerator software of an annotated ESI-MS/MS 
spectrum.  The software requires centroid MS/MS data to be imported as a text file.  
Knowledge of parameters such as the initiating end group, terminating end group and 
repeat unit empirical formulae, number of repeat units and the cation are required in 
order for the software to annotate the spectrum.   
 
 221 
 
 
Figure 6.7:  Screenshot from the Polymerator software of an annotated ESI-MS/MS spectrum 
from the lithiated 14mer of dihydroxyl end capped poly(ethylene glycol).  Predicted fragment 
ions are detailed above (left) the spectrum. 
 
Williams et al also implemented this software to aid the interpretation/annotation of 
desorption electrospray ionisation (DESI) Q-ToF MS/MS data (Williams, Hilton et al. 
2007).  Mass spectrometric sampling of DESI-generated ions is rapid and requires a 
minimal amount of sample preparation.  These properties coupled with the automated 
interpretation software allowed experiments and data analysis to be performed within 
minutes.    
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6.8.3.6 Gas-phase conformations 
It is believed that the structure of a synthetic polymer can be related to its performance.  
Structural changes can affect the physical and mechanical properties, thermal 
degradation and impact resistance of a polymeric material (Mark, Ngai et al. 2004).  The 
development of IM-MS has enabled the gas-phase conformation of synthetic polymers 
to be investigated.  IM-MS and molecular mechanics/dynamics have been used to probe 
the tertiary structure and gas-phase conformation of various polymer systems (Gidden, 
Bowers et al. 2002; Gidden, Jackson et al. 1999; Gidden, Wyttenbach et al. 1999; 
Gidden, Wyttenbach et al. 2000; von Helden, Wyttenbach et al. 1995a).  Initial studies 
characterised PEG coordination to the alkali cation sodium.  von Helden and co-workers 
demonstrated that singly charged PEG oligomers could adopt a compact structure (von 
Helden, Wyttenbach et al. 1995a; von Helden, Wyttenbach et al. 1995b).  This was 
because of the preferred crown ether coordination geometry to the cation.  It was 
observed that seven oxygen atoms in the nonamer structure could coordinate to one Na+ 
ion; five oxygen atoms coordinate in the same plane, one coordinates above the Na+ ion 
and the other coordinates below the Na+ ion (von Helden, Wyttenbach et al. 1995a).  
This binding mechanism completely encases the cation.  Further investigations showed 
that the cross-section of PEG increased linearly with oligomer size; a common 
observation for structurally related ions (Gidden, Wyttenbach et al. 2000; von Helden, 
Wyttenbach et al. 1995b).  Two different polyethers, PPG and poly(tetramethylene 
glycol) PTMEG, were used to study the effect of repeat unit composition, flexibility and 
chain length on the gas-phase conformation.  It was observed that all sodiated polyethers 
had similar structural features with each polymer coordinating to the cation via its 
oxygen atoms.  The differences in repeat unit length and flexibility did, however, create 
structural changes between each polyether (see Figure 6.8).  It was observed that the 
conformation of the polymer became more flexible as the temperature was increased.  
This observation was rationalised by molecular dynamic stimulations which showed that 
certain sections of the oligomer, that were not coordinated to the Na+ ion, could unravel 
(Gidden, Wyttenbach et al. 2000).   
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The gas phase conformation of other polymer classes has been studied and found to 
differ from the polyethers (Gidden, Bowers et al. 2002; Gidden, Jackson et al. 1999).  
Oxygen atoms within PMMA can coordinate to the cation to form a horse-shoe 
geometry.  Temperature dependence studies for PMMA showed a minimal increase in 
the cross-section of the oligomers.  This suggests that the cation can act as an anchor to 
limit the thermal motion of the coordinating oligomers.  Poly(styrene) conformational 
studies showed that the gas phase conformation is not dependent on the metal cation 
used.  Theoretical modelling of PS predicted the conformation to be quasi-linear in 
structure with the metal cation sandwiched between two central phenyl groups (see 
Figure 6.9c).  The collisional cross-sections of the theoretical model was in good 
agreement with experimental data (Gidden, Bowers et al. 2002).  Figure 6.9 shows a 
comparison of the coordination geometry to the Na+ cation and suggests that all three 
polymer classes studied (polyethers, polyacrylates and polystyrenes) have significantly 
different binding modes and coordination geometries.  These differences in gas-phase 
conformation could enable IM-MS to characterise different polymer systems by their 
rotationally-averaged cross-section as well as their m/z ratio.   
 
Figure 6.8:  Lowest energy molecular model structures for (a) ([PEG14 + Na]+) (b) ([PPG14 + 
Na]+) and (c) ([PTMEG14 + Na]+).  Carbon atoms are shown in grey, oxygen atoms red and 
sodium yellow.  The methyl group carbons in PPG are represented by X.  Taken from (Gidden, 
Wyttenbach et al. 2000). 
a b c
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Figure 6.9:  Lowest energy molecular model structures of cation coordination to synthetic 
polymers. (All hydrogen atoms have been omitted for clarity).  (a) PEG, carbon atoms are 
shown in grey, oxygen red, sodium yellow (Gidden, Wyttenbach et al. 2000).  (b) PMMA, 
carbon atoms are shown in grey, oxygen atoms are shown with dots, sodium labelled (Gidden, 
Jackson et al. 1999).  (c) PS, carbon atoms are shown in grey, hydrogen atoms are white, sodium 
cation is black (Gidden, Bowers et al. 2002). 
 
 
a b
c
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6.4 Aims 
The aim of this work is to develop and improve methods for structural characterisation 
of oligomeric and monomeric mixtures.  In particular, IM-MS and IM-MS/MS have 
been used as a rapid, information rich method of obtaining detailed structural 
information.   
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7.1 Introduction.  
Mass spectrometry is gaining in popularity as a technique that can be used to investigate 
the structure of polymers in the gas-phase.  An analytical challenge is introduced when 
MS is used to analyse polymers containing oligomers of differing structures, but 
isobaric molecular weights.  Polymer systems with oligomers of the same empirical 
formulae, that have different structures, cannot be easily differentiated by direct MS 
analysis without introducing a time consuming chromatographic step.  High resolution 
MS is required to differentiate between oligomers of the same nominal molecular 
weight, but differing empirical formulae.  Conventional MS resolution is defined as 
(m/∆m) at a certain m/z ratio with the value calculated at FWHM of the peak.  
Quadrupole mass spectrometers can reach unit mass resolution (up to approximately 
3000 FWHM), ToF analysers can exceed 12,000, Orbitraps have a resolving power of 
100,000 and FT-ICR mass spectrometers can have a resolving power of 1,000,000 or 
larger (Alber, Marshall et al. 1993; Kind and Fiehn 2006). 
 
When conducting MS/MS experiments, consideration should be given to the resolution 
under which the precursor ion has been selected, which form of activation has occurred, 
and the resolution at which the product ion spectrum has been acquired.  MS/MS 
experiments can either take place in space (Q-ToF, ToF-ToF, QQQ) or in time (Iontrap, 
Orbitrap, FT-ICR-MS).  The resolution available to select a precursor ion is normally 
much lower than that of the detecting analyser.  Commercial triple quadrupole or Q-ToF 
instruments have the ability to select ions at unit mass resolution over the mass range of 
the quadrupole.  In ToF-ToF instruments precursor ion resolution can be as low as ± 2.5 
Da, however, when post source decay experiments are used the precursor ion window 
can increase to 10 Da or more (Lin, Campbell et al. 2003).  In contrast, hybrid 
instruments with a magnetic sector device as the first analyser such as sector oa-ToF or 
four sector instruments were capable of precursor resolutions of > 10,000 FWHM.  
These machines are no longer widely in use because of cost, ease of use and other 
performance limitations.  Many modern instruments are capable of product ion 
resolutions in the tens of thousands, or in the case of FT-ICR-MS > 1 million; the 
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precursor ion selection does, however, not match this performance (Alber, Marshall et 
al. 1993).  Trapping technologies such as FT-ICR-MS instruments can rely on ion 
ejection approaches to select ions for their MS/MS experiments.  With FT-ICR-MS 
instrumentation, precursor ion selection prior to MS/MS experiments can be carried out 
in two main ways.  For example, ions can be selected for subsequent ion activation 
within the FT-ICR-MS instrument by means of an additional analyser such as a 
quadrupole or an ion trap device.  The capability of these technologies to resolve 
precursor ions rarely exceeds unit mass resolution.  Ions may also be selected for 
subsequent activation within the FT-ICR-MS cell itself by means of stored waveform 
inverse Fourier transform (SWIFT) or pulse shaping.  Routine, high sensitivity, 
precursor ion selection using these methods is again limited to unit mass precursor ion 
resolution.  More specialised non-routine experiments have been used, which 
demonstrate higher precursor ion resolution with values up to 20,000 for SWIFT and 
50,000 in correlated sweep excitation (COSE) experiments (Heck and Derrick 1997).  In 
FT-ICR mass spectrometry, the parent ion can be mass selectively trapped in the cell by 
ejecting all ions with different m/z values using appropriate RF ejection fields.  The 
mass resolution by FT-ICR parent ion selection is lower than the resolution at the 
detection stage of a FT-ICR mass spectrometer.  This is because parent ions can be 
unintentionally excited and/or ejected by an RF frequency (off-resonance) used to eject 
all other ions from the cell.  The SWIFT technique can minimise the unintentional off-
resonance effects by providing an excitation magnitude spectrum of a desired, “nearly” 
arbitrary, shape.  This reduces the amount of unintentional excitation the parent ion 
experiences (Heck and Derrick 1997).   
 
For some MS/MS experiments it is necessary to select more than one precursor and use 
the power of the analyser to characterise the mixture from the product ion spectrum (or 
further MS/MS experiments).  Unit mass precursor ion selection is not sufficient to 
select pure components for subsequent characterisation of complex mixtures of the type 
described here.  The potential of ion mobility has been evaluated for the shape-directed 
selection of unique precursor ions in a complex mixture. 
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The combination of ESI with ion mobility and MS/MS, in the same experiment, was 
used to generate structural information on polyethers, specifically poly(ethylene glycol) 
(PEG).  Separation of PEGs with the same nominal m/z ratio but differing structure was 
possible by means of ion mobility.  This allowed IM-MS/MS data to be obtained from 
individual components, in a mixture, with the same nominal m/z.  The MS/MS data 
obtained allowed structural identification of the separate components.  Separation of an 
isobaric polyether mixture by means of GPC coupled on-line to a NMR detector has also 
been demonstrated.   
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7.2 Results and Discussion. 
The polyether mixtures studied were di-hydroxyl end capped poly(ethylene glycol) 
(PEG) 1000 (1), PEG mono-oleate (2), stearyl alcohol initiated PEG (3) and PEG bis(2-
ethyl hexanoate) (4).  NMR data from all four compounds indicated that the structures 
of the polymers were those shown in Figure 7.1.  For all materials and methods please 
refer to Chapter 3. 
 
 
Figure 7.1:  Structures of di-hydroxyl end capped poly(ethylene glycol) (PEG) 1000 (1), PEG 
mono-oleate (2), stearyl alcohol initiated PEG (3) and PEG bis(2-ethyl hexanoate) (4). 
 
7.2.1 GPC-NMR 
It has been demonstrated that GPC coupled on-line to a NMR detector can separate 
complex synthetic polymer mixtures (Robertson, Heron et al. 2004).  Previous studies 
have employed this method to separate polymer formulations (Robertson, Heron et al. 
2004), to distinguish tacticity distributions of pure and mixed stereocomplexes (Hatada, 
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Ute et al. 1990; Ute, Niimi et al. 2001) and to characterise the structure and molecular 
mass of polymers in one experiment (Hatada, Ute et al. 1990; Hatada, Ute et al. 1989; 
Hatada, Ute et al. 1988; Kramer, Pasch et al. 1999; Ute, Niimi et al. 1999).  It is 
believed GPC-NMR can be an invaluable tool for the deformulation of complex 
mixtures.  Here GPC-NMR has been used to characterise a mixture of isobaric polyether 
samples and the results have been compared to IM-MS data. 
 
Figure 7.2 shows a GPC-1H NMR contour plot of stearyl alcohol initiated PEG (Mn 711) 
(green) overlaid with the contour plot of PEG bis(2-ethyl hexanoate) (Mn 650) (yellow).  
The y-axis shows the retention time, in seconds, with each graduation on the scale 
corresponding to four NMR data scans.  The x-axis shows the chemical shift of the 
compounds.  The proton density curve (y’-axis) is equivalent to the GPC chromatogram.  
The magnitude of the curve, relative to the baseline, is representative of the number of 
protons in the free induction decay (FID) at a particular retention time.  A 1D slice from 
the apex of each curve is shown at the top of the contour plot and the enlarged 1H NMR 
spectra of stearyl alcohol initiated PEG and PEG bis(2-ethyl hexanoate) are shown 
above and below the contour plot respectively.  The contour plot shows a continuous 
signal at 1.5 ppm for both the stearyl alcohol initiated PEG and PEG bis(2-ethyl 
hexanoate).  The presence of this signal is because of water in the CDCl3 solvent.  GPC 
separates compounds according to their size and shape.  In general, larger molecular 
weight compounds elute before smaller compounds.  This suggests that stearyl alcohol 
initiated PEG with a Mn 711 should elute before PEG bis(2-ethyl hexanoate) (Mn 650).  
The opposite is observed in Figure 7.2.  The retention time of the individual apexes is 
110 s for PEG bis(2-ethyl hexanoate) and 116 s for stearyl alcohol initiated PEG.  The 
reversed elution order, to that of the expected, could be because of 
hydrophobic/hydrophilic effects in the solution phase.  The stearyl alcohol initiated PEG 
has a hydroxyl end group.  This hydroxyl group could interact with water molecules in 
the CDCl3 solvent thereby prolonging its retention time in the GPC column.   
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Figure 7.2: GPC- H NMR contour plot of stearyl alcohol initiated PEG (Mn 711) (green) overlaid with the contour plot of
PEG bis(2-ethyl hexanoate) (Mn 650) (yellow). H NMR spectra of stearyl alcohol initiated PEG and PEG bis(2-ethyl hexanoate)
are shown above and below the contour plot respectively.
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[Insert Figure 7.2] 
Figure 7.2:  GPC-1H NMR contour plot of stearyl alcohol initiated PEG (Mn 711) (green) 
overlaid with the contour plot of PEG bis(2-ethyl hexanoate) (Mn 650) (yellow).  
1H NMR 
spectra of stearyl alcohol initiated PEG and PEG bis(2-ethyl hexanoate) are shown above and 
below the contour plot respectively.   
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The shape of the polymers will also have an effect on the elution order.  In the solution 
phase, PEG bis(2-ethyl hexanoate) may be more globular in structure than the stearyl 
alcohol initiated PEG.  This would also account for a faster elution time.  Molecular 
modelling would be required to verify this.   
 
NMR spectroscopy data are a representation of the average structure in solution for a 
polymeric mixture.  Online GPC-NMR can, however, analyse individual conformations 
in the solution-phase.  The proton density curve shows the molecular weight distribution 
of the individual polymer systems.  Characterisation by means of NMR spectroscopy 
represents the average number of repeat units in the polymer system.  Each data point on 
the GPC-NMR proton density curve corresponds to a 1D 1H NMR spectrum.  These 
data can be manipulated and the molecular weight distribution of the individual polymer 
systems can be calculated.  Figure 7.3 shows the integrated 1D 1H NMR spectrum of 
stearyl alcohol initiated PEG extracted from retention time 116 s (apex of curve).  From 
the integrated spectrum, the number of repeat units and the length of the stearyl alcohol 
initiator can be quantified.  The signal at 0.85 ppm corresponds to the three protons in 
the terminal methyl group from the stearyl alcohol initiator (labelled a in Figure 7.2 
(top) and Figure 7.3).  All other integrals on the spectrum are measured with respect to 
this methyl group.  The chemical shift signal ranging from 3.5-3.8 ppm corresponds to 
the four protons per ethylene oxide repeat unit (labelled d) (see Figure 7.3).  The 
number of repeat units can be calculated from dividing the integral value of d by the 
number of protons contributing to this signal – four.  An example calculation is shown 
in Figure 7.3.  The number of repeat units (n) calculated from 1D 1H NMR spectra, 
shown in Figure 7.2, for stearyl alcohol initiated PEG is n=10 and n=8 for PEG bis(2-
ethyl hexanoate).  The stearyl alcohol initiated PEG proton density curve represents a 
molecular weight distribution of n=1 to n=23 (inclusive) and the proton density curve 
for PEG bis(2-ethyl hexanoate) represents a molecular weight distribution of n=1 to 
n=21.  These molecular weight distributions are in good agreement with MALDI-MS 
data (not shown).   
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Figure 7.3:  1H NMR spectrum of stearyl alcohol initiated PEG.  Insert:  Example of how to 
calculate number of repeat units. 
 
The overlaid GPC-1H NMR contour plots of stearyl alcohol initiated PEG and PEG 
bis(2-ethyl hexanoate) are very similar (see Figure 7.2).  The major differences between 
the plots are the additional chemical shift signals at 2.25 ppm and 4.2 ppm for PEG 
bis(2-ethyl hexanoate) (labelled e and h respectively Figure 7.2 (bottom)).  The retention 
times and peak width of the proton density curve are similar.  The apex of the individual 
polymer systems are separated by a 6 s retention time difference.  Figure 7.4 shows the 
GPC-1H NMR contour plot of a mixture of stearyl alcohol initiated PEG and PEG 
bis(2ethyl hexanoate).  The presence of the chemical shift signals at 2.25 ppm and 4.2 
ppm, and the signal at 3.4 ppm suggests that PEG bis(2-ethyl hexanoate) and stearyl 
alcohol initiated PEG are present in the mixture respectively.  The proton density curve 
contains one maximum.  This suggests that the PEG samples are too similar in mass, 
size and shape to be separated by means of GPC.  van Gorken and co-workers showed 
that GPC-NMR with insufficient chromatographic separation could still be used to 
characterise a complex polymer mixture (Kitayama and Ute 2006; Van Gorkom and 
Hancewicz 1998).  They demonstrated that the GPC-NMR data could be manipulated by 
means of multivariate curve resolution and that this technique could extract the 
WEGRH001_PROTON-3.esp
4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
liz
e
d
In
te
n
si
ty
3.0032.592.112.1841.34
N
o
rm
a
lis
e
d
 in
te
n
s
ity
Chemical Shift ppm
a
a
b c d
b
c
d
n
CH2 CH2 CH2 O CH2CH2O HCH3
17
b
Calculating number of repeat units (n)
n = 
         4
Example:
When d = 41 and c = 2
n = 
           4
n = 
       4
n= 9.75
(d -c)
(41 - 2)
39
n ~ 10
 245 
 
individual components of the mixture according to their proton intensity profiles.  Their 
data did, however, show significantly better separation than that observed in Figure 7.4.  
The data shown here was not subject to multivariate analysis. 
 
 
Figure 7.4:  GPC-1H NMR contour plot of a mixture of stearyl alcohol initiated PEG and PEG 
bis(2-ethyl hexanoate).   
 
Figure 7.5 shows a GPC-1H NMR contour plot of PEG 1000 (Mn 1000) (yellow) 
overlaid with the contour plot of PEG mono-oleate (Mn 860) (green).  The y-axis shows 
the retention time with each graduation on the scale corresponding to four NMR data 
scans.  The x-axis shows the chemical shift of the compounds.  The proton density curve 
(y’-axis) is equivalent to the GPC chromatogram.  A 1D slice from the apex of each 
curve is shown at the top of the contour plot and the enlarged 1H NMR PEG mono-
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oleate and PEG 1000 are shown above and below the contour plot respectively.  The 
chemical signal at ~1.5 ppm in both the PEG 1000 and PEG mono-oleate contour plot is 
because of water present in the CDCl3 solvent (similar to Figure 7.2).  The proton 
density curve of the two polymer systems shows that PEG mono-oleate has a shorter 
apex of distribution (47 s) compared to PEG 1000 (50 s).  This elution order suggests 
that PEG mono-oleate is larger, on average, than PEG 1000.  The prolonged retention 
time of chemical signals on the contour plot and the relative width of the baseline in the 
proton density curve also indicate that PEG 1000 has a lower polydispersity than PEG 
mono-oleate.  This observation was confirmed by MALDI analysis (data not shown).  
The reversed elution order of stearyl alcohol initiated PEG and PEG bis(2-ethyl 
hexanoate) was proposed to be because of hydrophobic/hydrophilic effects in the 
solution phase.  These same hydroxyl group:water interactions could occur in both the 
PEG 1000 and PEG mono-oleate samples, however, because both of these compounds 
contain a free hydroxyl end group the effect of the hydrophilic interactions is assumed to 
be equivalent.  It was demonstrated that the mixture of stearyl alcohol initiated PEG and 
PEG bis(2-ethyl hexanoate) could not be separated by GPC-NMR despite a 6 s 
difference in their average proton density curve retention times (see Figure 7.4).  There 
is a 3 s difference in the retention time between the proton density curve of PEG 1000 
and PEG mono-oleate.  The GPC-NMR proton density curve of these compounds 
showed one peak maximum (data not shown).  This suggests that GPC-NMR has 
insufficient resolution, in this case, to separate the mixture of isobaric polymer systems 
into their individual components.    
 
In contrast to NMR and GPC-NMR, IM-MS has the advantage that it can analyse 
individual polymer oligomer conformations in the gas-phase as well as the overall 
average structure.  This ability to select oligomers may aid the separation and 
identification of the individual components in an isobaric polymer mixture. 
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[Insert Figure 7.5] 
Figure 7.5:  GPC-1H NMR contour plot of PEG 1000 (Mn 1000) (yellow) overlaid with the 
contour plot of PEG mono-oleate (Mn 860) (green).  
1H NMR PEG mono-oleate and PEG 1000 
are shown above and below the contour plot respectively. 
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7.2.2 Mass Spectrometry 
Oligomers of 1 and 2 have the same nominal m/z ratio but contain a different number of 
moles of ethylene oxide (EO) units.  An oligomer, for example, of 1 with 12 repeat units 
(n) of EO has the same nominal molecular weight as 2 with 6 repeat units (n) of 
monomer.  Oligomers of 3 and 4 have the same nominal m/z ratio and also have the 
same number of moles of EO units.  MS/MS data have been shown to provide structural 
information that can aid identification of unknown end groups in PEG (Jackson, 
Scrivens et al. 2000; Lattimer 1992a; Lattimer 1992b; Lattimer 1994; Lattimer, Munster 
et al. 1989).  This MS/MS methodology will not help for these mixtures of polyethers as 
the resolution of the quadrupole, ion trap, sector or ToF analyser typically used for 
precursor ion selection is not able to resolve the oligomers with the same nominal m/z 
ratio.  The combination of IM with MS/MS was employed to both provide the possible 
extra resolving power of the former with the possibility of structural identification 
and/or differentiation from the latter.  It was hoped that the isobaric oligomers could be 
separated using the difference in their rotationally-averaged cross-sections.  
 
All individual polyether samples were characterised by means of 1H and 13C NMR and 
MALDI-MS (data not shown) prior to IM-MS/MS analysis.  This confirmed that the 
samples had the expected structures (1-4,see Figure 7.1) and were of high purity.  A 
mixture of PEG 1000 and PEG mono-oleate was directly infused by means of ESI into 
the Synapt mass spectrometer.  Figure 7.6 shows the full separation of two isobaric 
oligomers (m/z 553) by ion mobility.  The IM-MS/MS product ion spectra from the 
lithiated oligomer, from PEG 1000 ([1 + Li]+) containing 12 moles of EO and PEG 
mono-oleate ([2 + Li]+) containing 6 moles of EO, are also displayed.  These three sets 
of data were all derived in the same experiment.  There is a clear differentiation of the 
two isobaric species, as observed from the IM arrival time distribution.  The IM-MS/MS 
data obtained from the separated components in the mixture enabled end group analysis 
and confirmation of the structure of the two oligomeric species.  The MS resolution 
required to separate these two oligomers (differing by m/z 0.0880 for [1 + Li]+ at m/z 
553.3411 and [2 + Li]+ at m/z 553.4292) is approximately 6,300.  This would not be 
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possible using standard quadrupoles for the first mass spectrometer in a MS/MS 
instrument, but the IM capability used here allows separation for structural analysis of 
this mixture of polyethers.  Good separation (but with slightly lower resolution of 
isobaric oligomers) was also obtained for higher molecular weight oligomers in this 
mixture of samples and the concurrent MS/MS data were used to differentiate between 1 
and 2.  The resolving power of IM-MS/MS is insufficient to resolve the higher 
molecular weight oligomers as shown in Figure 7.7.  The oligomers of [2 + Li]+, which 
are isobaric with [1 + Li]+, appear to have significantly larger rotationally averaged 
cross-sections.  This is probably because of the presence of the long oleate chain in the 
former oligomers, but modelling of the structures would be required to confirm this.  It 
is expected that cross-sections that are greater than 5% in difference would be resolved 
by the IM approach (Gidden, Wyttenbach et al. 2000). 
 
Lattimer initially demonstrated that MS/MS could be used to generate structural 
information from polymers such as PEG (Lattimer 1992a; Lattimer 1994).  Lattimer and 
coworkers and Jackson et al. have proposed mechanisms to account for the fragment 
ions generated, when lithium is used as the cation, in polyglycol spectra (Jackson, 
Scrivens et al. 2000; Lattimer 1992a; Lattimer 1992b; Lattimer 1994; Lattimer, Munster 
et al. 1989).  Four dominant series of fragment ions, notated An, Bn, Cn and Dn, were 
proposed to be generated from CID of polyglycols.  Jackson et al. postulated that, when 
observing the An, Bn and Cn series, fragments at the higher m/z are the most structurally 
informative for the generation of end group information (Jackson, Green et al. 2006).  
Additional fragment ions were also noted to be important for end group identification in 
the case of some functionalised polyglycols.  Similar fragmentation is noted for the 
poly(ethylene glycol)s studied here, with end group information proposed to be gleaned 
from peaks of the An, Bn and Cn series, plus initiator fragments from the oleate chain of 
2, at higher mass-to-charge ratios (selected peaks are labelled in Figure 7.6, following 
the notation proposed by Jackson et al. (Jackson, Green et al. 2006)) 
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Figure 7.6:  Arrival time distribution (bottom) of m/z 553 from a mixture of PEG 1000 and PEG 
mono-oleate and IM-MS/MS spectra (top) from the two peaks noted.  Peaks in the IM-MS/MS 
spectra are partially annotated as described previously by Jackson et al. (Jackson, Green et al. 
2006).  IM-MS/MS spectra are very similar to those noted from MS/MS data (without ion 
mobility separation) of the same oligomers, obtained from PEG 1000 and PEG mono-oleate 
separately (see Figure 7.10). 
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Figure 7.7:  Arrival time distribution (bottom) of m/z 817 from a mixture of PEG 1000 and PEG 
mono-oleate and IM-MS/MS spectra (top) from the two peaks noted.  Peaks in IM-MS/MS 
spectra are partially annotated as described previously by Jackson et al.8.  IM-MS/MS spectra 
are very similar to those noted from MS/MS data (without ion mobility separation) of the same 
oligomers, obtained from PEG 1000 and PEG mono-oleate. 
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Figure 7.8 shows the full separation of two isobaric oligomeric species (m/z 497), from 
stearyl alcohol initiated PEG and PEG bis(2-ethyl hexanoate) by ion mobility.  Also 
shown are the IM-MS/MS product ion spectra, which were generated in the same 
experiment, from the lithiated oligomers ([3 + Li]+ and [4 + Li]+) from stearyl alcohol 
initiated PEG and PEG bis(2-ethyl hexanoate), both of which contain 5 moles of EO.  
The arrival time distribution, combined with the IM-MS/MS, indicates that lithiated 
oligomers of PEG bis(2-ethyl hexanoate) have a more compact rotationally-averaged 
cross-section than those of the isobaric stearyl alcohol initiated PEG species.  The 
coordination to the lithium ion is likely to be stronger in PEG bis(2-ethyl hexanoate) due 
to the presence of two additional oxygen atoms when compared with stearyl alcohol 
initiated PEG.  This includes two carbonyl oxygen atoms which could show stronger 
interaction with the cation (Gidden, Wyttenbach et al. 2000; von Helden, Wyttenbach et 
al. 1995; Wyttenbach, von Helden et al. 1997).  Stearyl alcohol initiated PEG has a long 
alkyl chain from the initiating group; this may induce the  polymer to have a larger 
rotationally averaged cross-section (Robinson, Sellon et al. 2007; Ude, 
FernandezdelaMora et al. 2004).  Modelling of gas-phase oligomeric structures would 
be required to confirm this.  A MS resolution of approximately 6,800 would be required 
to fully separate lithiated pentamers of 3 and 4 (these oligomers have a difference of m/z 
0.0728 for [3 + Li]+ at m/z 497.4393 and [4 + Li]+ at m/z 497.3666).  A quadrupole 
would not be able to separate these oligomers for MS/MS experiments, but the ion 
mobility separation allows differentiation of the two oligomers.  Separation of higher 
molecular weight isobaric oligomers of 3 and 4 was also achieved, allowing end group 
identification by MS/MS, albeit with an increased overlap of the two peaks observed in 
the arrival time distribution (with increasing molecular weight of the oligomers). 
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Figure 7.8: Arrival time distribution (bottom) of m/z 497 from a mixture of stearyl alcohol 
initiated PEG and PEG bis(2-ethyl hexanoate) and IM-MS/MS spectra (top) from the two peaks 
noted.  Peaks in the IM-MS/MS spectra are partially annotated as described previously by 
Jackson et al. (Jackson, Green et al. 2006).  IM-MS/MS spectra are very similar to those noted 
from MS/MS data (without ion mobility separation) of the same oligomers, obtained from 
stearyl alcohol initiated PEG and PEG bis(2-ethyl hexanoate) separately (see Figure 7.10c and 
Figure 7.9 respectively). 
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The IM-MS/MS data obtained from the individual components in the mixture enabled 
end group analysis to be performed for the two polymers.  Fragmentation to form the 
An, Bn an Cn series of fragment ions (as partially annotated in Figure 7.8), along with 
characteristic losses of part or whole of the end groups, allows differentiation between 
the alcohol initiated PEG and the PEG di-ester.  Characteristic losses of both of the ester 
end groups, for example, is as expected from previous data from PEG (Jackson, Green 
et al. 2006).  Also, loss of the whole alkyl chain (losses of part of the stearyl chain in 
sequence are also noted), from the stearyl initiated PEG, would be expected from this 
previous work, as is noted in Figure 7.8 (see peak annotated as A’’5).  The annotation of 
fragment ion peaks is again as that proposed previously (Jackson, Green et al. 2006).  
The IM-MS/MS and ESI-MS/MS data (see Figure 7.9) shows an unusual ion differing 
by m/z 72 from the precursor ion.  This loss could correspond to C5H12 although more 
detailed work would be needed to confirm this.  The 1H and 13C NMR data, however, 
clearly indicate that 4 is the major structure of the di-ester.  Further work would be 
required to elucidate the fragmentation mechanism for this loss. 
 
ESI-MS/MS experiments were carried out for all four individual polyethers (without any 
ion mobility separation) using a standard quadrupole oa-TOF tandem mass 
spectrometer.  A comparison of the MS/MS data, with and without ion mobility 
separation, indicates that there is good agreement between the two sets of spectra (see 
Figure 7.9 and Figure 7.10).  Figure 7.10a shows a comparison of product ion spectra 
from the lithiated dodecamer of PEG 1000, acquired with IMS-MS/MS (Synapt HDMS, 
Waters, Manchester, UK) and ESI-MS/MS (Q-ToF I, Waters, Manchester, UK).  The 
data are very similar, with identical fragment ions (e.g. labelled An and Bn) observed in 
both spectra.  A slight variation in distribution is seen because of differences in 
experimental parameters (i.e. difference in collision energy and low mass cut off).  The 
similarity of both spectra validates the quality of the data obtained and the separation 
power of IMS.  This is indicative of full separation of the oligomers in the ion mobility 
cell and that good quality MS/MS data can be obtained using IM-MS/MS experiments 
(that enables end group information to be obtained). 
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Figure 7.9:  A comparison of product ion spectra from the lithiated pentamer of PEG bis(2-ethyl 
hexanoate), acquired with IMS-MS/MS (Synapt HDMS, Waters, Manchester, UK) and ESI-
MS/MS (Q-ToF I, Waters, Manchester, UK).  Characteristic fragmentation of di-esters is 
observed, with a partial loss of the ester end group (-C5H12) and the entire end group (A5) seen.  
The ion annotated as A5 - C5H12 indicates the loss of one ester end group with the partial loss of 
the other, whilst Aa5 identifies loss of both end groups. 
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Figure 7.10:  (a) A comparison of product ion spectra from the lithiated dodecamer of PEG 
1000, acquired with IMS-MS/MS (Synapt HDMS, Waters, Manchester, UK) and ESI-MS/MS 
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(Q-ToF I, Waters, Manchester, UK).  The data are very similar, with identical fragment ions 
(e.g. labelled An and Bn) observed in both spectra.  (b) A comparison of product ion spectra 
from the lithiated hexamer of PEG mono-oleate, acquired with IMS-MS/MS (Synapt HDMS, 
Waters, Manchester, UK) and ESI-MS/MS (Q-ToF I, Waters, Manchester, UK).  The same 
fragmentation series (e.g. An and Bn series) are observed in both spectra indicating the good 
quality of the data obtained and the separation power of IMS.  (c) A comparison of product ion 
spectra from the lithiated pentamer of stearyl alcohol initiated PEG, acquired with IMS-MS/MS 
(Synapt HDMS, Waters, Manchester, UK) and ESI-MS/MS (Q-ToF I, Waters, Manchester, 
UK).  Characteristic fragmentation to form the An and Bn series, and the loss of the whole alkyl 
chain (losses of part of the stearyl chain in sequence are also observed) from the stearyl initiated 
PEG is noted. 
 
7.2.3 IM-MS Poly(propylene glycol) 
The poly(propylene glycol) (PPG) mixtures studied were PPG mono butyl ether (5) and 
PPG bis (2-amino propyl ether) (6).  NMR data from the compounds indicated that the 
structures of the polymers were those shown in Figure 7.11.   
 
 
Figure 7.11:  Structures of poly(propylene glycol) (PPG) mono butyl ether (5) and PPG bis(2-
amino propyl ether) (6). 
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Oligomers of 5 and 6 have the same nominal m/z ratio and contain the same number of 
moles of propylene oxide (PO) units.  For example, an oligomer of 5 with 3 repeat units 
(n) of PO has the same nominal molecular weight as 6 with the same number of repeat 
units of monomer.  Figure 7.12 shows the lithiated mass spectra of PPG mono butyl 
ether, PPG bis (2-amino propyl ether) and a mixture of both polymer systems.  The ion 
series labelled with dots, in the PPG mono butyl ether mass spectrum, are the sodiated 
oligomers and have not been considered in this investigation.  In comparison to PPG bis 
(2-amino propyl ether), PPG mono butyl ether has a narrow charge state envelope 
distribution m/z range.  The number of isobaric oligomers present in the mixture is 
therefore limited to the lower m/z range.  The ATD at m/z 255 are inset in the respective 
mass spectra in Figure 7.12.  The dotted and dashed lines represent the apex of each 
ATD peak.  The ATD of the individual polymers are separated by two scan numbers.  
This suggests that PPG mono butyl ether and PPG bis (2-amino propyl ether) have a 
similar rotationally averaged cross-section.  The ATD for the PPG mono butyl ether and 
PPG bis (2-amino propyl ether) mixture cannot distinguish between the isobaric 
oligomers.  The MS resolution required to separate these two oligomers (differing by 
m/z 0.0368 for [5 + Li]+ at m/z 255.2984 and [6 + Li]+ at m/z 255.2616) is approximately 
7,000.  A quadrupole would not be able to separate these oligomers for MS/MS 
experiments, and ion mobility cannot aid the separation which would allow 
differentiation of the two oligomers.  Previous ion mobility studies have shown isomers 
with a collision cross-section that differ by 5-10% appear as a shoulder or distinct 
separate peak in the ATDs (Gidden, Jackson et al. 1999; Gidden, Wyttenbach et al. 
1999; Gidden, Wyttenbach et al. 2000; von Helden, Hsu et al. 1991; von Helden, 
Wyttenbach et al. 1995).  This suggests that the cross-section of PPG mono butyl ether 
and PPG bis (2-amino propyl ether) differ by less than 5%.   
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Figure 7.12:  A comparison of lithiated mass spectra of polypropylene glycol (PPG) mono butyl ether and PPG bis(2-amino propyl ether).  Blue 
highlighted region indicates 255 m/z (a) Mass spectrum of lithiated PPG mono butyl ether and PPG bis(2-amino propyl ether) mixture.  Inset 
arrival time distribution (ATD) for 255 m/z.  (b) Mass spectrum of lithiated PPG mono butyl ether, series of peaks marked with dots are the 
sodiated oligomers.  Inset ATD for 255 m/z.  (c) Mass spectrum of lithiated PPG bis(2-amino propyl ether).  Inset ATD for 255 m/z. 
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7.2.4 GPC-NMR vs IM-MS/MS 
GPC-NMR and IM-MS/MS were used to separate isobaric polyether mixtures of 
PEG 1000 and PEG mono-oleate, and stearyl alcohol initiated PEG mixed with PEG 
bis(2ethyl hexanoate).  The elution order of PEG 1000 and PEG mono-oleate were 
the same when characterised by means of GPC-NMR and IMS-MS/MS.  It was 
observed that the elution order of stearyl alcohol initiated PEG and PEG bis(2-ethyl 
hexanoate) differed between the two techniques.  IMS-MS suggested that oligomers 
of PEG bis(2-ethyl hexanoate) have a more compact rotationally-averaged cross-
section than those of the isobaric stearyl alcohol initiated PEG species.  In contrast, 
the elution order of GPC-NMR implies that PEG bis(2-ethyl hexanoate) is larger 
than stearyl alcohol initiated PEG.  A possible explanation for these contradicting 
observations is that the GPC-NMR elution order could be affected by 
hydrophobic/hydrophilic interactions between the polymer and solvent.  It was 
postulated that the hydroxyl end group in stearyl alcohol initiated PEG could interact 
with water molecules in the CDCl3 solvent which could prolong its retention time in 
the GPC column.  The experiment could be repeated with a different solvent system 
to investigate if this phenomena was solvent related.  It was observed that IM-MS 
had a greater separation power of both isobaric PEG mixtures than GPC-NMR.  This 
is because IM-MS can analyse individual polymer oligomer conformations in the 
gas-phase as well as the overall average structure.  This study suggests that IM-
MS/MS would be the preferred technology to successfully separate and identify 
synthetic isobaric polyether systems; especially when taking speed and sensitivity 
into account.   
 
7.3 Conclusions. 
GPC-NMR has been used to study two mixtures of synthetic isobaric polyether 
systems, PEG 1000 mixed with PEG mono-oleate, and stearyl alcohol initiated PEG 
with PEG bis(2-ethyl hexanoate).  It was observed that the overall mass, size and 
shape of the isobaric mixtures could not be separated by GPC-NMR.  Manipulation 
of individual 1H NMR spectra allowed the number of repeat units in the polymer to 
be calculated.  Previous studies have demonstrated that this technique can aid the 
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deformulation of complex polymer systems (Robertson, Heron et al. 2004), 
however, this study has shown it cannot separate isobaric mixtures. 
 
ESI-IM-MS/MS has been used to study three mixtures of synthetic polymers: PEG 
1000 and PEG mono-oleate (with different concentrations of EO in isobaric 
oligomers), stearyl alcohol initiated PEG and PEG bis(2-ethyl hexanoate) (isobaric 
oligomers containing the same number of moles of EO), plus PPG mono butyl ether 
and PPG bis (2-amino propyl ether) (isobaric oligomers containing the same number 
of moles of PO).  The effective use of ion mobility as a high resolution separation 
device for precursor ions, in MS/MS experiments, has allowed the clear 
differentiation of isobaric polyether species.  The resolving power of IM-MS/MS is 
insufficient to resolve the higher molecular weight oligomers with limited separation 
observed with precursor ion resolution > 10,000.  ESI-MS/MS alone was not able to 
significantly resolve these isobaric species, due to the inherent limitations in 
precursor ion resolution of the quadrupole analyser used.  It has been observed that 
the MS/MS data with and without ion mobility separation are in good agreement.  
This indicates that oligomers can be fully separated by ion mobility.  The MS/MS 
data from the resolved oligomers enabled full structural characterisation, with 
different end groups being identified.  The fragment ion peaks observed are similar 
to those proposed previously by Lattimer (Lattimer 1992a; Lattimer 1994)  and 
Jackson et al. (Jackson, Green et al. 2006).  ESI-IM provides an extra dimension of 
fast, sensitive, gas phase, ion separation enabling isobaric synthetic polymers to be 
differentiated by their size, shape and charge (Trimpin, Plasencia et al. 2007).  The 
approach is still in the early stages of development and it is likely that further 
improvements in resolution of the technique will extend the approach into a fast, 
sensitive, information-rich method for studying complex polymer mixtures.  This 
will help to quickly and effectively identify other isobaric synthetic polymer species.    
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Chapter 8 
Conclusions and Future Work 
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Travelling-wave IM-MS in conjunction with other biophysical techniques was used 
to characterise the structure of various prion proteins and synthetic polymer systems.   
 
8.1 Prion Proteins 
Recombinant prion proteins were expressed in E. coli and purified prior to their 
structural analysis.  Truncated conformational isoforms, representative of PrPC and 
PrPSc, which had the same nominal m/z ratio but differing secondary structure, were 
distinguished between by means of IM-MS.  The differences in ATD and estimated 
cross-section were more prominent in the mouse PrP species than the Syrian hamster 
PrP.  A greater difference was observed between the two conformational isoforms at 
acidic pH than at pH 7.0.   
 
The structure of the full-length prion protein was probed by means of IM-MS.  A 
comparison of the estimated cross-sections of truncated prion protein constructs and 
full-length constructs suggested that the N-terminal flexible tail was associated with 
the core structure.  Computer modelled structures and their respective theoretical 
cross-sections also supported the hypothesis that the N-terminal flexible tail is 
associated with the core PrP structure. 
 
Three different full-length mammalian PrP constructs were studied by means of IM-
MS.  It was observed that all three species had similar compact conformations at the 
lower (native) charge states, whereas each species had distinctive estimated cross-
sections at the higher charge states.  It was shown that ovine PrP structure was more 
stable than the corresponding Syrian hamster and mouse PrP counterparts.  It was 
proposed that the differences in structural stability were because of key amino acid 
mutations in the PrP primary sequence.   
 
Metal binding to two different prion protein constructs was investigated.  It was 
observed that Cu2+ ions could coordinate to all histidine residues in the octarepeat 
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region in both the prion peptide and full-length protein.  It was shown that different 
stoichiometric ratios of PrP:Cu2+ resulted in a different number of Cu2+ ions 
coordinated to the octarepeat region.  The estimated cross-section of copper 
coordination to the bovine peptide suggested that different conformations were 
present at different levels of copper occupancy.  The difference in estimated cross-
section between the apo PrP peptide and copper bound counterparts was significant.  
In contrast, there was no significant different in estimated cross-section or ATDs 
between the apo full-length PrP and the copper or manganese bound species.  
Experiments suggested that copper coordination was favoured over manganese 
coordination.   
 
8.1.1  Future directions 
The field of prion protein research is vast and numerous key questions still remain 
unanswered.  The new emerging IM-MS technique could aid the study and 
understanding of the in vivo prion structure.  At present, little is known about the in 
vivo prion structure because of its complex natural environment and post-
translational modifications such as glycosylation.  In order to study the in vivo 
protein by means of IM-MS, a de-glycosylation and amplification protocol will need 
to be developed.  Although there are several hypotheses for the conversion of PrPC to 
PrPSc, the essential misfolding event has yet to be observed.  IM-MS has been used 
to investigate the key steps involved in the amyloid assembly pathway for other 
amyloidosis such as Alzheimer’s disease (Bernstein, Dupuis et al. 2009; Bernstein, 
Wyttenbach et al. 2005; Clemmer and Valentine 2009) and a plausible mechanism 
for the formation of Aβ oligomers was proposed from IM-MS data.  The amyloid 
assembly pathway for the prion protein has been investigated using size-exclusion 
chromatography (Rezaei, Eghiaian et al. 2005) but, to date, mass spectrometry 
analysis on these oligomeric states has not been published.  IM-MS could have the 
potential to define the amyloid assembly pathway and may also be used to study the 
higher order oligomers which form the symptomatic fibrillar structures in the brain.   
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Chapter 4 discussed that the 1D estimated cross-section plot did not fully represent 
the ATD data.  The development of a three-dimensional contour plot would help to 
visualise the estimated cross-section data.    
8.2 Synthetic polymers 
The ion mobility device was used as a high resolution separation technique to 
distinguish between mixtures of isobaric synthetic polymers.  It was observed that 
the resolving power of IM-MS/MS is insufficient to resolve the higher molecular 
weight oligomers.  In comparison, GPC-NMR analysis of the same isobaric mixture 
could not separate the two components.  It was observed that IM-MS was better than 
GPC-NMR at separating isobaric PEG mixtures, especially when taking speed and 
sensitivity into account.   
 
8.2.1 Future directions 
Polymer chemistry is evolving.  Interest in the polymer research field is moving 
away from high-value commodity products and low tonnage specialty products such 
as PP and PEEK, to lower molecular weight materials that can be used in 
manufacturing and biomedical research.  An example of these new developments is 
the creation of a polyether copolymer that, once formed into nanospheres, can 
circulate around the body mimicking the movement of cells (Langer and Tirrell 
2004).  In contrast to natural macromolecules, the three-dimensional structure of 
synthetic polymer systems have not been characterised by means of X-ray 
crystallography or NMR spectroscopy.  IM-MS and computer modelling could be 
used to characterise the structure of these new lower molecular weight materials.  
The resulting data could suggest the three-dimensional structure of synthetic polymer 
systems and conclusions could be drawn on how these new polymeric materials can 
interact with one another and, in the case of biomedical research, how these 
materials interact with the natural ligand or cofactor.   
 
Recently, a new T-Wave device has been developed called the Synapt G2 (Waters, 
Manchester, UK) which became commercially available in December 2009.  This 
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instrument has been described as the “next generation” in IM-MS, by its 
manufacturer, and has considerable advantages over the previous Synapt instrument.  
The Synapt G2 has improved mobility resolution (upto x4 of the Synapt), a hybrid 
TDC/ADC detector and improved ToF detector resolution.  The improved T-Wave 
mobility resolution has allowed a greater separation of isobaric polymer systems (see 
Figure 8.1).  It was observed that the resolving power of IM-MS/MS (by means of 
the Synapt) was insufficient to resolve higher molecular weight oligomers in an 
isobaric PEG 1000, PEG monooleate mixture (see Figure 7.6 and 7.7).  In contrast, 
the resolving power of the Synapt G2, has allowed all isobaric oligomers in the PEG 
1000, PEG monooleate mixture to be separated, as shown in Figure 8.2.  All isobaric 
oligomers were separated by means of the Synapt G2 and had baseline resolution.  
An example of the Synapt G2 data is shown in Figure 8.1. 
 
 
Figure 8.1:  Arrival time distribution (bottom) of m/z 1126 from a mixture of PEG 1000 and 
PEG mono-oleate and IM-MS/MS spectra (top) from the two peaks noted.  Data obtained by 
means of Synapt G2 (Waters, Manchester, UK). 
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Figure 8.2:  Mobilogram showing the total separation of PEG 1000 and PEG monooleate 
oligomers.  Data obtained by means of Synapt G2 (Waters, Manchester, UK). 
 
The development of the new IM-MS device brings with it the opportunity to perform 
many novel and exciting experiments, in which both natural and synthetic 
macromolecules can be characterised.   
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